Effects	16371368	2	O
of	16371368	2	O
a	16371368	2	O
leukemia	16371368	2	O
-	16371368	2	O
associated	16371368	2	O
gain	16371368	2	O
-	16371368	2	O
of	16371368	2	O
-	16371368	2	O
function	16371368	2	O
mutation	16371368	2	O
of	16371368	2	O
SHP-2	16371368	2	O
phosphatase	16371368	2	O
on	16371368	2	O
interleukin-3	16371368	2	O
signaling	16371368	2	O
.	16371368	2	O
Mutations	16371368	2	B-Var
in	16371368	2	O
SHP-2	16371368	2	B-Gene
phosphatase	16371368	2	O
that	16371368	2	O
cause	16371368	2	O
hyperactivation	16371368	2	B-PosReg
of	16371368	2	O
its	16371368	2	O
catalytic	16371368	2	O
activity	16371368	2	O
have	16371368	2	O
been	16371368	2	O
identified	16371368	2	O
in	16371368	2	O
human	16371368	2	B-Disease
leukemias	16371368	2	I-Disease
,	16371368	2	O
particularly	16371368	2	O
juvenile	16371368	2	B-Disease
myelomonocytic	16371368	2	I-Disease
leukemia	16371368	2	I-Disease
,	16371368	2	O
which	16371368	2	O
is	16371368	2	O
characterized	16371368	2	O
by	16371368	2	O
hypersensitivity	16371368	2	O
of	16371368	2	O
myeloid	16371368	2	O
progenitor	16371368	2	O
cells	16371368	2	O
to	16371368	2	O
granulocyte	16371368	2	O
macrophage	16371368	2	O
colony	16371368	2	O
-	16371368	2	O
stimulating	16371368	2	O
factor	16371368	2	O
and	16371368	2	O
interleukin	16371368	2	O
(	16371368	2	O
IL	16371368	2	O
)	16371368	2	O
-	16371368	2	O
3	16371368	2	O
.	16371368	2	O
However	16371368	2	O
,	16371368	2	O
the	16371368	2	O
molecular	16371368	2	O
mechanisms	16371368	2	O
by	16371368	2	O
which	16371368	2	O
gain	16371368	2	O
-	16371368	2	O
of	16371368	2	O
-	16371368	2	O
function	16371368	2	O
(	16371368	2	O
GOF	16371368	2	O
)	16371368	2	O
mutations	16371368	2	O
of	16371368	2	O
SHP-2	16371368	2	O
induce	16371368	2	O
hematopoietic	16371368	2	O
malignancies	16371368	2	O
are	16371368	2	O
not	16371368	2	O
fully	16371368	2	O
understood	16371368	2	O
.	16371368	2	O
These	16371368	2	O
results	16371368	2	O
raised	16371368	2	O
the	16371368	2	O
possibility	16371368	2	O
that	16371368	2	O
SHP-2	16371368	2	O
-	16371368	2	O
associated	16371368	2	O
leukemias	16371368	2	O
are	16371368	2	O
not	16371368	2	O
solely	16371368	2	O
attributed	16371368	2	O
to	16371368	2	O
the	16371368	2	O
increased	16371368	2	O
catalytic	16371368	2	O
activity	16371368	2	O
of	16371368	2	O
GOF	16371368	2	O
mutant	16371368	2	O
SHP-2	16371368	2	O
.	16371368	2	O
GOF	16371368	2	O
mutant	16371368	2	O
SHP-2	16371368	2	O
must	16371368	2	O
have	16371368	2	O
gained	16371368	2	O
additional	16371368	2	O
capacities	16371368	2	O
.	16371368	2	O
To	16371368	2	O
test	16371368	2	O
this	16371368	2	O
possibility	16371368	2	O
,	16371368	2	O
we	16371368	2	O
investigated	16371368	2	O
effects	16371368	2	O
of	16371368	2	O
a	16371368	2	O
GOF	16371368	2	O
mutation	16371368	2	O
of	16371368	2	O
SHP-2	16371368	2	O
(	16371368	2	O
SHP-2	16371368	2	O
E76K	16371368	2	O
)	16371368	2	O
on	16371368	2	O
hematopoietic	16371368	2	O
cell	16371368	2	O
function	16371368	2	O
and	16371368	2	O
IL-3	16371368	2	O
signal	16371368	2	O
transduction	16371368	2	O
by	16371368	2	O
comparing	16371368	2	O
with	16371368	2	O
those	16371368	2	O
of	16371368	2	O
overexpressed	16371368	2	O
WT	16371368	2	O
SHP-2	16371368	2	O
.	16371368	2	O
Our	16371368	2	O
results	16371368	2	O
showed	16371368	2	O
that	16371368	2	O
SHP-2	16371368	2	B-Gene
E76K	16371368	2	B-Var
mutation	16371368	2	I-Var
caused	16371368	2	O
myeloproliferative	16371368	2	B-Disease
disease	16371368	2	I-Disease
in	16371368	2	I-Disease
mice	16371368	2	I-Disease
,	16371368	2	O
while	16371368	2	O
overexpression	16371368	2	O
of	16371368	2	O
WT	16371368	2	O
SHP-2	16371368	2	O
decreased	16371368	2	O
hematopoietic	16371368	2	O
potential	16371368	2	O
of	16371368	2	O
the	16371368	2	O
transduced	16371368	2	O
cells	16371368	2	O
in	16371368	2	O
recipient	16371368	2	O
animals	16371368	2	O
.	16371368	2	O
The	16371368	2	O
E76K	16371368	2	B-Var
mutation	16371368	2	I-Var
in	16371368	2	I-Var
the	16371368	2	I-Var
N	16371368	2	I-Var
-	16371368	2	I-Var
terminal	16371368	2	I-Var
Src	16371368	2	I-Var
homology	16371368	2	I-Var
2	16371368	2	I-Var
domain	16371368	2	I-Var
increased	16371368	2	B-PosReg
interactions	16371368	2	O
of	16371368	2	O
mutant	16371368	2	B-Var
SHP-2	16371368	2	B-Gene
with	16371368	2	O
Grb2	16371368	2	O
,	16371368	2	O
Gab2	16371368	2	O
,	16371368	2	O
and	16371368	2	O
p85	16371368	2	O
,	16371368	2	O
leading	16371368	2	O
to	16371368	2	O
hyperactivation	16371368	2	B-PosReg
of	16371368	2	O
IL-3	16371368	2	O
-	16371368	2	O
induced	16371368	2	O
Erk	16371368	2	O
and	16371368	2	O
phosphatidylinositol	16371368	2	O
3	16371368	2	O
-	16371368	2	O
kinase	16371368	2	O
(	16371368	2	O
PI3K	16371368	2	O
)	16371368	2	O
pathways	16371368	2	O
.	16371368	2	O
In	16371368	2	O
addition	16371368	2	O
,	16371368	2	O
despite	16371368	2	O
the	16371368	2	O
substantial	16371368	2	O
increase	16371368	2	B-PosReg
in	16371368	2	O
the	16371368	2	O
catalytic	16371368	2	O
activity	16371368	2	O
,	16371368	2	O
dephosphorylation	16371368	2	O
of	16371368	2	O
STAT5	16371368	2	O
by	16371368	2	O
SHP-2	16371368	2	B-Gene
E76K	16371368	2	B-Var
was	16371368	2	O
dampened	16371368	2	B-NegReg
.	16371368	2	O
Furthermore	16371368	2	O
,	16371368	2	O
catalytically	16371368	2	B-Var
inactive	16371368	2	I-Var
SHP-2	16371368	2	I-Var
E76K	16371368	2	I-Var
with	16371368	2	I-Var
an	16371368	2	I-Var
additional	16371368	2	I-Var
C459S	16371368	2	I-Var
mutation	16371368	2	I-Var
retained	16371368	2	O
the	16371368	2	O
capability	16371368	2	O
to	16371368	2	O
increase	16371368	2	B-PosReg
the	16371368	2	O
interaction	16371368	2	O
with	16371368	2	O
Gab2	16371368	2	O
and	16371368	2	O
to	16371368	2	O
enhance	16371368	2	B-PosReg
the	16371368	2	O
activation	16371368	2	O
of	16371368	2	O
the	16371368	2	O
PI3K	16371368	2	O
pathway	16371368	2	O
.	16371368	2	O
Taken	16371368	2	O
together	16371368	2	O
,	16371368	2	O
these	16371368	2	O
studies	16371368	2	O
suggest	16371368	2	O
that	16371368	2	O
in	16371368	2	O
addition	16371368	2	O
to	16371368	2	O
the	16371368	2	O
elevated	16371368	2	O
catalytic	16371368	2	O
activity	16371368	2	O
,	16371368	2	O
fundamental	16371368	2	O
changes	16371368	2	O
in	16371368	2	O
physical	16371368	2	O
and	16371368	2	O
functional	16371368	2	O
interactions	16371368	2	O
between	16371368	2	O
GOF	16371368	2	O
mutant	16371368	2	O
SHP-2	16371368	2	O
and	16371368	2	O
signaling	16371368	2	O
partners	16371368	2	O
also	16371368	2	O
play	16371368	2	O
an	16371368	2	O
important	16371368	2	O
role	16371368	2	O
in	16371368	2	O
SHP-2	16371368	2	O
-	16371368	2	O
related	16371368	2	O
leukemigenesis	16371368	2	O
.	16371368	2	O

Previously	17435236	0	O
we	17435236	0	O
have	17435236	0	O
found	17435236	0	O
that	17435236	0	O
loss	17435236	0	O
-	17435236	0	O
of	17435236	0	O
-	17435236	0	O
function	17435236	0	O
(	17435236	0	O
LOF	17435236	0	O
)	17435236	0	O
mutations	17435236	0	B-Var
in	17435236	0	O
the	17435236	0	O
Drosophila	17435236	0	B-Gene
gene	17435236	0	I-Gene
blue	17435236	0	I-Gene
cheese	17435236	0	I-Gene
(	17435236	0	O
bchs	17435236	0	O
)	17435236	0	O
lead	17435236	0	O
to	17435236	0	O
reduced	17435236	0	B-NegReg
adult	17435236	0	O
life	17435236	0	O
span	17435236	0	O
,	17435236	0	O
increased	17435236	0	B-PosReg
neuronal	17435236	0	O
death	17435236	0	O
,	17435236	0	O
and	17435236	0	O
widespread	17435236	0	O
CNS	17435236	0	O
degeneration	17435236	0	B-NegReg
that	17435236	0	O
is	17435236	0	O
associated	17435236	0	O
with	17435236	0	O
the	17435236	0	O
formation	17435236	0	O
of	17435236	0	O
ubiquitinated	17435236	0	O
-	17435236	0	O
protein	17435236	0	O
aggregates	17435236	0	O
.	17435236	0	O
We	17435236	0	O
found	17435236	0	O
that	17435236	0	O
mutations	17435236	0	O
in	17435236	0	O
select	17435236	0	O
autophagic	17435236	0	O
and	17435236	0	O
endocytic	17435236	0	O
trafficking	17435236	0	O
genes	17435236	0	O
,	17435236	0	O
defects	17435236	0	O
in	17435236	0	O
cytoskeletal	17435236	0	O
and	17435236	0	O
motor	17435236	0	O
proteins	17435236	0	O
,	17435236	0	O
as	17435236	0	O
well	17435236	0	O
as	17435236	0	O
mutations	17435236	0	O
in	17435236	0	O
the	17435236	0	O
SUMO	17435236	0	O
and	17435236	0	O
ubiquitin	17435236	0	O
signaling	17435236	0	O
pathways	17435236	0	O
behave	17435236	0	O
as	17435236	0	O
modifiers	17435236	0	O
of	17435236	0	O
the	17435236	0	O
Bchs	17435236	0	O
gain	17435236	0	O
-	17435236	0	O
of	17435236	0	O
-	17435236	0	O
function	17435236	0	O
(	17435236	0	O
GOF	17435236	0	O
)	17435236	0	O
eye	17435236	0	O
phenotype	17435236	0	O
.	17435236	0	O
Individual	17435236	0	O
mutant	17435236	0	O
alleles	17435236	0	O
that	17435236	0	O
produced	17435236	0	O
viable	17435236	0	O
adults	17435236	0	O
were	17435236	0	O
further	17435236	0	O
examined	17435236	0	O
for	17435236	0	O
bchs	17435236	0	O
-	17435236	0	O
like	17435236	0	O
phenotypes	17435236	0	O
.	17435236	0	O
Mutations	17435236	0	B-Var
in	17435236	0	O
several	17435236	0	O
lysosomal	17435236	0	B-Gene
trafficking	17435236	0	I-Gene
genes	17435236	0	I-Gene
resulted	17435236	0	O
in	17435236	0	O
significantly	17435236	0	O
decreased	17435236	0	B-NegReg
adult	17435236	0	O
life	17435236	0	O
spans	17435236	0	O
and	17435236	0	O
several	17435236	0	O
mutants	17435236	0	O
showed	17435236	0	O
changes	17435236	0	B-Reg
in	17435236	0	O
ubiquitinated	17435236	0	O
protein	17435236	0	O
profiles	17435236	0	O
as	17435236	0	O
young	17435236	0	O
adults	17435236	0	O
.	17435236	0	O

Isolation	18031991	0	O
and	18031991	0	O
characterization	18031991	0	O
of	18031991	0	O
a	18031991	0	O
novel	18031991	0	O
human	18031991	0	O
RGS	18031991	0	O
mutant	18031991	0	O
displaying	18031991	0	O
gain	18031991	0	O
-	18031991	0	O
of	18031991	0	O
-	18031991	0	O
function	18031991	0	O
activity	18031991	0	O
.	18031991	0	O
Previous	18031991	0	O
studies	18031991	0	O
have	18031991	0	O
centered	18031991	0	O
on	18031991	0	O
reducing	18031991	0	B-NegReg
or	18031991	0	O
inhibiting	18031991	0	B-NegReg
the	18031991	0	O
action	18031991	0	O
of	18031991	0	O
RGS	18031991	0	O
proteins	18031991	0	O
,	18031991	0	O
utilizing	18031991	0	O
inactive	18031991	0	O
mutants	18031991	0	O
or	18031991	0	O
small	18031991	0	O
molecular	18031991	0	O
RGS	18031991	0	O
inhibitors	18031991	0	O
.	18031991	0	O
Here	18031991	0	O
we	18031991	0	O
describe	18031991	0	O
the	18031991	0	O
isolation	18031991	0	O
and	18031991	0	O
characterization	18031991	0	O
of	18031991	0	O
a	18031991	0	O
novel	18031991	0	O
human	18031991	0	O
RGS4	18031991	0	B-Var
mutant	18031991	0	I-Var
which	18031991	0	O
displays	18031991	0	O
enhanced	18031991	0	B-PosReg
or	18031991	0	O
gain	18031991	0	B-PosReg
-	18031991	0	I-PosReg
of	18031991	0	I-PosReg
-	18031991	0	I-PosReg
function	18031991	0	I-PosReg
(	18031991	0	O
GOF	18031991	0	O
)	18031991	0	O
activity	18031991	0	O
.	18031991	0	O
RGS4	18031991	0	O
(	18031991	0	O
S30C	18031991	0	O
)	18031991	0	O
demonstrates	18031991	0	O
GOF	18031991	0	O
activity	18031991	0	O
both	18031991	0	O
in	18031991	0	O
an	18031991	0	O
in	18031991	0	O
vivo	18031991	0	O
yeast	18031991	0	O
-	18031991	0	O
based	18031991	0	O
signalling	18031991	0	O
pathway	18031991	0	O
and	18031991	0	O
in	18031991	0	O
vitro	18031991	0	O
against	18031991	0	O
the	18031991	0	O
Galpha	18031991	0	O
(	18031991	0	O
o1	18031991	0	O
)	18031991	0	O
subunit	18031991	0	O
contained	18031991	0	O
in	18031991	0	O
an	18031991	0	O
alpha	18031991	0	O
(	18031991	0	O
2	18031991	0	O
A	18031991	0	O
)	18031991	0	O
-	18031991	0	O
adrenoreceptor	18031991	0	O
-	18031991	0	O
Galpha	18031991	0	O
(	18031991	0	O
o1	18031991	0	O
)	18031991	0	O
(	18031991	0	O
C351I	18031991	0	O
)	18031991	0	O
fusion	18031991	0	O
protein	18031991	0	O
.	18031991	0	O
Mutational	18031991	0	O
analysis	18031991	0	O
of	18031991	0	O
serine	18031991	0	O
30	18031991	0	O
identified	18031991	0	O
a	18031991	0	O
number	18031991	0	O
of	18031991	0	O
alternative	18031991	0	O
substitutions	18031991	0	O
that	18031991	0	O
result	18031991	0	O
in	18031991	0	O
GOF	18031991	0	O
activity	18031991	0	O
.	18031991	0	O
GOF	18031991	0	O
activity	18031991	0	O
was	18031991	0	O
retained	18031991	0	O
upon	18031991	0	O
transposition	18031991	0	O
of	18031991	0	O
the	18031991	0	O
serine	18031991	0	O
30	18031991	0	O
-	18031991	0	O
cysteine	18031991	0	O
mutation	18031991	0	O
to	18031991	0	O
the	18031991	0	O
equivalent	18031991	0	O
serine	18031991	0	O
residue	18031991	0	O
in	18031991	0	O
human	18031991	0	O
RGS16	18031991	0	O
.	18031991	0	O
As	18031991	0	O
with	18031991	0	O
previously	18031991	0	O
identified	18031991	0	O
GOF	18031991	0	O
mutants	18031991	0	O
,	18031991	0	O
RGS4	18031991	0	B-Var
(	18031991	0	I-Var
S30C	18031991	0	I-Var
/	18031991	0	I-Var
S30F	18031991	0	I-Var
/	18031991	0	I-Var
S30K	18031991	0	I-Var
)	18031991	0	I-Var
demonstrate	18031991	0	O
increased	18031991	0	B-PosReg
steady	18031991	0	O
state	18031991	0	O
protein	18031991	0	O
levels	18031991	0	O
,	18031991	0	O
however	18031991	0	O
these	18031991	0	O
mutants	18031991	0	O
also	18031991	0	O
demonstrate	18031991	0	O
enhanced	18031991	0	B-PosReg
GAP	18031991	0	O
activity	18031991	0	O
through	18031991	0	O
an	18031991	0	O
additional	18031991	0	O
mechanism	18031991	0	O
distinct	18031991	0	O
from	18031991	0	O
the	18031991	0	O
increased	18031991	0	O
protein	18031991	0	O
content	18031991	0	O
.	18031991	0	O
The	18031991	0	O
identification	18031991	0	O
of	18031991	0	O
human	18031991	0	O
RGS	18031991	0	O
mutants	18031991	0	O
with	18031991	0	O
GOF	18031991	0	O
activity	18031991	0	O
may	18031991	0	O
provide	18031991	0	O
novel	18031991	0	O
therapeutic	18031991	0	O
agents	18031991	0	O
for	18031991	0	O
the	18031991	0	O
treatment	18031991	0	O
of	18031991	0	O
signaling	18031991	0	O
-	18031991	0	O
based	18031991	0	O
diseases	18031991	0	O
and	18031991	0	O
the	18031991	0	O
ability	18031991	0	O
to	18031991	0	O
transpose	18031991	0	O
these	18031991	0	O
mutations	18031991	0	O
to	18031991	0	O
other	18031991	0	O
human	18031991	0	O
RGS	18031991	0	O
proteins	18031991	0	O
extends	18031991	0	O
their	18031991	0	O
application	18031991	0	O
to	18031991	0	O
multiple	18031991	0	O
pathways	18031991	0	O
.	18031991	0	O

Conditional	18594199	0	O
RNA	18594199	0	O
interference	18594199	0	O
in	18594199	0	O
vivo	18594199	0	O
to	18594199	0	O
study	18594199	0	O
mutant	18594199	0	O
p53	18594199	0	O
oncogenic	18594199	0	O
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
on	18594199	0	O
tumor	18594199	0	O
malignancy	18594199	0	O
.	18594199	0	O
Mutant	18594199	0	B-Var
p53	18594199	0	B-Gene
proteins	18594199	0	O
are	18594199	0	O
thought	18594199	0	O
to	18594199	0	O
have	18594199	0	O
acquired	18594199	0	O
a	18594199	0	O
"	18594199	0	O
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
"	18594199	0	O
(	18594199	0	O
GOF	18594199	0	O
)	18594199	0	O
activity	18594199	0	O
that	18594199	0	O
mainly	18594199	0	O
contributes	18594199	0	B-PosReg
to	18594199	0	O
tumor	18594199	0	O
aggressiveness	18594199	0	O
.	18594199	0	O
Previously	18594199	0	O
we	18594199	0	O
reported	18594199	0	O
that	18594199	0	O
constitutive	18594199	0	O
downregulation	18594199	0	B-NegReg
of	18594199	0	O
mutant	18594199	0	B-Var
p53	18594199	0	B-Gene
by	18594199	0	O
RNA	18594199	0	O
interference	18594199	0	O
reduces	18594199	0	B-NegReg
the	18594199	0	O
tumorigenicity	18594199	0	O
of	18594199	0	O
cancer	18594199	0	O
cells	18594199	0	O
in	18594199	0	O
an	18594199	0	O
animal	18594199	0	O
model	18594199	0	O
;	18594199	0	O
however	18594199	0	O
,	18594199	0	O
effects	18594199	0	O
of	18594199	0	O
adaptation	18594199	0	O
to	18594199	0	O
long	18594199	0	O
-	18594199	0	O
term	18594199	0	O
mutant	18594199	0	O
p53	18594199	0	O
inhibition	18594199	0	O
could	18594199	0	O
not	18594199	0	O
be	18594199	0	O
excluded	18594199	0	O
.	18594199	0	O
To	18594199	0	O
address	18594199	0	O
this	18594199	0	O
point	18594199	0	O
,	18594199	0	O
mimicking	18594199	0	O
more	18594199	0	O
physiological	18594199	0	O
conditions	18594199	0	O
,	18594199	0	O
we	18594199	0	O
now	18594199	0	O
describe	18594199	0	O
the	18594199	0	O
establishment	18594199	0	O
of	18594199	0	O
a	18594199	0	O
lentiviral	18594199	0	O
-	18594199	0	O
based	18594199	0	O
system	18594199	0	O
for	18594199	0	O
conditional	18594199	0	O
interference	18594199	0	O
with	18594199	0	O
mutant	18594199	0	O
p53	18594199	0	O
expression	18594199	0	O
.	18594199	0	O
In	18594199	0	O
vivo	18594199	0	O
studies	18594199	0	O
assessed	18594199	0	O
the	18594199	0	O
efficacy	18594199	0	O
of	18594199	0	O
conditional	18594199	0	O
RNA	18594199	0	O
interference	18594199	0	O
in	18594199	0	O
inhibiting	18594199	0	B-NegReg
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
activity	18594199	0	O
of	18594199	0	O
mutant	18594199	0	B-Var
p53	18594199	0	B-Gene
proteins	18594199	0	O
by	18594199	0	O
reducing	18594199	0	O
tumor	18594199	0	O
growth	18594199	0	O
ability	18594199	0	O
.	18594199	0	O
Moreover	18594199	0	O
by	18594199	0	O
using	18594199	0	O
this	18594199	0	O
system	18594199	0	O
,	18594199	0	O
microarray	18594199	0	O
data	18594199	0	O
were	18594199	0	O
validated	18594199	0	O
in	18594199	0	O
vitro	18594199	0	O
and	18594199	0	O
in	18594199	0	O
vivo	18594199	0	O
and	18594199	0	O
putative	18594199	0	O
mutant	18594199	0	O
p53	18594199	0	O
target	18594199	0	O
genes	18594199	0	O
that	18594199	0	O
may	18594199	0	O
contribute	18594199	0	O
to	18594199	0	O
its	18594199	0	O
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
effects	18594199	0	O
in	18594199	0	O
cancer	18594199	0	O
were	18594199	0	O
identified	18594199	0	O
.	18594199	0	O
Results	18594199	0	O
are	18594199	0	O
confirmatory	18594199	0	O
that	18594199	0	O
depletion	18594199	0	O
of	18594199	0	O
mutant	18594199	0	B-Var
p53	18594199	0	B-Gene
protein	18594199	0	O
impacts	18594199	0	B-Reg
on	18594199	0	O
tumor	18594199	0	O
malignancy	18594199	0	O
and	18594199	0	O
validated	18594199	0	O
the	18594199	0	O
inducible	18594199	0	O
lentiviral	18594199	0	O
-	18594199	0	O
based	18594199	0	O
system	18594199	0	O
as	18594199	0	O
an	18594199	0	O
efficient	18594199	0	O
tool	18594199	0	O
to	18594199	0	O
study	18594199	0	O
the	18594199	0	O
gain	18594199	0	O
of	18594199	0	O
function	18594199	0	O
activity	18594199	0	O
of	18594199	0	O
human	18594199	0	O
tumor	18594199	0	O
derived	18594199	0	O
p53	18594199	0	O
mutants	18594199	0	O
.	18594199	0	O

The	19338054	1	O
MC1R	19338054	1	O
gene	19338054	1	O
is	19338054	1	O
highly	19338054	1	O
polymorphic	19338054	1	O
,	19338054	1	O
but	19338054	1	O
only	19338054	1	O
a	19338054	1	O
few	19338054	1	O
naturally	19338054	1	O
occurring	19338054	1	O
alleles	19338054	1	O
have	19338054	1	O
been	19338054	1	O
functionally	19338054	1	O
characterized	19338054	1	O
,	19338054	1	O
which	19338054	1	O
complicates	19338054	1	O
the	19338054	1	O
establishment	19338054	1	O
of	19338054	1	O
accurate	19338054	1	O
correlations	19338054	1	O
between	19338054	1	O
the	19338054	1	O
signaling	19338054	1	O
properties	19338054	1	O
of	19338054	1	O
mutant	19338054	1	O
alleles	19338054	1	O
and	19338054	1	O
defined	19338054	1	O
cutaneous	19338054	1	O
phenotypes	19338054	1	O
.	19338054	1	O
Two	19338054	1	O
variants	19338054	1	O
(	19338054	1	O
c.152	19338054	1	O
T	19338054	1	O
>	19338054	1	O
C	19338054	1	O
,	19338054	1	O
p.Val51Ala	19338054	1	O
and	19338054	1	O
c.865	19338054	1	O
T	19338054	1	O
>	19338054	1	O
C	19338054	1	O
,	19338054	1	O
p.Cys289Arg	19338054	1	O
)	19338054	1	O
have	19338054	1	O
never	19338054	1	O
been	19338054	1	O
described	19338054	1	O
,	19338054	1	O
and	19338054	1	O
the	19338054	1	O
others	19338054	1	O
(	19338054	1	O
c.112	19338054	1	O
G	19338054	1	O
>	19338054	1	O
A	19338054	1	O
,	19338054	1	O
p.Val38Met	19338054	1	O
;	19338054	1	O
c.122	19338054	1	O
C	19338054	1	O
>	19338054	1	O
T	19338054	1	O
,	19338054	1	O
p.Ser41Phe	19338054	1	O
;	19338054	1	O
c.383	19338054	1	O
T	19338054	1	O
>	19338054	1	O
C	19338054	1	O
,	19338054	1	O
p.Met128Thr	19338054	1	O
;	19338054	1	O
and	19338054	1	O
c.842	19338054	1	O
A	19338054	1	O
>	19338054	1	O
G	19338054	1	O
,	19338054	1	O
p.Asn281Ser	19338054	1	O
)	19338054	1	O
have	19338054	1	O
not	19338054	1	O
been	19338054	1	O
analyzed	19338054	1	O
for	19338054	1	O
function	19338054	1	O
.	19338054	1	O
p.Asn281Ser	19338054	1	B-Var
corresponds	19338054	1	O
to	19338054	1	O
a	19338054	1	O
functionally	19338054	1	O
silent	19338054	1	B-NegReg
polymorphism	19338054	1	O
.	19338054	1	O
The	19338054	1	O
other	19338054	1	O
mutations	19338054	1	O
are	19338054	1	O
associated	19338054	1	O
with	19338054	1	O
varying	19338054	1	O
degrees	19338054	1	O
of	19338054	1	O
loss	19338054	1	O
of	19338054	1	O
function	19338054	1	O
(	19338054	1	O
LOF	19338054	1	O
)	19338054	1	O
,	19338054	1	O
from	19338054	1	O
moderate	19338054	1	O
decreases	19338054	1	B-NegReg
in	19338054	1	O
coupling	19338054	1	O
to	19338054	1	O
the	19338054	1	O
cAMP	19338054	1	O
pathway	19338054	1	O
(	19338054	1	B-Var
p.Val38Met	19338054	1	I-Var
and	19338054	1	O
p.Val51Ala	19338054	1	B-Var
)	19338054	1	I-Var
to	19338054	1	O
nearly	19338054	1	O
complete	19338054	1	O
absence	19338054	1	B-NegReg
of	19338054	1	O
functional	19338054	1	O
coupling	19338054	1	O
(	19338054	1	B-Var
p.Ser41Phe	19338054	1	I-Var
,	19338054	1	O
p.Met128Thr	19338054	1	B-Var
,	19338054	1	O
and	19338054	1	O
p.Cys289Arg	19338054	1	B-Var
)	19338054	1	I-Var
.	19338054	1	O
The	19338054	1	O
LOF	19338054	1	O
p.Met128Thr	19338054	1	B-Var
and	19338054	1	O
p.Cys289Arg	19338054	1	B-Var
mutants	19338054	1	O
are	19338054	1	O
trafficked	19338054	1	O
to	19338054	1	O
the	19338054	1	O
cell	19338054	1	O
surface	19338054	1	O
,	19338054	1	O
but	19338054	1	O
are	19338054	1	O
unable	19338054	1	B-NegReg
to	19338054	1	O
bind	19338054	1	O
agonists	19338054	1	O
efficiently	19338054	1	O
.	19338054	1	O
Conversely	19338054	1	O
,	19338054	1	O
LOF	19338054	1	O
of	19338054	1	O
p.Val38Met	19338054	1	B-Var
,	19338054	1	O
p.Ser41Phe	19338054	1	I-Var
,	19338054	1	O
and	19338054	1	I-Var
p.Val51Ala	19338054	1	I-Var
is	19338054	1	O
due	19338054	1	O
to	19338054	1	O
reduced	19338054	1	B-NegReg
cell	19338054	1	O
surface	19338054	1	O
expression	19338054	1	O
as	19338054	1	O
a	19338054	1	O
consequence	19338054	1	O
of	19338054	1	O
retention	19338054	1	O
in	19338054	1	O
the	19338054	1	O
endoplasmic	19338054	1	O
reticulum	19338054	1	O
(	19338054	1	O
ER	19338054	1	O
)	19338054	1	O
.	19338054	1	O
Therefore	19338054	1	O
,	19338054	1	O
LOF	19338054	1	O
of	19338054	1	O
MC1R	19338054	1	O
alleles	19338054	1	O
is	19338054	1	O
frequently	19338054	1	O
associated	19338054	1	O
with	19338054	1	O
aberrant	19338054	1	O
forward	19338054	1	O
trafficking	19338054	1	O
and	19338054	1	O
accumulation	19338054	1	O
within	19338054	1	O
the	19338054	1	O
ER	19338054	1	O
or	19338054	1	O
with	19338054	1	O
inability	19338054	1	O
to	19338054	1	O
bind	19338054	1	O
properly	19338054	1	O
the	19338054	1	O
activatory	19338054	1	O
ligand	19338054	1	O
.	19338054	1	O

Elevated	19917135	2	O
expression	19917135	2	O
of	19917135	2	O
p53	19917135	2	O
gain	19917135	2	O
-	19917135	2	O
of	19917135	2	O
-	19917135	2	O
function	19917135	2	O
mutation	19917135	2	O
R175H	19917135	2	O
in	19917135	2	O
endometrial	19917135	2	O
cancer	19917135	2	O
cells	19917135	2	O
can	19917135	2	O
increase	19917135	2	O
the	19917135	2	O
invasive	19917135	2	O
phenotypes	19917135	2	O
by	19917135	2	O
activation	19917135	2	O
of	19917135	2	O
the	19917135	2	O
EGFR	19917135	2	O
/	19917135	2	O
PI3K	19917135	2	O
/	19917135	2	O
AKT	19917135	2	O
pathway	19917135	2	O
.	19917135	2	O
In	19917135	2	O
addition	19917135	2	O
to	19917135	2	O
the	19917135	2	O
loss	19917135	2	O
of	19917135	2	O
tumor	19917135	2	O
suppression	19917135	2	O
function	19917135	2	O
and	19917135	2	O
exertion	19917135	2	O
of	19917135	2	O
dominant	19917135	2	O
-	19917135	2	O
negative	19917135	2	O
effects	19917135	2	O
over	19917135	2	O
the	19917135	2	O
remaining	19917135	2	O
wild	19917135	2	O
-	19917135	2	O
type	19917135	2	O
protein	19917135	2	O
,	19917135	2	O
several	19917135	2	O
p53	19917135	2	O
mutants	19917135	2	O
can	19917135	2	O
gain	19917135	2	O
novel	19917135	2	O
oncogenic	19917135	2	O
functions	19917135	2	O
(	19917135	2	O
gain	19917135	2	O
-	19917135	2	O
of	19917135	2	O
-	19917135	2	O
function	19917135	2	O
,	19917135	2	O
GOF	19917135	2	O
)	19917135	2	O
that	19917135	2	O
actively	19917135	2	O
regulate	19917135	2	O
cancer	19917135	2	O
development	19917135	2	O
and	19917135	2	O
progression	19917135	2	O
.	19917135	2	O
In	19917135	2	O
human	19917135	2	O
endometrial	19917135	2	O
cancer	19917135	2	O
,	19917135	2	O
p53	19917135	2	B-Gene
mutation	19917135	2	B-Var
is	19917135	2	O
more	19917135	2	O
often	19917135	2	O
associated	19917135	2	B-Reg
with	19917135	2	O
aggressive	19917135	2	B-Disease
nonendometrioid	19917135	2	I-Disease
cancer	19917135	2	I-Disease
.	19917135	2	O
However	19917135	2	O
,	19917135	2	O
it	19917135	2	O
was	19917135	2	O
unknown	19917135	2	O
if	19917135	2	O
p53	19917135	2	O
mutants	19917135	2	O
contributed	19917135	2	O
to	19917135	2	O
endometrial	19917135	2	O
cancer	19917135	2	O
progression	19917135	2	O
through	19917135	2	O
the	19917135	2	O
GOF	19917135	2	O
properties	19917135	2	O
.	19917135	2	O
METHODS	19917135	2	O
:	19917135	2	O
To	19917135	2	O
clarify	19917135	2	O
the	19917135	2	O
relationship	19917135	2	O
between	19917135	2	O
expression	19917135	2	O
of	19917135	2	O
p53	19917135	2	O
GOF	19917135	2	O
mutation	19917135	2	O
(	19917135	2	O
p53	19917135	2	O
-	19917135	2	O
R175H	19917135	2	O
)	19917135	2	O
and	19917135	2	O
invasive	19917135	2	O
potential	19917135	2	O
of	19917135	2	O
human	19917135	2	O
endometrial	19917135	2	O
cancer	19917135	2	O
KLE	19917135	2	O
cells	19917135	2	O
,	19917135	2	O
we	19917135	2	O
tested	19917135	2	B-Reg
the	19917135	2	O
consequences	19917135	2	O
of	19917135	2	O
up	19917135	2	B-PosReg
-	19917135	2	I-PosReg
regulation	19917135	2	I-PosReg
and	19917135	2	O
down	19917135	2	B-NegReg
-	19917135	2	I-NegReg
regulation	19917135	2	I-NegReg
of	19917135	2	O
p53	19917135	2	O
-	19917135	2	O
R175H	19917135	2	O
in	19917135	2	O
KLE	19917135	2	O
cells	19917135	2	O
by	19917135	2	O
inducing	19917135	2	B-Reg
p53	19917135	2	O
-	19917135	2	O
R175H	19917135	2	O
expression	19917135	2	O
vector	19917135	2	O
or	19917135	2	O
suppressing	19917135	2	B-NegReg
the	19917135	2	O
p53	19917135	2	B-Gene
gene	19917135	2	I-Gene
with	19917135	2	O
short	19917135	2	O
hairpin	19917135	2	O
RNA	19917135	2	O
.	19917135	2	O
RESULTS	19917135	2	O
:	19917135	2	O
We	19917135	2	O
found	19917135	2	O
that	19917135	2	O
forced	19917135	2	O
over	19917135	2	B-PosReg
-	19917135	2	I-PosReg
expression	19917135	2	I-PosReg
of	19917135	2	O
p53	19917135	2	B-Var
-	19917135	2	I-Var
R175H	19917135	2	I-Var
significantly	19917135	2	O
promoted	19917135	2	B-PosReg
cell	19917135	2	O
migration	19917135	2	O
and	19917135	2	O
invasion	19917135	2	O
,	19917135	2	O
and	19917135	2	O
induced	19917135	2	O
activation	19917135	2	B-PosReg
of	19917135	2	O
the	19917135	2	O
epidermal	19917135	2	O
growth	19917135	2	O
factor	19917135	2	O
receptor	19917135	2	O
(	19917135	2	O
EGFR	19917135	2	O
)	19917135	2	O
/	19917135	2	O
phosphatidylinositol	19917135	2	O
3	19917135	2	O
-	19917135	2	O
kinase	19917135	2	O
(	19917135	2	O
PI3K	19917135	2	O
)	19917135	2	O
/	19917135	2	O
AKT	19917135	2	O
pathway	19917135	2	O
.	19917135	2	O
Conversely	19917135	2	O
,	19917135	2	O
suppression	19917135	2	B-NegReg
of	19917135	2	O
p53	19917135	2	O
-	19917135	2	O
R175H	19917135	2	O
with	19917135	2	O
short	19917135	2	B-Gene
hairpin	19917135	2	I-Gene
RNA	19917135	2	I-Gene
significantly	19917135	2	O
inhibited	19917135	2	B-NegReg
cell	19917135	2	O
migration	19917135	2	O
and	19917135	2	O
invasion	19917135	2	O
,	19917135	2	O
and	19917135	2	O
resulted	19917135	2	O
in	19917135	2	O
attenuation	19917135	2	B-NegReg
of	19917135	2	O
EGFR	19917135	2	O
/	19917135	2	O
PI3K	19917135	2	O
/	19917135	2	O
AKT	19917135	2	O
pathway	19917135	2	O
.	19917135	2	O
CONCLUSION	19917135	2	O
:	19917135	2	O
These	19917135	2	O
findings	19917135	2	O
show	19917135	2	O
for	19917135	2	O
the	19917135	2	O
first	19917135	2	O
time	19917135	2	O
that	19917135	2	O
elevated	19917135	2	B-PosReg
expression	19917135	2	O
of	19917135	2	O
p53	19917135	2	B-Var
-	19917135	2	I-Var
R175H	19917135	2	I-Var
mutant	19917135	2	O
may	19917135	2	O
exert	19917135	2	O
gain	19917135	2	O
-	19917135	2	O
of	19917135	2	O
-	19917135	2	O
function	19917135	2	O
activity	19917135	2	O
to	19917135	2	O
activate	19917135	2	B-PosReg
the	19917135	2	O
EGFR	19917135	2	O
/	19917135	2	O
PI3K	19917135	2	O
/	19917135	2	O
AKT	19917135	2	O
pathway	19917135	2	O
and	19917135	2	O
thus	19917135	2	O
may	19917135	2	O
contribute	19917135	2	B-Reg
to	19917135	2	O
the	19917135	2	O
invasive	19917135	2	O
phenotype	19917135	2	O
in	19917135	2	O
endometrial	19917135	2	B-Disease
cancer	19917135	2	I-Disease
.	19917135	2	O

Genotype	20207543	4	O
-	20207543	4	O
phenotype	20207543	4	O
correlation	20207543	4	O
in	20207543	4	O
a	20207543	4	O
large	20207543	4	O
population	20207543	4	O
of	20207543	4	O
muscular	20207543	4	B-Disease
dystrophy	20207543	4	I-Disease
patients	20207543	4	O
with	20207543	4	B-Reg
LAMA2	20207543	4	B-Gene
mutations	20207543	4	B-Var
.	20207543	4	O
Merosin	20207543	4	B-Disease
deficient	20207543	4	I-Disease
congenital	20207543	4	I-Disease
muscular	20207543	4	I-Disease
dystrophy	20207543	4	I-Disease
1	20207543	4	I-Disease
A	20207543	4	I-Disease
(	20207543	4	O
MDC1A	20207543	4	O
)	20207543	4	O
results	20207543	4	B-Reg
from	20207543	4	I-Reg
mutations	20207543	4	B-Var
in	20207543	4	O
the	20207543	4	O
LAMA2	20207543	4	B-Gene
gene	20207543	4	O
.	20207543	4	O
We	20207543	4	O
identified	20207543	4	O
33	20207543	4	O
novel	20207543	4	O
LAMA2	20207543	4	O
mutations	20207543	4	O
;	20207543	4	O
these	20207543	4	O
were	20207543	4	O
distributed	20207543	4	O
throughout	20207543	4	O
the	20207543	4	O
gene	20207543	4	O
in	20207543	4	O
patients	20207543	4	O
with	20207543	4	O
absent	20207543	4	O
merosin	20207543	4	O
,	20207543	4	O
with	20207543	4	O
minor	20207543	4	O
clusters	20207543	4	O
in	20207543	4	O
exon	20207543	4	O
27	20207543	4	O
,	20207543	4	O
14	20207543	4	O
,	20207543	4	O
25	20207543	4	O
and	20207543	4	O
26	20207543	4	O
(	20207543	4	O
55%	20207543	4	O
of	20207543	4	O
mutations	20207543	4	O
)	20207543	4	O
.	20207543	4	O
Patients	20207543	4	O
with	20207543	4	O
residual	20207543	4	O
merosin	20207543	4	O
often	20207543	4	O
carried	20207543	4	O
at	20207543	4	O
least	20207543	4	O
one	20207543	4	O
splice	20207543	4	O
site	20207543	4	O
mutation	20207543	4	O
and	20207543	4	O
less	20207543	4	O
frequently	20207543	4	O
frameshift	20207543	4	O
mutations	20207543	4	O
.	20207543	4	O
This	20207543	4	O
large	20207543	4	O
study	20207543	4	O
identified	20207543	4	O
novel	20207543	4	O
LAMA2	20207543	4	O
mutations	20207543	4	O
and	20207543	4	O
highlights	20207543	4	O
the	20207543	4	O
role	20207543	4	O
of	20207543	4	O
immunohistochemical	20207543	4	O
studies	20207543	4	O
for	20207543	4	O
merosin	20207543	4	O
status	20207543	4	O
in	20207543	4	O
predicting	20207543	4	O
clinical	20207543	4	O
severity	20207543	4	O
of	20207543	4	O
MDC1A	20207543	4	O
.	20207543	4	O

Deregulation	20399956	3	O
of	20399956	3	O
signaling	20399956	3	O
pathways	20399956	3	O
,	20399956	3	O
through	20399956	3	O
mutation	20399956	3	O
or	20399956	3	O
other	20399956	3	O
molecular	20399956	3	O
changes	20399956	3	O
,	20399956	3	O
can	20399956	3	O
ultimately	20399956	3	O
result	20399956	3	O
in	20399956	3	O
disease	20399956	3	O
.	20399956	3	O
In	20399956	3	O
the	20399956	3	O
last	20399956	3	O
decade	20399956	3	O
,	20399956	3	O
germline	20399956	3	O
mutations	20399956	3	O
in	20399956	3	O
the	20399956	3	O
human	20399956	3	O
PTPN11	20399956	3	O
gene	20399956	3	O
,	20399956	3	O
encoding	20399956	3	O
Shp2	20399956	3	O
,	20399956	3	O
were	20399956	3	O
linked	20399956	3	O
to	20399956	3	O
Noonan	20399956	3	O
(	20399956	3	O
NS	20399956	3	O
)	20399956	3	O
and	20399956	3	O
LEOPARD	20399956	3	O
syndromes	20399956	3	O
,	20399956	3	O
two	20399956	3	O
multisymptomatic	20399956	3	O
developmental	20399956	3	O
disorders	20399956	3	O
that	20399956	3	O
are	20399956	3	O
characterized	20399956	3	O
by	20399956	3	O
short	20399956	3	O
stature	20399956	3	O
,	20399956	3	O
craniofacial	20399956	3	O
defects	20399956	3	O
,	20399956	3	O
cardiac	20399956	3	O
defects	20399956	3	O
,	20399956	3	O
and	20399956	3	O
mental	20399956	3	O
retardation	20399956	3	O
.	20399956	3	O
Somatic	20399956	3	O
Shp2	20399956	3	B-Gene
mutations	20399956	3	B-Var
are	20399956	3	O
also	20399956	3	O
associated	20399956	3	B-Reg
with	20399956	3	O
several	20399956	3	O
types	20399956	3	O
of	20399956	3	O
human	20399956	3	O
malignancies	20399956	3	O
,	20399956	3	O
such	20399956	3	O
as	20399956	3	O
the	20399956	3	O
most	20399956	3	O
common	20399956	3	O
juvenile	20399956	3	B-Disease
leukemia	20399956	3	I-Disease
,	20399956	3	O
juvenile	20399956	3	B-Disease
myelomonocytic	20399956	3	I-Disease
leukemia	20399956	3	I-Disease
(	20399956	3	O
JMML	20399956	3	O
)	20399956	3	O
.	20399956	3	O
Whereas	20399956	3	O
NS	20399956	3	B-Disease
and	20399956	3	O
JMML	20399956	3	B-Disease
are	20399956	3	O
caused	20399956	3	O
by	20399956	3	O
gain	20399956	3	B-PosReg
-	20399956	3	I-PosReg
of	20399956	3	I-PosReg
-	20399956	3	I-PosReg
function	20399956	3	I-PosReg
(	20399956	3	O
GOF	20399956	3	O
)	20399956	3	O
mutations	20399956	3	B-Var
of	20399956	3	O
Shp2	20399956	3	B-Gene
,	20399956	3	O
loss	20399956	3	B-NegReg
-	20399956	3	I-NegReg
of	20399956	3	I-NegReg
-	20399956	3	I-NegReg
function	20399956	3	I-NegReg
(	20399956	3	O
LOF	20399956	3	O
)	20399956	3	O
mutations	20399956	3	B-Var
are	20399956	3	O
thought	20399956	3	O
to	20399956	3	O
be	20399956	3	O
associated	20399956	3	O
with	20399956	3	O
LEOPARD	20399956	3	B-Disease
syndrome	20399956	3	I-Disease
.	20399956	3	O
Animal	20399956	3	O
models	20399956	3	O
that	20399956	3	O
carry	20399956	3	O
conditional	20399956	3	O
LOF	20399956	3	O
and	20399956	3	O
GOF	20399956	3	O
mutations	20399956	3	O
have	20399956	3	O
allowed	20399956	3	O
a	20399956	3	O
better	20399956	3	O
understanding	20399956	3	O
of	20399956	3	O
the	20399956	3	O
mechanism	20399956	3	O
of	20399956	3	O
Shp2	20399956	3	O
function	20399956	3	O
in	20399956	3	O
disease	20399956	3	O
,	20399956	3	O
and	20399956	3	O
shed	20399956	3	O
light	20399956	3	O
on	20399956	3	O
the	20399956	3	O
role	20399956	3	O
of	20399956	3	O
Shp2	20399956	3	O
in	20399956	3	O
signaling	20399956	3	O
pathways	20399956	3	O
that	20399956	3	O
control	20399956	3	O
decisive	20399956	3	O
events	20399956	3	O
during	20399956	3	O
embryonic	20399956	3	O
development	20399956	3	O
or	20399956	3	O
during	20399956	3	O
cellular	20399956	3	O
transformation	20399956	3	O
/	20399956	3	O
tumorigenesis	20399956	3	O
.	20399956	3	O

Mutant	20696700	0	B-Var
p53	20696700	0	B-Gene
facilitates	20696700	0	B-PosReg
somatic	20696700	0	O
cell	20696700	0	O
reprogramming	20696700	0	O
and	20696700	0	O
augments	20696700	0	B-NegReg
the	20696700	0	O
malignant	20696700	0	O
potential	20696700	0	O
of	20696700	0	O
reprogrammed	20696700	0	O
cells	20696700	0	O
.	20696700	0	O
As	20696700	0	O
p53	20696700	0	O
is	20696700	0	O
usually	20696700	0	O
mutated	20696700	0	O
in	20696700	0	O
human	20696700	0	O
tumors	20696700	0	O
and	20696700	0	O
many	20696700	0	O
mutated	20696700	0	B-Var
forms	20696700	0	I-Var
of	20696700	0	O
p53	20696700	0	B-Gene
gain	20696700	0	B-PosReg
novel	20696700	0	O
activities	20696700	0	O
,	20696700	0	O
we	20696700	0	O
studied	20696700	0	O
the	20696700	0	O
influence	20696700	0	O
of	20696700	0	O
mutant	20696700	0	O
p53	20696700	0	O
(	20696700	0	O
mut	20696700	0	O
-	20696700	0	O
p53	20696700	0	O
)	20696700	0	O
on	20696700	0	O
somatic	20696700	0	O
cell	20696700	0	O
reprogramming	20696700	0	O
.	20696700	0	O
Our	20696700	0	O
data	20696700	0	O
indicate	20696700	0	O
a	20696700	0	O
novel	20696700	0	O
gain	20696700	0	B-PosReg
of	20696700	0	O
function	20696700	0	O
(	20696700	0	O
GOF	20696700	0	O
)	20696700	0	O
property	20696700	0	O
for	20696700	0	O
mut	20696700	0	B-Var
-	20696700	0	I-Var
p53	20696700	0	I-Var
,	20696700	0	O
which	20696700	0	O
markedly	20696700	0	O
enhanced	20696700	0	B-PosReg
the	20696700	0	O
efficiency	20696700	0	O
of	20696700	0	O
the	20696700	0	O
reprogramming	20696700	0	O
process	20696700	0	O
compared	20696700	0	O
with	20696700	0	O
p53	20696700	0	O
deficiency	20696700	0	O
.	20696700	0	O
Although	20696700	0	O
p53	20696700	0	O
knockout	20696700	0	O
(	20696700	0	O
KO	20696700	0	O
)	20696700	0	O
cells	20696700	0	O
reprogrammed	20696700	0	O
with	20696700	0	O
only	20696700	0	O
Oct4	20696700	0	O
and	20696700	0	O
Sox2	20696700	0	O
maintained	20696700	0	O
their	20696700	0	O
pluripotent	20696700	0	O
capacity	20696700	0	O
in	20696700	0	O
vivo	20696700	0	O
,	20696700	0	O
reprogrammed	20696700	0	O
cells	20696700	0	O
expressing	20696700	0	O
mutant	20696700	0	B-Var
p53	20696700	0	B-Gene
lost	20696700	0	B-NegReg
this	20696700	0	O
capability	20696700	0	O
and	20696700	0	O
gave	20696700	0	B-Reg
rise	20696700	0	I-Reg
to	20696700	0	O
malignant	20696700	0	O
tumors	20696700	0	O
.	20696700	0	O
This	20696700	0	O
novel	20696700	0	O
GOF	20696700	0	O
of	20696700	0	O
mut	20696700	0	O
-	20696700	0	O
p53	20696700	0	O
is	20696700	0	O
not	20696700	0	O
attributed	20696700	0	O
to	20696700	0	O
its	20696700	0	O
effect	20696700	0	O
on	20696700	0	O
proliferation	20696700	0	O
,	20696700	0	O
as	20696700	0	O
both	20696700	0	O
p53	20696700	0	O
KO	20696700	0	O
and	20696700	0	O
mut	20696700	0	O
-	20696700	0	O
p53	20696700	0	O
cells	20696700	0	O
displayed	20696700	0	O
similar	20696700	0	O
proliferation	20696700	0	O
rates	20696700	0	O
.	20696700	0	O

NOTCH3	20935329	4	B-Gene
mutations	20935329	4	B-Var
and	20935329	4	O
clinical	20935329	4	O
features	20935329	4	O
in	20935329	4	O
33	20935329	4	O
mainland	20935329	4	O
Chinese	20935329	4	O
families	20935329	4	O
with	20935329	4	B-Reg
CADASIL	20935329	4	B-Disease
.	20935329	4	O
BACKGROUND	20935329	4	O
:	20935329	4	O
Cerebral	20935329	4	B-Disease
autosomal	20935329	4	I-Disease
dominant	20935329	4	I-Disease
arteriopathy	20935329	4	I-Disease
with	20935329	4	I-Disease
subcortical	20935329	4	I-Disease
infarcts	20935329	4	I-Disease
and	20935329	4	I-Disease
leucoencephalopathy	20935329	4	I-Disease
(	20935329	4	O
CADASIL	20935329	4	O
)	20935329	4	O
is	20935329	4	O
an	20935329	4	O
inherited	20935329	4	O
small	20935329	4	O
-	20935329	4	O
vessel	20935329	4	O
disease	20935329	4	O
caused	20935329	4	B-Reg
by	20935329	4	I-Reg
mutations	20935329	4	B-Var
in	20935329	4	O
NOTCH3	20935329	4	B-Gene
.	20935329	4	O
OBJECTIVE	20935329	4	O
:	20935329	4	O
To	20935329	4	O
identify	20935329	4	O
NOTCH3	20935329	4	O
mutations	20935329	4	O
and	20935329	4	O
analyse	20935329	4	O
the	20935329	4	O
clinical	20935329	4	O
and	20935329	4	O
MRI	20935329	4	O
findings	20935329	4	O
in	20935329	4	O
a	20935329	4	O
large	20935329	4	O
series	20935329	4	O
of	20935329	4	O
CADASIL	20935329	4	O
patients	20935329	4	O
from	20935329	4	O
mainland	20935329	4	O
China	20935329	4	O
.	20935329	4	O
RESULTS	20935329	4	O
:	20935329	4	O
20	20935329	4	O
different	20935329	4	O
NOTCH3	20935329	4	O
mutations	20935329	4	O
were	20935329	4	O
identified	20935329	4	O
in	20935329	4	O
33	20935329	4	O
families	20935329	4	O
,	20935329	4	O
including	20935329	4	O
seven	20935329	4	O
novel	20935329	4	O
mutations	20935329	4	O
.	20935329	4	O
The	20935329	4	O
highest	20935329	4	O
mutation	20935329	4	O
frequency	20935329	4	O
was	20935329	4	O
in	20935329	4	O
exons	20935329	4	O
4	20935329	4	O
(	20935329	4	O
55%	20935329	4	O
)	20935329	4	O
and	20935329	4	O
3	20935329	4	O
(	20935329	4	O
30%	20935329	4	O
)	20935329	4	O
.	20935329	4	O

Prevalence	20961759	4	O
,	20961759	4	O
mutation	20961759	4	O
spectrum	20961759	4	O
and	20961759	4	O
phenotypic	20961759	4	O
variability	20961759	4	O
in	20961759	4	O
Norwegian	20961759	4	O
patients	20961759	4	O
with	20961759	4	O
Limb	20961759	4	O
Girdle	20961759	4	O
Muscular	20961759	4	O
Dystrophy	20961759	4	O
2	20961759	4	O
I.	20961759	4	O
Mutations	20961759	4	B-Var
in	20961759	4	O
the	20961759	4	O
FKRP	20961759	4	B-Gene
(	20961759	4	O
Fukutin	20961759	4	O
Related	20961759	4	O
Protein	20961759	4	O
)	20961759	4	O
gene	20961759	4	O
produce	20961759	4	B-Reg
a	20961759	4	O
range	20961759	4	O
of	20961759	4	O
phenotypes	20961759	4	O
including	20961759	4	O
Limb	20961759	4	B-Disease
Girdle	20961759	4	I-Disease
Muscular	20961759	4	I-Disease
Dystrophy	20961759	4	I-Disease
Type	20961759	4	I-Disease
2	20961759	4	I-Disease
I	20961759	4	I-Disease
(	20961759	4	O
LGMD2I	20961759	4	O
)	20961759	4	O
.	20961759	4	O
In	20961759	4	O
order	20961759	4	O
to	20961759	4	O
investigate	20961759	4	O
the	20961759	4	O
prevalence	20961759	4	O
,	20961759	4	O
the	20961759	4	O
mutation	20961759	4	O
spectrum	20961759	4	O
and	20961759	4	O
possible	20961759	4	O
genotype	20961759	4	O
-	20961759	4	O
phenotype	20961759	4	O
correlation	20961759	4	O
,	20961759	4	O
we	20961759	4	O
studied	20961759	4	O
a	20961759	4	O
cohort	20961759	4	O
of	20961759	4	O
Norwegian	20961759	4	O
patients	20961759	4	O
with	20961759	4	O
LGMD2I	20961759	4	O
,	20961759	4	O
ascertained	20961759	4	O
in	20961759	4	O
a	20961759	4	O
4	20961759	4	O
-	20961759	4	O
year	20961759	4	O
period	20961759	4	O
.	20961759	4	O
In	20961759	4	O
this	20961759	4	O
retrospective	20961759	4	O
study	20961759	4	O
of	20961759	4	O
genetically	20961759	4	O
tested	20961759	4	O
patients	20961759	4	O
,	20961759	4	O
we	20961759	4	O
identified	20961759	4	O
88	20961759	4	O
patients	20961759	4	O
from	20961759	4	O
69	20961759	4	O
families	20961759	4	O
,	20961759	4	O
who	20961759	4	O
were	20961759	4	O
either	20961759	4	O
homozygous	20961759	4	O
or	20961759	4	O
compound	20961759	4	O
heterozygous	20961759	4	O
for	20961759	4	O
FKRP	20961759	4	O
mutations	20961759	4	O
.	20961759	4	O
Seven	20961759	4	O
different	20961759	4	O
FKRP	20961759	4	O
mutations	20961759	4	O
,	20961759	4	O
including	20961759	4	O
three	20961759	4	O
novel	20961759	4	O
changes	20961759	4	O
,	20961759	4	O
were	20961759	4	O
detected	20961759	4	O
.	20961759	4	O
Seventy	20961759	4	O
-	20961759	4	O
six	20961759	4	O
patients	20961759	4	O
were	20961759	4	O
homozygous	20961759	4	O
for	20961759	4	O
the	20961759	4	O
common	20961759	4	O
c.826	20961759	4	O
C	20961759	4	O
>	20961759	4	O
A	20961759	4	O
mutation	20961759	4	O
.	20961759	4	O

Mutant	21187651	0	O
p53	21187651	0	O
R248Q	21187651	0	O
but	21187651	0	O
not	21187651	0	O
R248W	21187651	0	O
enhances	21187651	0	O
in	21187651	0	O
vitro	21187651	0	O
invasiveness	21187651	0	O
of	21187651	0	O
human	21187651	0	O
lung	21187651	0	O
cancer	21187651	0	O
NCI	21187651	0	O
-	21187651	0	O
H1299	21187651	0	O
cells	21187651	0	O
.	21187651	0	O
More	21187651	0	O
than	21187651	0	O
half	21187651	0	O
of	21187651	0	O
all	21187651	0	O
human	21187651	0	B-Disease
cancers	21187651	0	I-Disease
are	21187651	0	O
associated	21187651	0	B-Reg
with	21187651	0	O
mutations	21187651	0	B-Var
of	21187651	0	O
the	21187651	0	O
TP53	21187651	0	B-Gene
gene	21187651	0	O
.	21187651	0	O
In	21187651	0	O
regard	21187651	0	O
to	21187651	0	O
the	21187651	0	O
functional	21187651	0	O
interaction	21187651	0	O
with	21187651	0	O
the	21187651	0	O
remaining	21187651	0	O
wild	21187651	0	O
-	21187651	0	O
type	21187651	0	O
(	21187651	0	O
WT	21187651	0	O
)	21187651	0	O
p53	21187651	0	O
allele	21187651	0	O
,	21187651	0	O
p53	21187651	0	O
mutations	21187651	0	O
are	21187651	0	O
classified	21187651	0	O
into	21187651	0	O
two	21187651	0	O
types	21187651	0	O
,	21187651	0	O
recessive	21187651	0	O
and	21187651	0	O
dominant	21187651	0	B-Var
-	21187651	0	I-Var
negative	21187651	0	I-Var
(	21187651	0	I-Var
DN	21187651	0	I-Var
)	21187651	0	I-Var
mutations	21187651	0	I-Var
.	21187651	0	O
The	21187651	0	O
latter	21187651	0	O
mutant	21187651	0	O
protein	21187651	0	O
has	21187651	0	O
a	21187651	0	O
DN	21187651	0	O
activity	21187651	0	O
over	21187651	0	B-PosReg
the	21187651	0	I-PosReg
remaining	21187651	0	I-PosReg
WT	21187651	0	I-PosReg
allele	21187651	0	I-PosReg
.	21187651	0	O
We	21187651	0	O
previously	21187651	0	O
showed	21187651	0	O
that	21187651	0	O
the	21187651	0	O
DN	21187651	0	O
p53	21187651	0	O
mutant	21187651	0	O
was	21187651	0	O
useful	21187651	0	O
as	21187651	0	O
a	21187651	0	O
predictor	21187651	0	O
of	21187651	0	O
poor	21187651	0	O
outcome	21187651	0	O
or	21187651	0	O
a	21187651	0	O
risk	21187651	0	O
factor	21187651	0	O
for	21187651	0	O
metastatic	21187651	0	O
recurrence	21187651	0	O
in	21187651	0	O
patients	21187651	0	O
with	21187651	0	O
some	21187651	0	O
types	21187651	0	O
of	21187651	0	O
cancers	21187651	0	O
,	21187651	0	O
regardless	21187651	0	O
of	21187651	0	O
the	21187651	0	O
presence	21187651	0	O
or	21187651	0	O
absence	21187651	0	O
of	21187651	0	O
loss	21187651	0	O
of	21187651	0	O
heterozygosity	21187651	0	O
(	21187651	0	O
LOH	21187651	0	O
)	21187651	0	O
of	21187651	0	O
WT	21187651	0	O
p53	21187651	0	O
,	21187651	0	O
suggesting	21187651	0	O
that	21187651	0	O
the	21187651	0	O
DN	21187651	0	B-Var
p53	21187651	0	B-Gene
had	21187651	0	O
'	21187651	0	B-PosReg
gain	21187651	0	I-PosReg
-	21187651	0	I-PosReg
of	21187651	0	I-PosReg
-	21187651	0	I-PosReg
function	21187651	0	I-PosReg
(	21187651	0	I-PosReg
GOF	21187651	0	I-PosReg
)	21187651	0	I-PosReg
'	21187651	0	I-PosReg
activity	21187651	0	I-PosReg
besides	21187651	0	O
the	21187651	0	O
transdominance	21187651	0	O
function	21187651	0	O
.	21187651	0	O
In	21187651	0	O
this	21187651	0	O
study	21187651	0	O
,	21187651	0	O
we	21187651	0	O
investigated	21187651	0	O
GOF	21187651	0	O
activity	21187651	0	O
of	21187651	0	O
two	21187651	0	O
DN	21187651	0	O
p53	21187651	0	O
mutants	21187651	0	O
which	21187651	0	O
had	21187651	0	O
a	21187651	0	O
point	21187651	0	O
mutation	21187651	0	O
at	21187651	0	O
codon	21187651	0	O
248	21187651	0	O
(	21187651	0	O
R248Q	21187651	0	O
and	21187651	0	O
R248W	21187651	0	O
)	21187651	0	O
,	21187651	0	O
one	21187651	0	O
of	21187651	0	O
the	21187651	0	O
hot	21187651	0	O
spots	21187651	0	O
,	21187651	0	O
by	21187651	0	O
transfecting	21187651	0	O
them	21187651	0	O
respectively	21187651	0	O
into	21187651	0	O
H1299	21187651	0	O
cells	21187651	0	O
which	21187651	0	O
originally	21187651	0	O
expressed	21187651	0	O
no	21187651	0	O
p53	21187651	0	O
protein	21187651	0	O
.	21187651	0	O
Growth	21187651	0	O
activity	21187651	0	O
of	21187651	0	O
the	21187651	0	O
transfectants	21187651	0	O
with	21187651	0	O
the	21187651	0	O
two	21187651	0	O
mutants	21187651	0	O
was	21187651	0	O
not	21187651	0	O
different	21187651	0	O
from	21187651	0	O
that	21187651	0	O
of	21187651	0	O
parent	21187651	0	O
or	21187651	0	O
Mock	21187651	0	O
transfectants	21187651	0	O
.	21187651	0	O
Meanwhile	21187651	0	O
,	21187651	0	O
in	21187651	0	O
vitro	21187651	0	O
invasions	21187651	0	O
of	21187651	0	O
Matrigel	21187651	0	O
and	21187651	0	O
type	21187651	0	O
I	21187651	0	O
collagen	21187651	0	O
gel	21187651	0	O
by	21187651	0	O
R248Q	21187651	0	B-Var
-	21187651	0	I-Var
transfectants	21187651	0	I-Var
were	21187651	0	O
significantly	21187651	0	O
higher	21187651	0	B-PosReg
than	21187651	0	O
those	21187651	0	O
by	21187651	0	O
R248W	21187651	0	O
-	21187651	0	O
transfectants	21187651	0	O
or	21187651	0	O
the	21187651	0	O
control	21187651	0	O
cells	21187651	0	O
.	21187651	0	O
However	21187651	0	O
,	21187651	0	O
there	21187651	0	O
were	21187651	0	O
no	21187651	0	O
differences	21187651	0	O
in	21187651	0	O
cell	21187651	0	O
motile	21187651	0	O
activities	21187651	0	O
,	21187651	0	O
expressions	21187651	0	O
of	21187651	0	O
extracellular	21187651	0	O
matrix	21187651	0	O
-	21187651	0	O
degradative	21187651	0	O
enzymes	21187651	0	O
such	21187651	0	O
as	21187651	0	O
matrix	21187651	0	O
metalloproteinases	21187651	0	O
,	21187651	0	O
urokinase	21187651	0	O
-	21187651	0	O
type	21187651	0	O
plasminogen	21187651	0	O
activator	21187651	0	O
and	21187651	0	O
heparanase	21187651	0	O
,	21187651	0	O
and	21187651	0	O
their	21187651	0	O
inhibitors	21187651	0	O
,	21187651	0	O
between	21187651	0	O
R248Q	21187651	0	O
-	21187651	0	O
and	21187651	0	O
R248W	21187651	0	O
-	21187651	0	O
transfectants	21187651	0	O
.	21187651	0	O
These	21187651	0	O
findings	21187651	0	O
indicate	21187651	0	O
that	21187651	0	O
the	21187651	0	O
p53	21187651	0	O
mutants	21187651	0	O
have	21187651	0	O
a	21187651	0	O
different	21187651	0	O
quality	21187651	0	O
in	21187651	0	O
GOF	21187651	0	O
activities	21187651	0	O
even	21187651	0	O
if	21187651	0	O
the	21187651	0	O
mutations	21187651	0	O
occurred	21187651	0	O
at	21187651	0	O
the	21187651	0	O
same	21187651	0	O
codon	21187651	0	O
.	21187651	0	O
And	21187651	0	O
detailed	21187651	0	O
information	21187651	0	O
of	21187651	0	O
the	21187651	0	O
status	21187651	0	O
of	21187651	0	O
p53	21187651	0	O
,	21187651	0	O
including	21187651	0	O
transdominancy	21187651	0	O
and	21187651	0	O
GOF	21187651	0	O
activity	21187651	0	O
,	21187651	0	O
is	21187651	0	O
expected	21187651	0	O
to	21187651	0	O
be	21187651	0	O
useful	21187651	0	O
for	21187651	0	O
diagnosis	21187651	0	O
and	21187651	0	O
therapeutic	21187651	0	O
strategy	21187651	0	O
fitting	21187651	0	O
the	21187651	0	O
individual	21187651	0	O
patients	21187651	0	O
.	21187651	0	O

Gain	22114072	2	O
-	22114072	2	O
of	22114072	2	O
-	22114072	2	O
function	22114072	2	O
mutant	22114072	2	B-Var
p53	22114072	2	B-Gene
upregulates	22114072	2	B-PosReg
CXC	22114072	2	O
chemokines	22114072	2	O
and	22114072	2	O
enhances	22114072	2	B-PosReg
cell	22114072	2	O
migration	22114072	2	O
.	22114072	2	O
Here	22114072	2	O
,	22114072	2	O
we	22114072	2	O
examined	22114072	2	O
potential	22114072	2	O
mechanisms	22114072	2	O
through	22114072	2	O
which	22114072	2	O
gain	22114072	2	O
-	22114072	2	O
of	22114072	2	O
-	22114072	2	O
function	22114072	2	O
(	22114072	2	O
GOF	22114072	2	O
)	22114072	2	O
p53	22114072	2	O
proteins	22114072	2	O
can	22114072	2	O
induce	22114072	2	O
motility	22114072	2	O
.	22114072	2	O
Cells	22114072	2	O
expressing	22114072	2	O
GOF	22114072	2	O
p53	22114072	2	B-Var
-	22114072	2	I-Var
R175H	22114072	2	I-Var
,	22114072	2	O
-	22114072	2	I-Var
R273H	22114072	2	I-Var
and	22114072	2	I-Var
-	22114072	2	I-Var
D281G	22114072	2	I-Var
showed	22114072	2	O
enhanced	22114072	2	B-PosReg
migration	22114072	2	O
,	22114072	2	O
which	22114072	2	O
was	22114072	2	O
reversed	22114072	2	O
by	22114072	2	O
RNA	22114072	2	O
interference	22114072	2	O
(	22114072	2	O
RNAi	22114072	2	O
)	22114072	2	O
or	22114072	2	O
transactivation	22114072	2	O
-	22114072	2	O
deficient	22114072	2	O
mutants	22114072	2	O
.	22114072	2	O
In	22114072	2	O
cells	22114072	2	O
with	22114072	2	O
engineered	22114072	2	O
or	22114072	2	O
endogenous	22114072	2	O
p53	22114072	2	O
mutants	22114072	2	O
,	22114072	2	O
enhanced	22114072	2	O
migration	22114072	2	O
was	22114072	2	O
reduced	22114072	2	O
by	22114072	2	O
downregulation	22114072	2	O
of	22114072	2	O
nuclear	22114072	2	O
factor	22114072	2	O
-	22114072	2	O
kappaB2	22114072	2	O
,	22114072	2	O
a	22114072	2	O
GOF	22114072	2	O
p53	22114072	2	O
target	22114072	2	O
.	22114072	2	O
We	22114072	2	O
found	22114072	2	O
that	22114072	2	O
GOF	22114072	2	B-Var
p53	22114072	2	I-Var
proteins	22114072	2	O
upregulate	22114072	2	B-PosReg
CXC	22114072	2	O
-	22114072	2	O
chemokine	22114072	2	O
expression	22114072	2	O
,	22114072	2	O
the	22114072	2	O
inflammatory	22114072	2	O
mediators	22114072	2	O
that	22114072	2	O
contribute	22114072	2	O
to	22114072	2	O
multiple	22114072	2	O
aspects	22114072	2	O
of	22114072	2	O
tumorigenesis	22114072	2	O
.	22114072	2	O
Transcription	22114072	2	O
was	22114072	2	O
elevated	22114072	2	B-PosReg
as	22114072	2	O
CXCL5	22114072	2	O
and	22114072	2	O
CXCL8	22114072	2	O
promoter	22114072	2	O
activity	22114072	2	O
was	22114072	2	O
higher	22114072	2	B-PosReg
in	22114072	2	O
cells	22114072	2	O
expressing	22114072	2	O
GOF	22114072	2	B-Var
p53	22114072	2	I-Var
,	22114072	2	O
whereas	22114072	2	O
wild	22114072	2	O
-	22114072	2	O
type	22114072	2	O
p53	22114072	2	O
repressed	22114072	2	O
promoter	22114072	2	O
activity	22114072	2	O
.	22114072	2	O
Chromatin	22114072	2	O
immunoprecipitation	22114072	2	O
assays	22114072	2	O
revealed	22114072	2	O
enhanced	22114072	2	O
presence	22114072	2	O
of	22114072	2	O
acetylated	22114072	2	O
histone	22114072	2	O
H3	22114072	2	O
on	22114072	2	O
the	22114072	2	O
CXCL5	22114072	2	O
promoter	22114072	2	O
in	22114072	2	O
H1299	22114072	2	O
/	22114072	2	O
R273H	22114072	2	O
cells	22114072	2	O
,	22114072	2	O
in	22114072	2	O
agreement	22114072	2	O
with	22114072	2	O
increased	22114072	2	O
transcriptional	22114072	2	O
activity	22114072	2	O
of	22114072	2	O
the	22114072	2	O
promoter	22114072	2	O
,	22114072	2	O
whereas	22114072	2	O
RNAi	22114072	2	O
-	22114072	2	O
mediated	22114072	2	O
repression	22114072	2	O
of	22114072	2	O
CXCL5	22114072	2	O
inhibited	22114072	2	O
cell	22114072	2	O
migration	22114072	2	O
.	22114072	2	O
Consistent	22114072	2	O
with	22114072	2	O
this	22114072	2	O
,	22114072	2	O
knockdown	22114072	2	O
of	22114072	2	O
the	22114072	2	O
endogenous	22114072	2	B-Var
mutant	22114072	2	I-Var
p53	22114072	2	B-Gene
in	22114072	2	O
lung	22114072	2	O
cancer	22114072	2	O
or	22114072	2	O
melanoma	22114072	2	O
cells	22114072	2	O
reduced	22114072	2	B-NegReg
CXCL5	22114072	2	O
expression	22114072	2	O
and	22114072	2	O
cell	22114072	2	O
migration	22114072	2	O
.	22114072	2	O
Furthermore	22114072	2	O
,	22114072	2	O
short	22114072	2	O
hairpin	22114072	2	O
RNA	22114072	2	O
knockdown	22114072	2	O
of	22114072	2	O
mutant	22114072	2	B-Var
p53	22114072	2	B-Gene
in	22114072	2	O
MDA	22114072	2	O
-	22114072	2	O
MB-231	22114072	2	O
cells	22114072	2	O
reduced	22114072	2	B-NegReg
expression	22114072	2	O
of	22114072	2	O
a	22114072	2	O
number	22114072	2	O
of	22114072	2	O
key	22114072	2	O
targets	22114072	2	O
,	22114072	2	O
including	22114072	2	O
several	22114072	2	O
chemokines	22114072	2	O
and	22114072	2	O
other	22114072	2	O
inflammatory	22114072	2	O
mediators	22114072	2	O
.	22114072	2	O
Finally	22114072	2	O
,	22114072	2	O
CXCL5	22114072	2	O
expression	22114072	2	O
was	22114072	2	O
also	22114072	2	O
elevated	22114072	2	B-PosReg
in	22114072	2	O
lung	22114072	2	B-Disease
tumor	22114072	2	I-Disease
samples	22114072	2	O
containing	22114072	2	O
GOF	22114072	2	B-Var
p53	22114072	2	I-Var
,	22114072	2	O
indicating	22114072	2	O
relevance	22114072	2	O
to	22114072	2	O
human	22114072	2	O
cancer	22114072	2	O
.	22114072	2	O
The	22114072	2	O
data	22114072	2	O
suggest	22114072	2	O
a	22114072	2	O
mechanistic	22114072	2	O
link	22114072	2	O
between	22114072	2	O
GOF	22114072	2	O
p53	22114072	2	O
proteins	22114072	2	O
and	22114072	2	O
chemokines	22114072	2	O
in	22114072	2	O
enhanced	22114072	2	O
cell	22114072	2	O
motility	22114072	2	O
.	22114072	2	O

Allele	22989750	2	O
specific	22989750	2	O
gain	22989750	2	B-PosReg
-	22989750	2	I-PosReg
of	22989750	2	I-PosReg
-	22989750	2	I-PosReg
function	22989750	2	I-PosReg
activity	22989750	2	O
of	22989750	2	O
p53	22989750	2	B-Gene
mutants	22989750	2	B-Var
in	22989750	2	O
lung	22989750	2	B-Disease
cancer	22989750	2	I-Disease
cells	22989750	2	O
.	22989750	2	O
p53	22989750	2	B-Gene
mutations	22989750	2	B-Var
are	22989750	2	O
mostly	22989750	2	O
single	22989750	2	O
amino	22989750	2	O
acid	22989750	2	O
changes	22989750	2	O
resulting	22989750	2	B-Reg
in	22989750	2	I-Reg
expression	22989750	2	O
of	22989750	2	O
a	22989750	2	O
stable	22989750	2	O
mutant	22989750	2	O
protein	22989750	2	O
with	22989750	2	O
"	22989750	2	B-PosReg
gain	22989750	2	I-PosReg
of	22989750	2	I-PosReg
function	22989750	2	I-PosReg
"	22989750	2	I-PosReg
(	22989750	2	O
GOF	22989750	2	O
)	22989750	2	O
activity	22989750	2	O
having	22989750	2	O
a	22989750	2	O
dominant	22989750	2	O
oncogenic	22989750	2	O
role	22989750	2	O
rather	22989750	2	O
than	22989750	2	O
simple	22989750	2	O
loss	22989750	2	O
of	22989750	2	O
function	22989750	2	O
of	22989750	2	O
wild	22989750	2	O
-	22989750	2	O
type	22989750	2	O
p53	22989750	2	O
.	22989750	2	O
Knock	22989750	2	O
-	22989750	2	O
down	22989750	2	O
of	22989750	2	O
mutant	22989750	2	O
p53	22989750	2	O
in	22989750	2	O
human	22989750	2	O
lung	22989750	2	O
cancer	22989750	2	O
cell	22989750	2	O
lines	22989750	2	O
with	22989750	2	O
different	22989750	2	O
endogenous	22989750	2	O
p53	22989750	2	B-Gene
mutants	22989750	2	B-Var
results	22989750	2	O
in	22989750	2	O
loss	22989750	2	B-NegReg
of	22989750	2	O
GOF	22989750	2	O
activity	22989750	2	O
as	22989750	2	O
shown	22989750	2	O
by	22989750	2	O
lowering	22989750	2	B-NegReg
of	22989750	2	O
cell	22989750	2	O
growth	22989750	2	O
rate	22989750	2	O
.	22989750	2	O
Two	22989750	2	O
lung	22989750	2	O
cancer	22989750	2	O
cell	22989750	2	O
lines	22989750	2	O
,	22989750	2	O
ABC1	22989750	2	O
and	22989750	2	O
H1437	22989750	2	O
,	22989750	2	O
carrying	22989750	2	O
endogenous	22989750	2	O
mutants	22989750	2	B-Var
p53	22989750	2	I-Var
-	22989750	2	I-Var
P278S	22989750	2	I-Var
and	22989750	2	I-Var
-	22989750	2	I-Var
R267P	22989750	2	I-Var
,	22989750	2	O
show	22989750	2	O
reduction	22989750	2	B-NegReg
in	22989750	2	O
growth	22989750	2	O
rate	22989750	2	O
on	22989750	2	O
knock	22989750	2	O
-	22989750	2	O
down	22989750	2	O
on	22989750	2	O
p53	22989750	2	O
levels	22989750	2	O
.	22989750	2	O
Interestingly	22989750	2	O
,	22989750	2	O
while	22989750	2	O
the	22989750	2	O
mutant	22989750	2	O
p53	22989750	2	O
target	22989750	2	O
promoter	22989750	2	O
Axl	22989750	2	O
was	22989750	2	O
activated	22989750	2	O
by	22989750	2	O
both	22989750	2	O
the	22989750	2	O
mutants	22989750	2	O
,	22989750	2	O
the	22989750	2	O
p21	22989750	2	O
promoter	22989750	2	O
was	22989750	2	O
activated	22989750	2	O
by	22989750	2	O
p53	22989750	2	O
-	22989750	2	O
R267P	22989750	2	O
and	22989750	2	O
wild	22989750	2	O
-	22989750	2	O
type	22989750	2	O
p53	22989750	2	O
but	22989750	2	O
not	22989750	2	O
by	22989750	2	O
p53	22989750	2	O
-	22989750	2	O
P278S	22989750	2	O
;	22989750	2	O
showing	22989750	2	O
a	22989750	2	O
clear	22989750	2	O
difference	22989750	2	O
in	22989750	2	O
transcriptional	22989750	2	O
activity	22989750	2	O
between	22989750	2	O
the	22989750	2	O
two	22989750	2	O
mutants	22989750	2	O
.	22989750	2	O
Our	22989750	2	O
results	22989750	2	O
demonstrate	22989750	2	O
allele	22989750	2	O
specificity	22989750	2	O
between	22989750	2	O
GOF	22989750	2	O
p53	22989750	2	O
mutants	22989750	2	O
and	22989750	2	O
attempt	22989750	2	O
to	22989750	2	O
show	22989750	2	O
that	22989750	2	O
the	22989750	2	O
specificity	22989750	2	O
is	22989750	2	O
dependent	22989750	2	O
on	22989750	2	O
the	22989750	2	O
transactivation	22989750	2	O
property	22989750	2	O
of	22989750	2	O
GOF	22989750	2	O
p53	22989750	2	O
;	22989750	2	O
it	22989750	2	O
also	22989750	2	O
suggests	22989750	2	O
importance	22989750	2	O
of	22989750	2	O
p21	22989750	2	O
activation	22989750	2	O
in	22989750	2	O
tumor	22989750	2	O
suppression	22989750	2	O
by	22989750	2	O
p53	22989750	2	O
.	22989750	2	O

Gain	23264849	0	O
-	23264849	0	O
of	23264849	0	O
-	23264849	0	O
Function	23264849	0	O
Activity	23264849	0	O
of	23264849	0	O
Mutant	23264849	0	O
p53	23264849	0	O
in	23264849	0	O
Lung	23264849	0	O
Cancer	23264849	0	O
through	23264849	0	O
Up	23264849	0	O
-	23264849	0	O
Regulation	23264849	0	O
of	23264849	0	O
Receptor	23264849	0	O
Protein	23264849	0	O
Tyrosine	23264849	0	O
Kinase	23264849	0	O
Axl	23264849	0	O
.	23264849	0	O
p53	23264849	0	O
mutations	23264849	0	O
are	23264849	0	O
present	23264849	0	O
in	23264849	0	O
up	23264849	0	O
to	23264849	0	O
70%	23264849	0	O
of	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
.	23264849	0	O
Cancer	23264849	0	O
cells	23264849	0	O
with	23264849	0	O
p53	23264849	0	B-Gene
mutations	23264849	0	B-Var
,	23264849	0	O
in	23264849	0	O
general	23264849	0	O
,	23264849	0	O
grow	23264849	0	O
more	23264849	0	O
aggressively	23264849	0	B-PosReg
than	23264849	0	O
those	23264849	0	O
with	23264849	0	O
wild	23264849	0	O
-	23264849	0	O
type	23264849	0	O
p53	23264849	0	O
or	23264849	0	O
no	23264849	0	O
p53	23264849	0	O
.	23264849	0	O
Expression	23264849	0	O
of	23264849	0	O
tumor	23264849	0	O
-	23264849	0	O
derived	23264849	0	O
mutant	23264849	0	B-Var
p53	23264849	0	B-Gene
in	23264849	0	O
cells	23264849	0	O
leads	23264849	0	O
to	23264849	0	O
up	23264849	0	B-PosReg
-	23264849	0	I-PosReg
regulated	23264849	0	I-PosReg
expression	23264849	0	O
of	23264849	0	O
genes	23264849	0	O
that	23264849	0	O
may	23264849	0	O
affect	23264849	0	B-Reg
cell	23264849	0	O
growth	23264849	0	O
and	23264849	0	O
oncogenesis	23264849	0	O
.	23264849	0	O
In	23264849	0	O
our	23264849	0	O
study	23264849	0	O
of	23264849	0	O
this	23264849	0	O
aggressive	23264849	0	O
phenotype	23264849	0	O
,	23264849	0	O
we	23264849	0	O
have	23264849	0	O
investigated	23264849	0	O
the	23264849	0	O
receptor	23264849	0	O
protein	23264849	0	O
tyrosine	23264849	0	O
kinase	23264849	0	O
Axl	23264849	0	O
,	23264849	0	O
which	23264849	0	O
is	23264849	0	O
up	23264849	0	B-PosReg
-	23264849	0	I-PosReg
regulated	23264849	0	I-PosReg
by	23264849	0	O
p53	23264849	0	B-Gene
mutants	23264849	0	B-Var
at	23264849	0	O
both	23264849	0	O
RNA	23264849	0	O
and	23264849	0	O
protein	23264849	0	O
levels	23264849	0	O
in	23264849	0	O
H1299	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
cells	23264849	0	O
expressing	23264849	0	O
mutants	23264849	0	O
p53	23264849	0	O
-	23264849	0	O
R175H	23264849	0	O
,	23264849	0	O
-	23264849	0	O
R273H	23264849	0	O
,	23264849	0	O
and	23264849	0	O
-	23264849	0	O
D281G	23264849	0	O
.	23264849	0	O
Knockdown	23264849	0	O
of	23264849	0	O
endogenous	23264849	0	O
mutant	23264849	0	O
p53	23264849	0	O
levels	23264849	0	O
in	23264849	0	O
human	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
cells	23264849	0	O
H1048	23264849	0	O
(	23264849	0	O
p53	23264849	0	O
-	23264849	0	O
R273C	23264849	0	O
)	23264849	0	O
and	23264849	0	O
H1437	23264849	0	O
(	23264849	0	O
p53	23264849	0	O
-	23264849	0	O
R267P	23264849	0	O
)	23264849	0	O
led	23264849	0	O
to	23264849	0	O
a	23264849	0	O
reduction	23264849	0	O
in	23264849	0	O
the	23264849	0	O
level	23264849	0	O
of	23264849	0	O
Axl	23264849	0	O
as	23264849	0	O
well	23264849	0	O
.	23264849	0	O
This	23264849	0	O
effect	23264849	0	O
on	23264849	0	O
Axl	23264849	0	O
expression	23264849	0	O
is	23264849	0	O
refractory	23264849	0	O
to	23264849	0	O
the	23264849	0	O
mutations	23264849	0	O
at	23264849	0	O
positions	23264849	0	O
22	23264849	0	O
and	23264849	0	O
23	23264849	0	O
of	23264849	0	O
p53	23264849	0	O
,	23264849	0	O
suggesting	23264849	0	O
that	23264849	0	O
p53	23264849	0	O
'	23264849	0	O
s	23264849	0	O
transactivation	23264849	0	O
domain	23264849	0	O
may	23264849	0	O
not	23264849	0	O
play	23264849	0	O
a	23264849	0	O
critical	23264849	0	O
role	23264849	0	O
in	23264849	0	O
the	23264849	0	O
up	23264849	0	O
-	23264849	0	O
regulation	23264849	0	O
of	23264849	0	O
Axl	23264849	0	O
gene	23264849	0	O
expression	23264849	0	O
.	23264849	0	O
Chromatin	23264849	0	O
immunoprecipitation	23264849	0	O
(	23264849	0	O
ChIP	23264849	0	O
)	23264849	0	O
assays	23264849	0	O
carried	23264849	0	O
out	23264849	0	O
with	23264849	0	O
acetylated	23264849	0	O
histone	23264849	0	O
antibodies	23264849	0	O
demonstrated	23264849	0	O
induced	23264849	0	O
histone	23264849	0	B-Reg
acetylation	23264849	0	O
on	23264849	0	O
the	23264849	0	O
Axl	23264849	0	O
promoter	23264849	0	O
region	23264849	0	O
by	23264849	0	O
mutant	23264849	0	B-Var
p53	23264849	0	B-Gene
.	23264849	0	O
Direct	23264849	0	O
mutant	23264849	0	O
p53	23264849	0	O
nucleation	23264849	0	O
on	23264849	0	O
the	23264849	0	O
Axl	23264849	0	O
promoter	23264849	0	O
was	23264849	0	O
demonstrated	23264849	0	O
by	23264849	0	O
ChIP	23264849	0	O
assays	23264849	0	O
using	23264849	0	O
antibodies	23264849	0	O
against	23264849	0	O
p53	23264849	0	O
.	23264849	0	O
The	23264849	0	O
Axl	23264849	0	O
promoter	23264849	0	O
has	23264849	0	O
a	23264849	0	O
p53	23264849	0	O
/	23264849	0	O
p63	23264849	0	O
binding	23264849	0	O
site	23264849	0	O
,	23264849	0	O
which	23264849	0	O
however	23264849	0	O
is	23264849	0	O
not	23264849	0	O
required	23264849	0	O
for	23264849	0	O
mutant	23264849	0	O
p53	23264849	0	O
-	23264849	0	O
mediated	23264849	0	O
transactivation	23264849	0	O
.	23264849	0	O
Knockdown	23264849	0	O
of	23264849	0	O
Axl	23264849	0	O
by	23264849	0	O
Axl	23264849	0	O
-	23264849	0	O
specific	23264849	0	O
RNAi	23264849	0	O
caused	23264849	0	O
a	23264849	0	O
reduction	23264849	0	O
of	23264849	0	O
gain	23264849	0	O
-	23264849	0	O
of	23264849	0	O
-	23264849	0	O
function	23264849	0	O
(	23264849	0	O
GOF	23264849	0	O
)	23264849	0	O
activities	23264849	0	O
,	23264849	0	O
reducing	23264849	0	O
the	23264849	0	O
cell	23264849	0	O
growth	23264849	0	O
rate	23264849	0	O
and	23264849	0	O
motility	23264849	0	O
rate	23264849	0	O
in	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
cells	23264849	0	O
expressing	23264849	0	O
mutant	23264849	0	O
p53	23264849	0	O
.	23264849	0	O
This	23264849	0	O
indicates	23264849	0	O
that	23264849	0	O
for	23264849	0	O
lung	23264849	0	O
cancer	23264849	0	O
cell	23264849	0	O
lines	23264849	0	O
with	23264849	0	O
mutant	23264849	0	B-Var
p53	23264849	0	B-Gene
,	23264849	0	O
GOF	23264849	0	O
activities	23264849	0	O
are	23264849	0	O
mediated	23264849	0	B-Reg
in	23264849	0	O
part	23264849	0	O
through	23264849	0	O
Axl	23264849	0	O
.	23264849	0	O

Gain	23460523	0	O
-	23460523	0	O
of	23460523	0	O
-	23460523	0	O
function	23460523	0	O
mutations	23460523	0	O
in	23460523	0	O
PDR1	23460523	0	O
,	23460523	0	O
a	23460523	0	O
regulator	23460523	0	O
of	23460523	0	O
antifungal	23460523	0	O
drug	23460523	0	O
resistance	23460523	0	O
in	23460523	0	O
Candida	23460523	0	O
glabrata	23460523	0	O
,	23460523	0	O
control	23460523	0	O
adherence	23460523	0	O
to	23460523	0	O
host	23460523	0	O
cells	23460523	0	O
.	23460523	0	O
A	23460523	0	O
range	23460523	0	O
of	23460523	0	O
gain	23460523	0	B-PosReg
-	23460523	0	I-PosReg
of	23460523	0	I-PosReg
-	23460523	0	I-PosReg
function	23460523	0	I-PosReg
(	23460523	0	O
GOF	23460523	0	O
)	23460523	0	O
mutations	23460523	0	B-Var
in	23460523	0	O
CgPDR1	23460523	0	B-Gene
have	23460523	0	O
been	23460523	0	O
found	23460523	0	O
to	23460523	0	O
lead	23460523	0	B-PosReg
not	23460523	0	O
only	23460523	0	O
to	23460523	0	O
azole	23460523	0	O
resistance	23460523	0	O
but	23460523	0	O
also	23460523	0	O
to	23460523	0	O
enhanced	23460523	0	B-PosReg
virulence	23460523	0	O
.	23460523	0	O
To	23460523	0	O
identify	23460523	0	O
specific	23460523	0	O
CgPDR1	23460523	0	O
-	23460523	0	O
regulated	23460523	0	O
steps	23460523	0	O
of	23460523	0	O
the	23460523	0	O
host	23460523	0	O
-	23460523	0	O
pathogen	23460523	0	O
interaction	23460523	0	O
,	23460523	0	O
we	23460523	0	O
investigated	23460523	0	O
in	23460523	0	O
this	23460523	0	O
work	23460523	0	O
the	23460523	0	O
interaction	23460523	0	O
of	23460523	0	O
selected	23460523	0	O
CgPDR1	23460523	0	O
GOF	23460523	0	O
mutants	23460523	0	O
with	23460523	0	O
murine	23460523	0	O
bone	23460523	0	O
marrow	23460523	0	O
-	23460523	0	O
derived	23460523	0	O
macrophages	23460523	0	O
and	23460523	0	O
human	23460523	0	O
acute	23460523	0	O
monocytic	23460523	0	O
leukemia	23460523	0	O
cell	23460523	0	O
line	23460523	0	O
(	23460523	0	O
THP-1	23460523	0	O
)	23460523	0	O
-	23460523	0	O
derived	23460523	0	O
macrophages	23460523	0	O
,	23460523	0	O
as	23460523	0	O
well	23460523	0	O
as	23460523	0	O
different	23460523	0	O
epithelial	23460523	0	O
cell	23460523	0	O
lines	23460523	0	O
.	23460523	0	O
GOF	23460523	0	O
mutations	23460523	0	B-Var
in	23460523	0	O
CgPDR1	23460523	0	B-Gene
did	23460523	0	O
not	23460523	0	O
influence	23460523	0	O
survival	23460523	0	O
and	23460523	0	O
replication	23460523	0	O
within	23460523	0	O
macrophages	23460523	0	O
following	23460523	0	O
phagocytosis	23460523	0	O
but	23460523	0	O
led	23460523	0	O
to	23460523	0	O
decreased	23460523	0	B-NegReg
adherence	23460523	0	O
to	23460523	0	O
and	23460523	0	O
uptake	23460523	0	O
by	23460523	0	O
macrophages	23460523	0	O
.	23460523	0	O
The	23460523	0	O
interaction	23460523	0	O
with	23460523	0	O
epithelial	23460523	0	O
cells	23460523	0	O
revealed	23460523	0	O
an	23460523	0	O
opposite	23460523	0	O
trend	23460523	0	O
,	23460523	0	O
suggesting	23460523	0	O
that	23460523	0	O
GOF	23460523	0	O
mutations	23460523	0	B-Var
in	23460523	0	O
CgPDR1	23460523	0	B-Gene
may	23460523	0	O
favor	23460523	0	B-PosReg
epithelial	23460523	0	O
colonization	23460523	0	O
of	23460523	0	O
the	23460523	0	O
host	23460523	0	O
by	23460523	0	O
C.	23460523	0	O
glabrata	23460523	0	O
through	23460523	0	O
increased	23460523	0	B-PosReg
adherence	23460523	0	O
to	23460523	0	O
epithelial	23460523	0	O
cell	23460523	0	O
layers	23460523	0	O
.	23460523	0	O
These	23460523	0	O
data	23460523	0	O
reveal	23460523	0	O
that	23460523	0	O
GOF	23460523	0	O
mutations	23460523	0	B-Var
in	23460523	0	O
CgPDR1	23460523	0	B-Gene
modulate	23460523	0	B-Reg
the	23460523	0	O
interaction	23460523	0	O
with	23460523	0	O
host	23460523	0	O
cells	23460523	0	O
in	23460523	0	O
ways	23460523	0	O
that	23460523	0	O
may	23460523	0	O
contribute	23460523	0	O
to	23460523	0	O
increased	23460523	0	B-PosReg
virulence	23460523	0	O
.	23460523	0	O

Mutant	23680148	2	O
p53	23680148	2	O
prolongs	23680148	2	O
NF	23680148	2	O
-	23680148	2	O
B	23680148	2	O
activation	23680148	2	O
and	23680148	2	O
promotes	23680148	2	O
chronic	23680148	2	O
inflammation	23680148	2	O
and	23680148	2	O
inflammation	23680148	2	O
-	23680148	2	O
associated	23680148	2	O
colorectal	23680148	2	O
cancer	23680148	2	O
.	23680148	2	O
Common	23680148	2	O
mutant	23680148	2	O
p53	23680148	2	O
(	23680148	2	O
mutp53	23680148	2	O
)	23680148	2	O
isoforms	23680148	2	O
can	23680148	2	O
actively	23680148	2	O
promote	23680148	2	O
cancer	23680148	2	O
through	23680148	2	O
gain	23680148	2	O
-	23680148	2	O
of	23680148	2	O
-	23680148	2	O
function	23680148	2	O
(	23680148	2	O
GOF	23680148	2	O
)	23680148	2	O
mechanisms	23680148	2	O
.	23680148	2	O
Remarkably	23680148	2	O
,	23680148	2	O
when	23680148	2	O
exposed	23680148	2	O
to	23680148	2	O
dextran	23680148	2	O
sulfate	23680148	2	O
sodium	23680148	2	O
,	23680148	2	O
mice	23680148	2	O
harboring	23680148	2	O
a	23680148	2	O
germline	23680148	2	O
p53	23680148	2	O
mutation	23680148	2	O
develop	23680148	2	O
severe	23680148	2	O
chronic	23680148	2	O
inflammation	23680148	2	O
and	23680148	2	O
persistent	23680148	2	O
tissue	23680148	2	O
damage	23680148	2	O
,	23680148	2	O
and	23680148	2	O
are	23680148	2	O
highly	23680148	2	O
prone	23680148	2	O
to	23680148	2	O
inflammation	23680148	2	O
-	23680148	2	O
associated	23680148	2	O
colon	23680148	2	O
cancer	23680148	2	O
.	23680148	2	O
This	23680148	2	O
mutp53	23680148	2	O
GOF	23680148	2	O
is	23680148	2	O
manifested	23680148	2	O
by	23680148	2	O
rapid	23680148	2	O
onset	23680148	2	O
of	23680148	2	O
flat	23680148	2	O
dysplastic	23680148	2	O
lesions	23680148	2	O
that	23680148	2	O
progress	23680148	2	B-PosReg
to	23680148	2	O
invasive	23680148	2	B-Disease
carcinoma	23680148	2	I-Disease
with	23680148	2	O
mutp53	23680148	2	B-Var
accumulation	23680148	2	B-PosReg
and	23680148	2	O
augmented	23680148	2	O
NF	23680148	2	O
-	23680148	2	O
B	23680148	2	O
activation	23680148	2	B-PosReg
,	23680148	2	O
faithfully	23680148	2	O
recapitulating	23680148	2	O
features	23680148	2	O
frequently	23680148	2	O
observed	23680148	2	O
in	23680148	2	O
human	23680148	2	O
colitis	23680148	2	B-Disease
-	23680148	2	I-Disease
associated	23680148	2	I-Disease
colorectal	23680148	2	I-Disease
cancer	23680148	2	I-Disease
(	23680148	2	O
CAC	23680148	2	O
)	23680148	2	O
.	23680148	2	O
These	23680148	2	O
findings	23680148	2	O
might	23680148	2	O
explain	23680148	2	O
the	23680148	2	O
early	23680148	2	O
appearance	23680148	2	O
of	23680148	2	O
p53	23680148	2	O
mutations	23680148	2	O
in	23680148	2	O
human	23680148	2	O
CAC	23680148	2	O
.	23680148	2	O

Rett	23727441	4	B-Disease
syndrome	23727441	4	I-Disease
is	23727441	4	O
a	23727441	4	O
neurodevelopmental	23727441	4	O
disorder	23727441	4	O
caused	23727441	4	B-Reg
by	23727441	4	I-Reg
mutations	23727441	4	B-Var
in	23727441	4	O
the	23727441	4	O
X	23727441	4	O
-	23727441	4	O
linked	23727441	4	O
gene	23727441	4	O
encoding	23727441	4	O
methyl	23727441	4	O
-	23727441	4	O
CpG	23727441	4	O
-	23727441	4	O
binding	23727441	4	O
protein	23727441	4	O
2	23727441	4	O
(	23727441	4	B-Gene
MECP2	23727441	4	I-Gene
)	23727441	4	I-Gene
.	23727441	4	O

Clinical	23967324	2	O
relevance	23967324	2	O
of	23967324	2	O
gain	23967324	2	B-PosReg
-	23967324	2	I-PosReg
of	23967324	2	I-PosReg
-	23967324	2	I-PosReg
function	23967324	2	I-PosReg
mutations	23967324	2	B-Var
of	23967324	2	O
p53	23967324	2	B-Gene
in	23967324	2	O
high	23967324	2	B-Disease
-	23967324	2	I-Disease
grade	23967324	2	I-Disease
serous	23967324	2	I-Disease
ovarian	23967324	2	I-Disease
carcinoma	23967324	2	I-Disease
.	23967324	2	O
PURPOSE	23967324	2	O
:	23967324	2	O
Inactivation	23967324	2	O
of	23967324	2	O
TP53	23967324	2	O
,	23967324	2	O
which	23967324	2	O
occurs	23967324	2	O
predominantly	23967324	2	O
by	23967324	2	O
missense	23967324	2	O
mutations	23967324	2	O
in	23967324	2	O
exons	23967324	2	O
4	23967324	2	O
-	23967324	2	O
9	23967324	2	O
,	23967324	2	O
is	23967324	2	O
a	23967324	2	O
major	23967324	2	O
genetic	23967324	2	O
alteration	23967324	2	O
in	23967324	2	O
a	23967324	2	O
subset	23967324	2	O
of	23967324	2	O
human	23967324	2	O
cancer	23967324	2	O
.	23967324	2	O
In	23967324	2	O
spite	23967324	2	O
of	23967324	2	O
growing	23967324	2	O
evidence	23967324	2	O
that	23967324	2	O
gain	23967324	2	B-PosReg
-	23967324	2	I-PosReg
of	23967324	2	I-PosReg
-	23967324	2	I-PosReg
function	23967324	2	I-PosReg
(	23967324	2	O
GOF	23967324	2	O
)	23967324	2	O
mutations	23967324	2	B-Var
of	23967324	2	O
p53	23967324	2	B-Gene
also	23967324	2	O
have	23967324	2	O
oncogenic	23967324	2	O
activity	23967324	2	O
,	23967324	2	O
little	23967324	2	O
is	23967324	2	O
known	23967324	2	O
about	23967324	2	O
the	23967324	2	O
clinical	23967324	2	O
relevance	23967324	2	O
of	23967324	2	O
these	23967324	2	O
mutations	23967324	2	O
.	23967324	2	O
METHODS	23967324	2	O
:	23967324	2	O
The	23967324	2	O
clinicopathological	23967324	2	O
features	23967324	2	O
of	23967324	2	O
high	23967324	2	O
-	23967324	2	O
grade	23967324	2	O
serous	23967324	2	O
ovarian	23967324	2	O
carcinoma	23967324	2	O
(	23967324	2	O
HGS	23967324	2	O
-	23967324	2	O
OvCa	23967324	2	O
)	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
GOF	23967324	2	O
p53	23967324	2	O
mutations	23967324	2	O
were	23967324	2	O
evaluated	23967324	2	O
according	23967324	2	O
to	23967324	2	O
a	23967324	2	O
comprehensive	23967324	2	O
somatic	23967324	2	O
mutation	23967324	2	O
profile	23967324	2	O
comprised	23967324	2	O
of	23967324	2	O
whole	23967324	2	O
exome	23967324	2	O
sequencing	23967324	2	O
,	23967324	2	O
mRNA	23967324	2	O
expression	23967324	2	O
,	23967324	2	O
and	23967324	2	O
protein	23967324	2	O
expression	23967324	2	O
profiles	23967324	2	O
obtained	23967324	2	O
from	23967324	2	O
the	23967324	2	O
Cancer	23967324	2	O
Genome	23967324	2	O
Atlas	23967324	2	O
(	23967324	2	O
TCGA	23967324	2	O
)	23967324	2	O
.	23967324	2	O
RESULTS	23967324	2	O
:	23967324	2	O
Patients	23967324	2	O
with	23967324	2	O
a	23967324	2	O
mutant	23967324	2	O
p53	23967324	2	O
protein	23967324	2	O
(	23967324	2	O
mutp53	23967324	2	O
)	23967324	2	O
with	23967324	2	O
a	23967324	2	O
GOF	23967324	2	O
mutation	23967324	2	B-Var
showed	23967324	2	O
higher	23967324	2	B-PosReg
p53	23967324	2	O
mRNA	23967324	2	O
and	23967324	2	O
protein	23967324	2	O
expression	23967324	2	O
levels	23967324	2	O
than	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
p53	23967324	2	O
mutation	23967324	2	O
with	23967324	2	O
no	23967324	2	O
evidence	23967324	2	O
of	23967324	2	O
GOF	23967324	2	O
(	23967324	2	O
NE	23967324	2	O
-	23967324	2	O
GOF	23967324	2	O
)	23967324	2	O
.	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	O
were	23967324	2	O
more	23967324	2	O
likely	23967324	2	O
to	23967324	2	O
occur	23967324	2	O
within	23967324	2	O
mutational	23967324	2	O
hotspots	23967324	2	O
,	23967324	2	O
and	23967324	2	O
at	23967324	2	O
CpG	23967324	2	O
sites	23967324	2	O
,	23967324	2	O
and	23967324	2	O
resulted	23967324	2	O
in	23967324	2	O
mutp53	23967324	2	O
with	23967324	2	O
higher	23967324	2	O
functional	23967324	2	O
severity	23967324	2	O
(	23967324	2	O
FS	23967324	2	O
)	23967324	2	O
scores	23967324	2	O
.	23967324	2	O
Clinically	23967324	2	O
,	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	B-Var
showed	23967324	2	O
a	23967324	2	O
higher	23967324	2	B-PosReg
frequency	23967324	2	O
of	23967324	2	O
platinum	23967324	2	O
resistance	23967324	2	O
(	23967324	2	O
22	23967324	2	O
/	23967324	2	O
58	23967324	2	O
,	23967324	2	O
37.9%	23967324	2	O
)	23967324	2	O
than	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
NE	23967324	2	O
-	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	O
(	23967324	2	O
12	23967324	2	O
/	23967324	2	O
56	23967324	2	O
,	23967324	2	O
21.4%	23967324	2	O
)	23967324	2	O
(	23967324	2	O
p	23967324	2	O
=	23967324	2	O
0.054	23967324	2	O
)	23967324	2	O
.	23967324	2	O
Furthermore	23967324	2	O
,	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	B-Var
were	23967324	2	O
more	23967324	2	O
likely	23967324	2	O
to	23967324	2	O
develop	23967324	2	B-PosReg
distant	23967324	2	O
metastasis	23967324	2	O
(	23967324	2	O
36	23967324	2	O
/	23967324	2	O
55	23967324	2	O
,	23967324	2	O
65.5%	23967324	2	O
)	23967324	2	O
than	23967324	2	O
local	23967324	2	O
recurrence	23967324	2	O
(	23967324	2	O
19	23967324	2	O
/	23967324	2	O
55	23967324	2	O
,	23967324	2	O
34.5%	23967324	2	O
)	23967324	2	O
,	23967324	2	O
whereas	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
NE	23967324	2	O
-	23967324	2	O
GOF	23967324	2	O
mutations	23967324	2	O
showed	23967324	2	O
a	23967324	2	O
higher	23967324	2	O
frequency	23967324	2	O
of	23967324	2	O
locoregional	23967324	2	O
recurrence	23967324	2	O
(	23967324	2	O
26	23967324	2	O
/	23967324	2	O
47	23967324	2	O
,	23967324	2	O
55.3%	23967324	2	O
)	23967324	2	O
than	23967324	2	O
distant	23967324	2	O
metastasis	23967324	2	O
(	23967324	2	O
21	23967324	2	O
/	23967324	2	O
47	23967324	2	O
,	23967324	2	O
44.7%	23967324	2	O
)	23967324	2	O
(	23967324	2	O
p	23967324	2	O
=	23967324	2	O
0.035	23967324	2	O
)	23967324	2	O
.	23967324	2	O
There	23967324	2	O
were	23967324	2	O
no	23967324	2	O
differences	23967324	2	O
in	23967324	2	O
overall	23967324	2	O
or	23967324	2	O
progression	23967324	2	O
-	23967324	2	O
free	23967324	2	O
survival	23967324	2	O
between	23967324	2	O
patients	23967324	2	O
with	23967324	2	O
GOF	23967324	2	O
or	23967324	2	O
NE	23967324	2	O
-	23967324	2	O
GOF	23967324	2	O
mutp53	23967324	2	O
.	23967324	2	O
CONCLUSION	23967324	2	O
:	23967324	2	O
This	23967324	2	O
study	23967324	2	O
demonstrates	23967324	2	O
that	23967324	2	O
patient	23967324	2	O
with	23967324	2	O
GOF	23967324	2	B-PosReg
mutp53	23967324	2	B-Var
is	23967324	2	O
characterized	23967324	2	O
by	23967324	2	O
a	23967324	2	O
greater	23967324	2	B-PosReg
likelihood	23967324	2	O
of	23967324	2	O
platinum	23967324	2	O
treatment	23967324	2	O
resistance	23967324	2	O
and	23967324	2	O
distant	23967324	2	O
metastatic	23967324	2	O
properties	23967324	2	O
in	23967324	2	O
HGS	23967324	2	B-Disease
-	23967324	2	I-Disease
OvCa	23967324	2	I-Disease
.	23967324	2	O

Recurrent	24075313	4	O
de	24075313	4	O
novo	24075313	4	O
c.316	24075313	4	O
G	24075313	4	O
>	24075313	4	O
A	24075313	4	O
mutation	24075313	4	O
in	24075313	4	O
NIPA1	24075313	4	O
hotspot	24075313	4	O
.	24075313	4	O
Mutations	24075313	4	B-Var
in	24075313	4	O
the	24075313	4	O
NIPA1	24075313	4	B-Gene
cause	24075313	4	B-Reg
autosomal	24075313	4	O
dominant	24075313	4	O
form	24075313	4	O
of	24075313	4	O
hereditary	24075313	4	B-Disease
spastic	24075313	4	I-Disease
paraplegia	24075313	4	I-Disease
.	24075313	4	O
Allelic	24075313	4	O
heterogeneity	24075313	4	O
of	24075313	4	O
known	24075313	4	O
NIPA1	24075313	4	B-Gene
mutations	24075313	4	O
is	24075313	4	O
quite	24075313	4	O
limited	24075313	4	O
and	24075313	4	O
the	24075313	4	O
most	24075313	4	O
common	24075313	4	O
mutation	24075313	4	O
is	24075313	4	O
c.316	24075313	4	B-Var
G	24075313	4	I-Var
>	24075313	4	I-Var
A	24075313	4	I-Var
resulting	24075313	4	B-Reg
in	24075313	4	I-Reg
p.G106R	24075313	4	O
protein	24075313	4	O
change	24075313	4	O
.	24075313	4	O
Here	24075313	4	O
we	24075313	4	O
report	24075313	4	O
the	24075313	4	O
first	24075313	4	O
direct	24075313	4	O
evidence	24075313	4	O
of	24075313	4	O
de	24075313	4	O
novo	24075313	4	O
c.316	24075313	4	O
G	24075313	4	O
>	24075313	4	O
A	24075313	4	O
mutation	24075313	4	O
in	24075313	4	O
the	24075313	4	O
same	24075313	4	O
hotspot	24075313	4	O
of	24075313	4	O
the	24075313	4	O
gene	24075313	4	O
in	24075313	4	O
two	24075313	4	O
unrelated	24075313	4	O
patients	24075313	4	O
who	24075313	4	O
had	24075313	4	O
otherwise	24075313	4	O
a	24075313	4	O
prototypical	24075313	4	O
NIPA1	24075313	4	O
-	24075313	4	O
associated	24075313	4	O
phenotype	24075313	4	O
with	24075313	4	O
a	24075313	4	O
severe	24075313	4	O
form	24075313	4	O
of	24075313	4	O
uncomplicated	24075313	4	O
spastic	24075313	4	O
paraplegia	24075313	4	O
.	24075313	4	O
De	24075313	4	O
novo	24075313	4	O
nature	24075313	4	O
of	24075313	4	O
these	24075313	4	O
mutations	24075313	4	O
was	24075313	4	O
confirmed	24075313	4	O
by	24075313	4	O
sequencing	24075313	4	O
both	24075313	4	O
sets	24075313	4	O
of	24075313	4	O
clinically	24075313	4	O
unaffected	24075313	4	O
parents	24075313	4	O
and	24075313	4	O
confirmation	24075313	4	O
of	24075313	4	O
paternity	24075313	4	O
.	24075313	4	O
We	24075313	4	O
also	24075313	4	O
discuss	24075313	4	O
likely	24075313	4	O
molecular	24075313	4	O
mechanisms	24075313	4	O
accounting	24075313	4	O
for	24075313	4	O
recurrent	24075313	4	O
mutations	24075313	4	O
in	24075313	4	O
this	24075313	4	O
segment	24075313	4	O
of	24075313	4	O
the	24075313	4	O
gene	24075313	4	O
.	24075313	4	O
Apparently	24075313	4	O
sporadic	24075313	4	O
patients	24075313	4	O
without	24075313	4	O
a	24075313	4	O
positive	24075313	4	O
family	24075313	4	O
history	24075313	4	O
of	24075313	4	O
hereditary	24075313	4	O
spastic	24075313	4	O
paraplegia	24075313	4	O
need	24075313	4	O
to	24075313	4	O
be	24075313	4	O
also	24075313	4	O
evaluated	24075313	4	O
for	24075313	4	O
possible	24075313	4	O
disease	24075313	4	O
-	24075313	4	O
causing	24075313	4	O
mutations	24075313	4	O
in	24075313	4	O
genes	24075313	4	O
that	24075313	4	O
are	24075313	4	O
inherited	24075313	4	O
in	24075313	4	O
an	24075313	4	O
autosomal	24075313	4	O
dominant	24075313	4	O
fashion	24075313	4	O
.	24075313	4	O

Spliced	24356649	0	O
MDM2	24356649	0	O
isoforms	24356649	0	O
promote	24356649	0	O
mutant	24356649	0	O
p53	24356649	0	O
accumulation	24356649	0	O
and	24356649	0	O
gain	24356649	0	O
-	24356649	0	O
of	24356649	0	O
-	24356649	0	O
function	24356649	0	O
in	24356649	0	O
tumorigenesis	24356649	0	O
.	24356649	0	O
Mutant	24356649	0	B-Var
p53	24356649	0	O
(	24356649	0	O
Mutp53	24356649	0	O
)	24356649	0	O
proteins	24356649	0	O
often	24356649	0	O
gain	24356649	0	B-PosReg
new	24356649	0	I-PosReg
activities	24356649	0	I-PosReg
in	24356649	0	O
promoting	24356649	0	O
tumorigenesis	24356649	0	O
,	24356649	0	O
defined	24356649	0	O
as	24356649	0	O
gain	24356649	0	O
-	24356649	0	O
of	24356649	0	O
-	24356649	0	O
function	24356649	0	O
(	24356649	0	O
GOF	24356649	0	O
)	24356649	0	O
.	24356649	0	O
Mutp53	24356649	0	O
can	24356649	0	O
accumulate	24356649	0	O
to	24356649	0	O
high	24356649	0	O
levels	24356649	0	O
in	24356649	0	O
tumours	24356649	0	O
,	24356649	0	O
which	24356649	0	O
promotes	24356649	0	O
mutp53	24356649	0	B-Var
GOF	24356649	0	B-PosReg
in	24356649	0	O
tumorigenesis	24356649	0	O
.	24356649	0	O
MDM2	24356649	0	O
isoform	24356649	0	O
B	24356649	0	O
(	24356649	0	O
MDM2	24356649	0	O
-	24356649	0	O
B	24356649	0	O
)	24356649	0	O
,	24356649	0	O
the	24356649	0	O
MDM2	24356649	0	O
isoform	24356649	0	O
most	24356649	0	O
frequently	24356649	0	O
over	24356649	0	O
-	24356649	0	O
expressed	24356649	0	O
in	24356649	0	O
human	24356649	0	O
tumours	24356649	0	O
,	24356649	0	O
interacts	24356649	0	O
with	24356649	0	O
full	24356649	0	O
-	24356649	0	O
length	24356649	0	O
MDM2	24356649	0	O
to	24356649	0	O
inhibit	24356649	0	O
MDM2	24356649	0	O
-	24356649	0	O
mediated	24356649	0	O
mutp53	24356649	0	O
degradation	24356649	0	O
,	24356649	0	O
promoting	24356649	0	O
mutp53	24356649	0	O
accumulation	24356649	0	O
and	24356649	0	O
GOF	24356649	0	O
in	24356649	0	O
tumorigenesis	24356649	0	O
.	24356649	0	O
Thus	24356649	0	O
,	24356649	0	O
overexpression	24356649	0	O
of	24356649	0	O
MDM2	24356649	0	O
isoforms	24356649	0	O
promotes	24356649	0	O
mutp53	24356649	0	O
accumulation	24356649	0	O
in	24356649	0	O
tumours	24356649	0	O
,	24356649	0	O
contributing	24356649	0	O
to	24356649	0	O
mutp53	24356649	0	B-Var
GOF	24356649	0	B-PosReg
in	24356649	0	O
tumorigenesis	24356649	0	O
.	24356649	0	O

Mutant	24373920	2	B-Var
p53	24373920	2	B-Gene
gain	24373920	2	B-PosReg
of	24373920	2	I-PosReg
function	24373920	2	I-PosReg
can	24373920	2	O
be	24373920	2	O
at	24373920	2	O
the	24373920	2	O
root	24373920	2	O
of	24373920	2	O
dedifferentiation	24373920	2	O
of	24373920	2	O
human	24373920	2	B-Disease
osteosarcoma	24373920	2	I-Disease
MG63	24373920	2	O
cells	24373920	2	O
into	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cancer	24373920	2	O
stem	24373920	2	O
cells	24373920	2	O
.	24373920	2	O
TP53	24373920	2	O
is	24373920	2	O
the	24373920	2	O
most	24373920	2	O
frequently	24373920	2	O
mutated	24373920	2	O
tumor	24373920	2	O
suppressor	24373920	2	O
gene	24373920	2	O
in	24373920	2	O
cancers	24373920	2	O
and	24373920	2	O
mutant	24373920	2	O
p53	24373920	2	O
protein	24373920	2	O
(	24373920	2	O
mutp53	24373920	2	O
)	24373920	2	O
can	24373920	2	O
acquire	24373920	2	O
gain	24373920	2	O
of	24373920	2	O
function	24373920	2	O
(	24373920	2	O
GOF	24373920	2	O
)	24373920	2	O
strongly	24373920	2	O
contributing	24373920	2	O
to	24373920	2	O
malignancy	24373920	2	O
.	24373920	2	O
Studies	24373920	2	O
thus	24373920	2	O
far	24373920	2	O
have	24373920	2	O
not	24373920	2	O
shown	24373920	2	O
p53	24373920	2	O
-	24373920	2	O
GOF	24373920	2	O
in	24373920	2	O
osteosarcoma	24373920	2	O
.	24373920	2	O
By	24373920	2	O
RT	24373920	2	O
-	24373920	2	O
PCR	24373920	2	O
,	24373920	2	O
methylation	24373920	2	O
-	24373920	2	O
specific	24373920	2	O
PCR	24373920	2	O
,	24373920	2	O
fluorescent	24373920	2	O
in	24373920	2	O
situ	24373920	2	O
hybridization	24373920	2	O
,	24373920	2	O
DNA	24373920	2	O
sequence	24373920	2	O
,	24373920	2	O
western	24373920	2	O
blot	24373920	2	O
and	24373920	2	O
immunofluorescence	24373920	2	O
analyses	24373920	2	O
,	24373920	2	O
we	24373920	2	O
have	24373920	2	O
shown	24373920	2	O
that	24373920	2	O
-	24373920	2	O
in	24373920	2	O
comparison	24373920	2	O
with	24373920	2	O
parental	24373920	2	O
MG63	24373920	2	O
cells	24373920	2	O
where	24373920	2	O
TP53	24373920	2	O
gene	24373920	2	O
is	24373920	2	O
hypermethylated	24373920	2	O
,	24373920	2	O
rearranged	24373920	2	O
and	24373920	2	O
in	24373920	2	O
single	24373920	2	O
copy	24373920	2	O
-	24373920	2	O
in	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cells	24373920	2	O
,	24373920	2	O
TP53	24373920	2	O
is	24373920	2	O
unmethylated	24373920	2	O
,	24373920	2	O
rearranged	24373920	2	O
and	24373920	2	O
in	24373920	2	O
multiple	24373920	2	O
copies	24373920	2	O
,	24373920	2	O
and	24373920	2	O
mutp53	24373920	2	O
(	24373920	2	O
p53	24373920	2	O
-	24373920	2	O
R248W	24373920	2	O
/	24373920	2	O
P72R	24373920	2	O
)	24373920	2	O
is	24373920	2	O
post	24373920	2	O
-	24373920	2	O
translationally	24373920	2	O
modified	24373920	2	O
and	24373920	2	O
with	24373920	2	O
nuclear	24373920	2	O
localization	24373920	2	O
.	24373920	2	O
p53	24373920	2	O
-	24373920	2	O
R248W	24373920	2	O
/	24373920	2	O
P72R	24373920	2	O
-	24373920	2	O
knockdown	24373920	2	O
by	24373920	2	O
short	24373920	2	O
-	24373920	2	O
interfering	24373920	2	O
RNA	24373920	2	O
reduced	24373920	2	O
the	24373920	2	O
growth	24373920	2	O
and	24373920	2	O
replication	24373920	2	O
rate	24373920	2	O
of	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cells	24373920	2	O
,	24373920	2	O
markedly	24373920	2	O
increasing	24373920	2	O
cell	24373920	2	O
cycle	24373920	2	O
inhibitor	24373920	2	O
levels	24373920	2	O
and	24373920	2	O
sensitized	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cells	24373920	2	O
to	24373920	2	O
TRAIL	24373920	2	O
-	24373920	2	O
induced	24373920	2	O
apoptosis	24373920	2	O
by	24373920	2	O
DR5	24373920	2	O
up	24373920	2	O
-	24373920	2	O
regulation	24373920	2	O
;	24373920	2	O
moreover	24373920	2	O
,	24373920	2	O
it	24373920	2	O
strongly	24373920	2	O
decreased	24373920	2	O
the	24373920	2	O
levels	24373920	2	O
of	24373920	2	O
stemness	24373920	2	O
and	24373920	2	O
invasiveness	24373920	2	O
genes	24373920	2	O
.	24373920	2	O
We	24373920	2	O
have	24373920	2	O
also	24373920	2	O
found	24373920	2	O
that	24373920	2	O
the	24373920	2	O
ectopic	24373920	2	O
expression	24373920	2	O
of	24373920	2	O
p53	24373920	2	B-Var
-	24373920	2	I-Var
R248W	24373920	2	I-Var
/	24373920	2	I-Var
P72R	24373920	2	I-Var
in	24373920	2	O
MG63	24373920	2	O
cells	24373920	2	O
promoted	24373920	2	B-PosReg
cancer	24373920	2	O
stem	24373920	2	O
-	24373920	2	O
like	24373920	2	O
features	24373920	2	O
,	24373920	2	O
as	24373920	2	O
high	24373920	2	O
proliferation	24373920	2	O
rate	24373920	2	O
,	24373920	2	O
sphere	24373920	2	O
formation	24373920	2	O
,	24373920	2	O
clonogenic	24373920	2	O
growth	24373920	2	O
,	24373920	2	O
high	24373920	2	O
migration	24373920	2	O
and	24373920	2	O
invasive	24373920	2	O
ability	24373920	2	O
;	24373920	2	O
furthermore	24373920	2	O
,	24373920	2	O
it	24373920	2	O
strongly	24373920	2	O
increased	24373920	2	B-PosReg
the	24373920	2	O
levels	24373920	2	O
of	24373920	2	O
stemness	24373920	2	O
proteins	24373920	2	O
.	24373920	2	O
Overall	24373920	2	O
,	24373920	2	O
the	24373920	2	O
findings	24373920	2	O
suggest	24373920	2	O
the	24373920	2	O
involvement	24373920	2	B-Reg
of	24373920	2	O
p53	24373920	2	B-Var
-	24373920	2	I-Var
R248W	24373920	2	I-Var
/	24373920	2	I-Var
P72R	24373920	2	I-Var
at	24373920	2	O
the	24373920	2	O
origin	24373920	2	O
of	24373920	2	O
the	24373920	2	O
aberrant	24373920	2	O
characters	24373920	2	O
of	24373920	2	O
the	24373920	2	O
3	24373920	2	O
AB	24373920	2	O
-	24373920	2	O
OS	24373920	2	O
cells	24373920	2	O
with	24373920	2	O
the	24373920	2	O
hypothesis	24373920	2	O
that	24373920	2	O
its	24373920	2	O
GOF	24373920	2	O
can	24373920	2	O
be	24373920	2	O
at	24373920	2	O
the	24373920	2	O
root	24373920	2	O
of	24373920	2	O
the	24373920	2	O
dedifferentiation	24373920	2	O
of	24373920	2	O
MG63	24373920	2	O
cells	24373920	2	O
into	24373920	2	O
CSCs	24373920	2	O
.	24373920	2	O

Unequal	24603336	0	O
prognostic	24603336	0	O
potentials	24603336	0	O
of	24603336	0	O
p53	24603336	0	O
gain	24603336	0	O
-	24603336	0	O
of	24603336	0	O
-	24603336	0	O
function	24603336	0	O
mutations	24603336	0	O
in	24603336	0	O
human	24603336	0	O
cancers	24603336	0	O
associate	24603336	0	O
with	24603336	0	O
drug	24603336	0	O
-	24603336	0	O
metabolizing	24603336	0	O
activity	24603336	0	O
.	24603336	0	O
Mutation	24603336	0	O
of	24603336	0	O
p53	24603336	0	O
is	24603336	0	O
the	24603336	0	O
most	24603336	0	O
common	24603336	0	O
genetic	24603336	0	O
change	24603336	0	O
in	24603336	0	O
human	24603336	0	O
cancer	24603336	0	O
,	24603336	0	O
causing	24603336	0	O
complex	24603336	0	O
effects	24603336	0	O
including	24603336	0	O
not	24603336	0	O
only	24603336	0	O
loss	24603336	0	O
of	24603336	0	O
wild	24603336	0	O
-	24603336	0	O
type	24603336	0	O
function	24603336	0	O
but	24603336	0	O
also	24603336	0	O
gain	24603336	0	O
of	24603336	0	O
novel	24603336	0	O
oncogenic	24603336	0	O
functions	24603336	0	O
(	24603336	0	O
GOF	24603336	0	O
)	24603336	0	O
.	24603336	0	O
It	24603336	0	O
is	24603336	0	O
increasingly	24603336	0	O
likely	24603336	0	O
that	24603336	0	O
p53	24603336	0	O
-	24603336	0	O
hotspot	24603336	0	O
mutations	24603336	0	O
may	24603336	0	O
confer	24603336	0	O
different	24603336	0	O
types	24603336	0	O
and	24603336	0	O
magnitudes	24603336	0	O
of	24603336	0	O
GOF	24603336	0	O
,	24603336	0	O
but	24603336	0	O
the	24603336	0	O
evidences	24603336	0	O
are	24603336	0	O
mainly	24603336	0	O
supported	24603336	0	O
by	24603336	0	O
cellular	24603336	0	O
and	24603336	0	O
transgenic	24603336	0	O
animal	24603336	0	O
models	24603336	0	O
.	24603336	0	O
Here	24603336	0	O
we	24603336	0	O
combine	24603336	0	O
large	24603336	0	O
-	24603336	0	O
scale	24603336	0	O
cancer	24603336	0	O
genomic	24603336	0	O
data	24603336	0	O
to	24603336	0	O
characterize	24603336	0	O
the	24603336	0	O
prognostic	24603336	0	O
significance	24603336	0	O
of	24603336	0	O
different	24603336	0	O
p53	24603336	0	B-Gene
mutations	24603336	0	O
in	24603336	0	O
human	24603336	0	O
cancers	24603336	0	O
.	24603336	0	O
Unexpectedly	24603336	0	O
,	24603336	0	O
only	24603336	0	O
mutations	24603336	0	B-Var
on	24603336	0	I-Var
the	24603336	0	I-Var
Arg248	24603336	0	I-Var
and	24603336	0	I-Var
Arg282	24603336	0	I-Var
positions	24603336	0	O
displayed	24603336	0	O
significant	24603336	0	O
association	24603336	0	O
with	24603336	0	O
shorter	24603336	0	B-NegReg
patient	24603336	0	O
survival	24603336	0	O
,	24603336	0	O
but	24603336	0	O
such	24603336	0	O
association	24603336	0	O
was	24603336	0	O
not	24603336	0	O
evident	24603336	0	O
for	24603336	0	O
other	24603336	0	O
hotspot	24603336	0	O
GOF	24603336	0	O
mutations	24603336	0	O
.	24603336	0	O
Gene	24603336	0	O
set	24603336	0	O
enrichment	24603336	0	O
analysis	24603336	0	O
on	24603336	0	O
these	24603336	0	O
mutations	24603336	0	B-Var
revealed	24603336	0	O
higher	24603336	0	B-PosReg
activity	24603336	0	O
of	24603336	0	O
drug	24603336	0	O
-	24603336	0	O
metabolizing	24603336	0	O
enzymes	24603336	0	O
,	24603336	0	O
including	24603336	0	O
the	24603336	0	O
CYP3A4	24603336	0	O
cytochrome	24603336	0	O
P450	24603336	0	O
.	24603336	0	O
Ectopic	24603336	0	O
expression	24603336	0	O
of	24603336	0	O
p53	24603336	0	B-Gene
mutant	24603336	0	B-Var
R282W	24603336	0	I-Var
in	24603336	0	O
H1299	24603336	0	O
and	24603336	0	O
SaOS2	24603336	0	O
cells	24603336	0	O
significantly	24603336	0	O
upregulated	24603336	0	B-PosReg
CYP3A4	24603336	0	O
mRNA	24603336	0	O
and	24603336	0	O
protein	24603336	0	O
levels	24603336	0	O
,	24603336	0	O
and	24603336	0	O
cancer	24603336	0	O
cell	24603336	0	O
lines	24603336	0	O
bearing	24603336	0	O
mortality	24603336	0	O
-	24603336	0	O
associated	24603336	0	O
p53	24603336	0	B-Gene
mutations	24603336	0	B-Var
display	24603336	0	O
higher	24603336	0	B-PosReg
CYP3A4	24603336	0	O
expression	24603336	0	O
and	24603336	0	O
resistance	24603336	0	O
to	24603336	0	O
several	24603336	0	O
CYP3A4	24603336	0	O
-	24603336	0	O
metabolized	24603336	0	O
chemotherapeutic	24603336	0	O
drugs	24603336	0	O
.	24603336	0	O
Our	24603336	0	O
results	24603336	0	O
suggest	24603336	0	O
that	24603336	0	O
p53	24603336	0	O
mutations	24603336	0	O
have	24603336	0	O
unequal	24603336	0	O
GOF	24603336	0	O
activities	24603336	0	O
in	24603336	0	O
human	24603336	0	O
cancers	24603336	0	O
,	24603336	0	O
and	24603336	0	O
future	24603336	0	O
evaluation	24603336	0	O
of	24603336	0	O
p53	24603336	0	O
as	24603336	0	O
a	24603336	0	O
cancer	24603336	0	O
biomarker	24603336	0	O
should	24603336	0	O
consider	24603336	0	O
which	24603336	0	O
mutation	24603336	0	O
is	24603336	0	O
present	24603336	0	O
in	24603336	0	O
the	24603336	0	O
tumor	24603336	0	O
,	24603336	0	O
rather	24603336	0	O
than	24603336	0	O
having	24603336	0	O
comparison	24603336	0	O
between	24603336	0	O
wild	24603336	0	O
-	24603336	0	O
type	24603336	0	O
and	24603336	0	O
mutant	24603336	0	O
genotypes	24603336	0	O
.	24603336	0	O

Both	24632946	2	O
	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
loss	24632946	2	B-NegReg
-	24632946	2	I-NegReg
and	24632946	2	O
gain	24632946	2	B-PosReg
-	24632946	2	I-PosReg
of	24632946	2	I-PosReg
-	24632946	2	I-PosReg
function	24632946	2	I-PosReg
(	24632946	2	O
LOF	24632946	2	O
and	24632946	2	O
GOF	24632946	2	O
)	24632946	2	O
mutants	24632946	2	B-Var
displayed	24632946	2	O
abnormal	24632946	2	O
clefts	24632946	2	O
in	24632946	2	O
the	24632946	2	O
perineal	24632946	2	O
region	24632946	2	O
and	24632946	2	O
hypoplastic	24632946	2	O
elongation	24632946	2	O
of	24632946	2	O
the	24632946	2	O
URS	24632946	2	O
.	24632946	2	O
The	24632946	2	O
mutants	24632946	2	B-Var
also	24632946	2	O
displayed	24632946	2	O
reduced	24632946	2	B-NegReg
cell	24632946	2	O
proliferation	24632946	2	O
in	24632946	2	O
the	24632946	2	O
URS	24632946	2	O
mesenchyme	24632946	2	O
.	24632946	2	O
In	24632946	2	O
addition	24632946	2	O
,	24632946	2	O
the	24632946	2	O
	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
GOF	24632946	2	O
mutants	24632946	2	B-Var
displayed	24632946	2	O
reduced	24632946	2	O
apoptosis	24632946	2	O
and	24632946	2	O
subsequently	24632946	2	O
increased	24632946	2	O
apoptosis	24632946	2	O
in	24632946	2	O
the	24632946	2	O
URS	24632946	2	O
epithelium	24632946	2	O
.	24632946	2	O
The	24632946	2	O
expression	24632946	2	O
of	24632946	2	O
bone	24632946	2	B-Gene
morphogenetic	24632946	2	I-Gene
protein	24632946	2	I-Gene
(	24632946	2	I-Gene
Bmp	24632946	2	I-Gene
)	24632946	2	I-Gene
genes	24632946	2	I-Gene
,	24632946	2	O
such	24632946	2	O
as	24632946	2	O
Bmp4	24632946	2	B-Gene
and	24632946	2	O
Bmp7	24632946	2	B-Gene
,	24632946	2	O
was	24632946	2	O
also	24632946	2	O
ectopically	24632946	2	O
induced	24632946	2	B-PosReg
in	24632946	2	O
the	24632946	2	O
epithelia	24632946	2	O
of	24632946	2	O
the	24632946	2	O
URS	24632946	2	O
in	24632946	2	O
the	24632946	2	O
	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
GOF	24632946	2	O
mutants	24632946	2	B-Var
.	24632946	2	O
The	24632946	2	O
expression	24632946	2	O
of	24632946	2	O
the	24632946	2	O
Msx2	24632946	2	B-Gene
gene	24632946	2	I-Gene
and	24632946	2	O
phosphorylated	24632946	2	O
-	24632946	2	O
Smad1	24632946	2	O
/	24632946	2	O
5	24632946	2	O
/	24632946	2	O
8	24632946	2	O
,	24632946	2	O
possible	24632946	2	O
readouts	24632946	2	O
of	24632946	2	O
Bmp	24632946	2	O
signaling	24632946	2	O
,	24632946	2	O
was	24632946	2	O
also	24632946	2	O
increased	24632946	2	B-PosReg
in	24632946	2	O
the	24632946	2	O
mutants	24632946	2	B-Var
.	24632946	2	O
Moreover	24632946	2	O
,	24632946	2	O
we	24632946	2	O
introduced	24632946	2	O
an	24632946	2	O
additional	24632946	2	O
mutation	24632946	2	O
for	24632946	2	O
a	24632946	2	O
Bmp	24632946	2	O
receptor	24632946	2	O
gene	24632946	2	O
:	24632946	2	O
BmprIA	24632946	2	O
.	24632946	2	O
The	24632946	2	O
Shh	24632946	2	O
(	24632946	2	O
CreERT2	24632946	2	O
/	24632946	2	O
)	24632946	2	O
;	24632946	2	O
	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
(	24632946	2	O
flox	24632946	2	O
(	24632946	2	O
ex3	24632946	2	O
)	24632946	2	O
/	24632946	2	O
)	24632946	2	O
;	24632946	2	O
BmprIA	24632946	2	O
(	24632946	2	O
flox	24632946	2	O
/	24632946	2	O
-	24632946	2	O
)	24632946	2	O
mutants	24632946	2	O
displayed	24632946	2	O
partial	24632946	2	O
restoration	24632946	2	O
of	24632946	2	O
URS	24632946	2	O
elongation	24632946	2	O
compared	24632946	2	O
with	24632946	2	O
the	24632946	2	O
	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
GOF	24632946	2	O
mutants	24632946	2	O
.	24632946	2	O
These	24632946	2	O
results	24632946	2	O
indicate	24632946	2	O
that	24632946	2	O
some	24632946	2	O
ARM	24632946	2	B-Disease
phenotypes	24632946	2	O
in	24632946	2	O
the	24632946	2	O
	24632946	2	O
-	24632946	2	O
catenin	24632946	2	O
GOF	24632946	2	B-PosReg
mutants	24632946	2	B-Var
were	24632946	2	O
caused	24632946	2	B-Reg
by	24632946	2	I-Reg
abnormal	24632946	2	O
Bmp	24632946	2	O
signaling	24632946	2	O
.	24632946	2	O

In	24632949	0	O
Wif1	24632949	0	O
(	24632949	0	O
lacZ	24632949	0	O
/	24632949	0	O
lacZ	24632949	0	O
)	24632949	0	O
mutant	24632949	0	O
mice	24632949	0	O
and	24632949	0	O
cultured	24632949	0	O
urorectum	24632949	0	O
with	24632949	0	O
exogenous	24632949	0	O
Wif1	24632949	0	O
,	24632949	0	O
cloaca	24632949	0	O
septation	24632949	0	O
was	24632949	0	O
defective	24632949	0	O
with	24632949	0	O
undescended	24632949	0	O
urs	24632949	0	O
and	24632949	0	O
hypospadias	24632949	0	O
-	24632949	0	O
like	24632949	0	O
phenotypes	24632949	0	O
,	24632949	0	O
and	24632949	0	O
such	24632949	0	O
septation	24632949	0	O
defects	24632949	0	O
were	24632949	0	O
also	24632949	0	O
observed	24632949	0	O
in	24632949	0	O
Shh	24632949	0	O
(	24632949	0	O
-	24632949	0	O
/	24632949	0	O
-	24632949	0	O
)	24632949	0	O
mutants	24632949	0	O
and	24632949	0	O
in	24632949	0	O
endodermal	24632949	0	O
	24632949	0	O
-	24632949	0	O
catenin	24632949	0	O
gain	24632949	0	O
-	24632949	0	O
of	24632949	0	O
-	24632949	0	O
function	24632949	0	O
(	24632949	0	O
GOF	24632949	0	O
)	24632949	0	O
mutants	24632949	0	O
.	24632949	0	O
In	24632949	0	O
addition	24632949	0	O
,	24632949	0	O
Wif1	24632949	0	O
and	24632949	0	O
Shh	24632949	0	O
were	24632949	0	O
expressed	24632949	0	O
in	24632949	0	O
a	24632949	0	O
complementary	24632949	0	O
manner	24632949	0	O
in	24632949	0	O
the	24632949	0	O
cloaca	24632949	0	O
endoderm	24632949	0	O
,	24632949	0	O
and	24632949	0	O
Wif1	24632949	0	O
was	24632949	0	O
ectopically	24632949	0	O
expressed	24632949	0	O
in	24632949	0	O
the	24632949	0	O
urs	24632949	0	O
and	24632949	0	O
cm	24632949	0	O
associated	24632949	0	O
with	24632949	0	O
excessive	24632949	0	O
endodermal	24632949	0	O
apoptosis	24632949	0	O
and	24632949	0	O
septation	24632949	0	O
defects	24632949	0	O
in	24632949	0	O
Shh	24632949	0	O
(	24632949	0	O
-	24632949	0	O
/	24632949	0	O
-	24632949	0	O
)	24632949	0	O
mutants	24632949	0	O
.	24632949	0	O
Furthermore	24632949	0	O
,	24632949	0	O
apoptotic	24632949	0	O
cells	24632949	0	O
were	24632949	0	O
markedly	24632949	0	O
reduced	24632949	0	B-NegReg
in	24632949	0	O
the	24632949	0	O
endodermal	24632949	0	O
	24632949	0	O
-	24632949	0	O
catenin	24632949	0	O
GOF	24632949	0	B-PosReg
mutant	24632949	0	B-Var
embryos	24632949	0	O
,	24632949	0	O
which	24632949	0	O
counteracted	24632949	0	O
the	24632949	0	O
inhibitory	24632949	0	O
effects	24632949	0	O
of	24632949	0	O
Wif1	24632949	0	O
.	24632949	0	O

These	24730569	0	O
effects	24730569	0	O
required	24730569	0	O
functional	24730569	0	O
MC1R	24730569	0	O
and	24730569	0	O
were	24730569	0	O
absent	24730569	0	O
in	24730569	0	O
melanocytes	24730569	0	O
expressing	24730569	0	O
loss	24730569	0	O
of	24730569	0	O
function	24730569	0	O
(	24730569	0	O
LOF	24730569	0	O
)	24730569	0	O
MC1R	24730569	0	O
.	24730569	0	O
We	24730569	0	O
propose	24730569	0	O
that	24730569	0	O
	24730569	0	O
-	24730569	0	O
MSH	24730569	0	O
increases	24730569	0	O
UV	24730569	0	O
-	24730569	0	O
induced	24730569	0	O
H2AX	24730569	0	O
to	24730569	0	O
facilitate	24730569	0	O
formation	24730569	0	O
of	24730569	0	O
DNA	24730569	0	O
repair	24730569	0	O
complexes	24730569	0	O
and	24730569	0	O
repair	24730569	0	O
of	24730569	0	O
DNA	24730569	0	O
photoproducts	24730569	0	O
,	24730569	0	O
and	24730569	0	O
LOF	24730569	0	B-Var
of	24730569	0	O
MC1R	24730569	0	O
compromises	24730569	0	B-NegReg
the	24730569	0	O
DDR	24730569	0	O
and	24730569	0	O
genomic	24730569	0	O
stability	24730569	0	O
of	24730569	0	O
melanocytes	24730569	0	O
.	24730569	0	O

Estimates	24808909	1	O
from	24808909	1	O
large	24808909	1	O
scale	24808909	1	O
genome	24808909	1	O
sequencing	24808909	1	O
studies	24808909	1	O
indicate	24808909	1	O
that	24808909	1	O
each	24808909	1	O
human	24808909	1	O
carries	24808909	1	O
up	24808909	1	O
to	24808909	1	O
20	24808909	1	O
genetic	24808909	1	O
variants	24808909	1	O
that	24808909	1	O
are	24808909	1	O
predicted	24808909	1	O
to	24808909	1	O
results	24808909	1	O
in	24808909	1	O
loss	24808909	1	O
of	24808909	1	O
function	24808909	1	O
(	24808909	1	O
LOF	24808909	1	O
)	24808909	1	O
of	24808909	1	O
protein	24808909	1	O
-	24808909	1	O
coding	24808909	1	O
genes	24808909	1	O
.	24808909	1	O
Here	24808909	1	O
,	24808909	1	O
we	24808909	1	O
show	24808909	1	O
that	24808909	1	O
two	24808909	1	O
hypocholesterolemia	24808909	1	B-Disease
-	24808909	1	I-Disease
associated	24808909	1	I-Disease
LOF	24808909	1	B-NegReg
mutations	24808909	1	B-Var
in	24808909	1	O
the	24808909	1	O
PCSK9	24808909	1	B-Gene
gene	24808909	1	O
can	24808909	1	O
be	24808909	1	O
accurately	24808909	1	O
imputed	24808909	1	O
into	24808909	1	O
large	24808909	1	O
-	24808909	1	O
scale	24808909	1	O
GWAS	24808909	1	O
datasets	24808909	1	O
which	24808909	1	O
raises	24808909	1	O
the	24808909	1	O
possibility	24808909	1	O
of	24808909	1	O
assessing	24808909	1	O
LOFs	24808909	1	O
through	24808909	1	O
genomics	24808909	1	O
-	24808909	1	O
linked	24808909	1	O
medical	24808909	1	O
records	24808909	1	O
.	24808909	1	O

Until	24946076	1	O
recently	24946076	1	O
,	24946076	1	O
no	24946076	1	O
loss	24946076	1	O
-	24946076	1	O
of	24946076	1	O
-	24946076	1	O
function	24946076	1	O
(	24946076	1	O
LOF	24946076	1	O
)	24946076	1	O
mutations	24946076	1	O
in	24946076	1	O
PDGF	24946076	1	O
or	24946076	1	O
PDGF	24946076	1	O
receptor	24946076	1	O
genes	24946076	1	O
were	24946076	1	O
reported	24946076	1	O
as	24946076	1	O
causally	24946076	1	O
linked	24946076	1	O
to	24946076	1	O
a	24946076	1	O
human	24946076	1	O
disease	24946076	1	O
.	24946076	1	O
This	24946076	1	O
changed	24946076	1	O
in	24946076	1	O
2013	24946076	1	O
when	24946076	1	O
reports	24946076	1	O
appeared	24946076	1	O
on	24946076	1	O
presumed	24946076	1	O
LOF	24946076	1	B-NegReg
mutations	24946076	1	B-Var
in	24946076	1	O
the	24946076	1	O
genes	24946076	1	O
encoding	24946076	1	O
PDGF	24946076	1	B-Gene
-	24946076	1	I-Gene
B	24946076	1	I-Gene
and	24946076	1	O
its	24946076	1	O
receptor	24946076	1	O
PDGF	24946076	1	O
receptor	24946076	1	O
-	24946076	1	O
beta	24946076	1	O
(	24946076	1	B-Gene
PDGF	24946076	1	I-Gene
-	24946076	1	I-Gene
R	24946076	1	I-Gene
)	24946076	1	I-Gene
in	24946076	1	O
familial	24946076	1	B-Disease
idiopathic	24946076	1	I-Disease
basal	24946076	1	I-Disease
ganglia	24946076	1	I-Disease
calcification	24946076	1	I-Disease
(	24946076	1	O
IBGC	24946076	1	O
)	24946076	1	O
,	24946076	1	O
a	24946076	1	O
brain	24946076	1	O
disease	24946076	1	O
characterized	24946076	1	O
by	24946076	1	O
anatomically	24946076	1	O
localized	24946076	1	O
calcifications	24946076	1	O
in	24946076	1	O
or	24946076	1	O
near	24946076	1	O
the	24946076	1	O
blood	24946076	1	O
microvessels	24946076	1	O
.	24946076	1	O

Mutant	24998848	0	O
p53	24998848	0	O
gains	24998848	0	O
new	24998848	0	O
function	24998848	0	O
in	24998848	0	O
promoting	24998848	0	O
inflammatory	24998848	0	O
signals	24998848	0	O
by	24998848	0	O
repression	24998848	0	O
of	24998848	0	O
the	24998848	0	O
secreted	24998848	0	O
interleukin-1	24998848	0	O
receptor	24998848	0	O
antagonist	24998848	0	O
.	24998848	0	O
Missense	24998848	0	B-Var
mutations	24998848	0	I-Var
can	24998848	0	O
add	24998848	0	O
novel	24998848	0	O
functions	24998848	0	O
(	24998848	0	O
gain	24998848	0	O
-	24998848	0	O
of	24998848	0	O
-	24998848	0	O
function	24998848	0	O
,	24998848	0	O
GOF	24998848	0	O
)	24998848	0	O
that	24998848	0	O
promote	24998848	0	B-PosReg
tumor	24998848	0	O
malignancy	24998848	0	O
.	24998848	0	O
Here	24998848	0	O
we	24998848	0	O
report	24998848	0	O
that	24998848	0	O
mutant	24998848	0	B-Var
(	24998848	0	O
mut	24998848	0	O
)	24998848	0	O
p53	24998848	0	B-Gene
promotes	24998848	0	B-PosReg
tumor	24998848	0	O
malignancy	24998848	0	O
by	24998848	0	O
suppressing	24998848	0	B-NegReg
the	24998848	0	O
expression	24998848	0	O
of	24998848	0	O
a	24998848	0	O
natural	24998848	0	O
occurring	24998848	0	O
anti	24998848	0	O
-	24998848	0	O
inflammatory	24998848	0	O
cytokine	24998848	0	O
,	24998848	0	O
the	24998848	0	O
secreted	24998848	0	O
interleukin-1	24998848	0	O
receptor	24998848	0	O
antagonist	24998848	0	O
(	24998848	0	O
sIL-1	24998848	0	O
Ra	24998848	0	O
,	24998848	0	O
IL1RN	24998848	0	O
)	24998848	0	O
.	24998848	0	O

In	25157153	1	O
rare	25157153	1	O
families	25157153	1	O
,	25157153	1	O
loss	25157153	1	B-NegReg
-	25157153	1	I-NegReg
of	25157153	1	I-NegReg
-	25157153	1	I-NegReg
function	25157153	1	I-NegReg
(	25157153	1	O
LOF	25157153	1	O
)	25157153	1	O
mutations	25157153	1	B-Var
in	25157153	1	O
PPARG	25157153	1	B-Gene
are	25157153	1	O
known	25157153	1	O
to	25157153	1	O
cosegregate	25157153	1	O
with	25157153	1	O
lipodystrophy	25157153	1	B-Disease
and	25157153	1	O
insulin	25157153	1	B-Disease
resistance	25157153	1	I-Disease
;	25157153	1	I-Disease
in	25157153	1	O
the	25157153	1	O
general	25157153	1	O
population	25157153	1	O
,	25157153	1	O
the	25157153	1	O
common	25157153	1	O
P12A	25157153	1	B-Var
variant	25157153	1	I-Var
is	25157153	1	O
associated	25157153	1	O
with	25157153	1	O
a	25157153	1	O
decreased	25157153	1	B-NegReg
risk	25157153	1	O
of	25157153	1	O
type	25157153	1	B-Disease
2	25157153	1	I-Disease
diabetes	25157153	1	I-Disease
(	25157153	1	O
T2D	25157153	1	O
)	25157153	1	O
.	25157153	1	O
Carrying	25157153	1	O
any	25157153	1	O
of	25157153	1	O
these	25157153	1	O
nine	25157153	1	O
LOF	25157153	1	O
variants	25157153	1	O
was	25157153	1	O
associated	25157153	1	O
with	25157153	1	O
a	25157153	1	O
substantial	25157153	1	O
increase	25157153	1	O
in	25157153	1	O
risk	25157153	1	O
of	25157153	1	O
T2D	25157153	1	O
(	25157153	1	O
OR	25157153	1	O
=	25157153	1	O
7.22	25157153	1	O
;	25157153	1	O
P	25157153	1	O
=	25157153	1	O
0.005	25157153	1	O
)	25157153	1	O
.	25157153	1	O

Loss	25805808	1	O
-	25805808	1	O
of	25805808	1	O
-	25805808	1	O
function	25805808	1	O
de	25805808	1	O
novo	25805808	1	O
mutations	25805808	1	O
play	25805808	1	O
an	25805808	1	O
important	25805808	1	O
role	25805808	1	O
in	25805808	1	O
severe	25805808	1	O
human	25805808	1	O
neural	25805808	1	O
tube	25805808	1	O
defects	25805808	1	O
.	25805808	1	O
Anencephaly	25805808	1	O
and	25805808	1	O
spina	25805808	1	O
bifida	25805808	1	O
are	25805808	1	O
severe	25805808	1	O
NTDs	25805808	1	O
that	25805808	1	O
affect	25805808	1	O
reproductive	25805808	1	O
fitness	25805808	1	O
and	25805808	1	O
suggest	25805808	1	O
a	25805808	1	O
role	25805808	1	O
for	25805808	1	O
de	25805808	1	O
novo	25805808	1	O
mutations	25805808	1	O
(	25805808	1	O
DNMs	25805808	1	O
)	25805808	1	O
in	25805808	1	O
their	25805808	1	O
aetiology	25805808	1	O
.	25805808	1	O

A	25915599	0	O
typical	25915599	0	O
human	25915599	0	O
exome	25915599	0	O
harbors	25915599	0	O
dozens	25915599	0	O
of	25915599	0	O
loss	25915599	0	O
-	25915599	0	O
of	25915599	0	O
-	25915599	0	O
function	25915599	0	O
(	25915599	0	O
LOF	25915599	0	O
)	25915599	0	O
variants	25915599	0	O
,	25915599	0	O
which	25915599	0	O
can	25915599	0	O
lower	25915599	0	O
disease	25915599	0	O
risk	25915599	0	O
factor	25915599	0	O
levels	25915599	0	O
and	25915599	0	O
affect	25915599	0	O
drug	25915599	0	O
efficacy	25915599	0	O
.	25915599	0	O
We	25915599	0	O
hypothesized	25915599	0	O
that	25915599	0	O
LOF	25915599	0	O
variants	25915599	0	O
are	25915599	0	O
enriched	25915599	0	O
in	25915599	0	O
genes	25915599	0	O
influencing	25915599	0	O
risk	25915599	0	O
factor	25915599	0	O
levels	25915599	0	O
and	25915599	0	O
the	25915599	0	O
onset	25915599	0	O
of	25915599	0	O
common	25915599	0	O
chronic	25915599	0	O
diseases	25915599	0	O
,	25915599	0	O
such	25915599	0	O
as	25915599	0	O
cardiovascular	25915599	0	O
disease	25915599	0	O
and	25915599	0	O
diabetes	25915599	0	O
.	25915599	0	O
To	25915599	0	O
test	25915599	0	O
this	25915599	0	O
hypothesis	25915599	0	O
,	25915599	0	O
we	25915599	0	O
sequenced	25915599	0	O
the	25915599	0	O
exomes	25915599	0	O
of	25915599	0	O
8	25915599	0	O
,	25915599	0	O
554	25915599	0	O
individuals	25915599	0	O
and	25915599	0	O
analyzed	25915599	0	O
the	25915599	0	O
effects	25915599	0	O
of	25915599	0	O
predicted	25915599	0	O
LOF	25915599	0	O
variants	25915599	0	O
on	25915599	0	O
20	25915599	0	O
chronic	25915599	0	O
disease	25915599	0	O
risk	25915599	0	O
factor	25915599	0	O
phenotypes	25915599	0	O
.	25915599	0	O
Previously	25915599	0	O
unknown	25915599	0	O
relationships	25915599	0	O
included	25915599	0	O
elevated	25915599	0	B-PosReg
fasting	25915599	0	O
glucose	25915599	0	O
in	25915599	0	O
carriers	25915599	0	O
of	25915599	0	O
heterozygous	25915599	0	O
LOF	25915599	0	B-NegReg
variation	25915599	0	B-Var
in	25915599	0	O
TXNDC5	25915599	0	B-Gene
,	25915599	0	O
which	25915599	0	O
encodes	25915599	0	O
a	25915599	0	O
biomarker	25915599	0	O
for	25915599	0	O
type	25915599	0	O
1	25915599	0	O
diabetes	25915599	0	O
progression	25915599	0	O
,	25915599	0	O
and	25915599	0	O
apparent	25915599	0	O
recessive	25915599	0	B-NegReg
effects	25915599	0	I-NegReg
of	25915599	0	O
C1QTNF8	25915599	0	B-Gene
on	25915599	0	O
serum	25915599	0	O
magnesium	25915599	0	O
levels	25915599	0	O
.	25915599	0	O

Mutant	25954247	0	O
p53	25954247	0	O
-	25954247	0	O
Heat	25954247	0	O
Shock	25954247	0	O
Response	25954247	0	O
Oncogenic	25954247	0	O
Cooperation	25954247	0	O
:	25954247	0	O
A	25954247	0	O
New	25954247	0	O
Mechanism	25954247	0	O
of	25954247	0	O
Cancer	25954247	0	O
Cell	25954247	0	O
Survival	25954247	0	O
.	25954247	0	O
Not	25954247	0	O
surprisingly	25954247	0	O
,	25954247	0	O
mutations	25954247	0	O
in	25954247	0	O
the	25954247	0	O
p53	25954247	0	O
gene	25954247	0	O
are	25954247	0	O
the	25954247	0	O
most	25954247	0	O
frequent	25954247	0	O
genetic	25954247	0	O
alteration	25954247	0	O
in	25954247	0	O
human	25954247	0	O
cancers	25954247	0	O
.	25954247	0	O
Importantly	25954247	0	O
,	25954247	0	O
mutant	25954247	0	B-Var
p53	25954247	0	B-Gene
(	25954247	0	O
mutp53	25954247	0	O
)	25954247	0	O
proteins	25954247	0	O
not	25954247	0	O
only	25954247	0	O
lose	25954247	0	B-NegReg
their	25954247	0	O
wild	25954247	0	O
-	25954247	0	O
type	25954247	0	O
tumor	25954247	0	O
suppressor	25954247	0	O
activity	25954247	0	O
but	25954247	0	O
also	25954247	0	O
can	25954247	0	O
actively	25954247	0	B-PosReg
promote	25954247	0	I-PosReg
tumor	25954247	0	O
development	25954247	0	O
.	25954247	0	O
Two	25954247	0	O
main	25954247	0	O
mechanisms	25954247	0	O
accounting	25954247	0	O
for	25954247	0	O
mutp53	25954247	0	B-Var
proto	25954247	0	O
-	25954247	0	O
oncogenic	25954247	0	O
activity	25954247	0	O
are	25954247	0	O
inhibition	25954247	0	O
of	25954247	0	O
the	25954247	0	O
wild	25954247	0	O
-	25954247	0	O
type	25954247	0	O
p53	25954247	0	O
in	25954247	0	O
a	25954247	0	O
dominant	25954247	0	O
-	25954247	0	O
negative	25954247	0	O
fashion	25954247	0	O
and	25954247	0	O
gain	25954247	0	B-PosReg
of	25954247	0	O
additional	25954247	0	O
oncogenic	25954247	0	O
activities	25954247	0	O
known	25954247	0	O
as	25954247	0	O
gain	25954247	0	O
-	25954247	0	O
of	25954247	0	O
-	25954247	0	O
function	25954247	0	O
(	25954247	0	O
GOF	25954247	0	O
)	25954247	0	O
.	25954247	0	O
Here	25954247	0	O
,	25954247	0	O
we	25954247	0	O
discuss	25954247	0	O
a	25954247	0	O
novel	25954247	0	O
mechanism	25954247	0	O
of	25954247	0	O
mutp53	25954247	0	B-Var
GOF	25954247	0	O
,	25954247	0	O
which	25954247	0	O
relies	25954247	0	O
on	25954247	0	O
its	25954247	0	O
oncogenic	25954247	0	O
cooperation	25954247	0	O
with	25954247	0	O
the	25954247	0	O
heat	25954247	0	O
shock	25954247	0	O
machinery	25954247	0	O
.	25954247	0	O

Identification	26197705	0	O
and	26197705	0	O
functional	26197705	0	O
characterization	26197705	0	O
of	26197705	0	O
natural	26197705	0	O
human	26197705	0	O
melanocortin	26197705	0	O
1	26197705	0	O
receptor	26197705	0	O
mutant	26197705	0	O
alleles	26197705	0	O
in	26197705	0	O
Pakistani	26197705	0	O
population	26197705	0	O
.	26197705	0	O
Six	26197705	0	O
MC1R	26197705	0	O
mutations	26197705	0	O
segregated	26197705	0	O
with	26197705	0	O
the	26197705	0	O
phenotype	26197705	0	O
in	26197705	0	O
seven	26197705	0	O
families	26197705	0	O
,	26197705	0	O
including	26197705	0	O
a	26197705	0	O
p.Val174del	26197705	0	O
in	26197705	0	O
-	26197705	0	O
frame	26197705	0	O
deletion	26197705	0	O
and	26197705	0	O
a	26197705	0	O
p.Tyr298*	26197705	0	O
nonsense	26197705	0	O
mutation	26197705	0	O
,	26197705	0	O
that	26197705	0	O
were	26197705	0	O
analyzed	26197705	0	O
for	26197705	0	O
function	26197705	0	O
in	26197705	0	O
heterologous	26197705	0	O
HEK293	26197705	0	O
cells	26197705	0	O
.	26197705	0	O
p.Tyr298*	26197705	0	B-Var
MC1R	26197705	0	B-Gene
showed	26197705	0	O
no	26197705	0	B-NegReg
agonist	26197705	0	O
-	26197705	0	O
induced	26197705	0	O
signaling	26197705	0	O
to	26197705	0	O
the	26197705	0	O
cAMP	26197705	0	O
or	26197705	0	O
ERK	26197705	0	O
pathways	26197705	0	O
,	26197705	0	O
nor	26197705	0	B-NegReg
detectable	26197705	0	O
agonist	26197705	0	O
binding	26197705	0	O
.	26197705	0	O
Conversely	26197705	0	O
,	26197705	0	O
signaling	26197705	0	O
was	26197705	0	O
comparable	26197705	0	O
for	26197705	0	O
p.Val174del	26197705	0	B-Var
and	26197705	0	O
wild	26197705	0	O
-	26197705	0	O
type	26197705	0	O
in	26197705	0	O
HEK	26197705	0	O
cells	26197705	0	O
overexpressing	26197705	0	O
the	26197705	0	O
proteins	26197705	0	O
,	26197705	0	O
but	26197705	0	O
binding	26197705	0	O
analysis	26197705	0	O
suggested	26197705	0	O
impaired	26197705	0	B-NegReg
cell	26197705	0	O
surface	26197705	0	O
expression	26197705	0	O
.	26197705	0	O
Flow	26197705	0	O
cytometry	26197705	0	O
and	26197705	0	O
confocal	26197705	0	O
imaging	26197705	0	O
studies	26197705	0	O
revealed	26197705	0	O
reduced	26197705	0	B-NegReg
plasma	26197705	0	O
membrane	26197705	0	O
expression	26197705	0	O
of	26197705	0	O
p.Val174del	26197705	0	B-Var
and	26197705	0	O
p.Tyr298*	26197705	0	B-Var
.	26197705	0	O
Therefore	26197705	0	O
,	26197705	0	O
p.Tyr298*	26197705	0	B-Var
was	26197705	0	O
a	26197705	0	O
total	26197705	0	O
loss	26197705	0	B-NegReg
-	26197705	0	I-NegReg
of	26197705	0	I-NegReg
-	26197705	0	I-NegReg
function	26197705	0	I-NegReg
(	26197705	0	O
LOF	26197705	0	O
)	26197705	0	O
allele	26197705	0	O
,	26197705	0	O
while	26197705	0	O
p.Val174del	26197705	0	B-Var
displayed	26197705	0	O
a	26197705	0	O
partial	26197705	0	B-NegReg
LOF	26197705	0	I-NegReg
attribute	26197705	0	O
.	26197705	0	O

Gain	26331536	0	O
-	26331536	0	O
of	26331536	0	O
-	26331536	0	O
function	26331536	0	O
p53	26331536	0	O
mutants	26331536	0	O
co	26331536	0	O
-	26331536	0	O
opt	26331536	0	O
chromatin	26331536	0	O
pathways	26331536	0	O
to	26331536	0	O
drive	26331536	0	O
cancer	26331536	0	O
growth	26331536	0	O
.	26331536	0	O
Prevalent	26331536	0	O
p53	26331536	0	B-Gene
missense	26331536	0	B-Var
mutations	26331536	0	I-Var
abrogate	26331536	0	B-NegReg
its	26331536	0	O
tumour	26331536	0	O
suppressive	26331536	0	O
function	26331536	0	O
and	26331536	0	O
lead	26331536	0	O
to	26331536	0	O
a	26331536	0	O
'	26331536	0	B-PosReg
gain	26331536	0	I-PosReg
-	26331536	0	I-PosReg
of	26331536	0	I-PosReg
-	26331536	0	I-PosReg
function	26331536	0	I-PosReg
'	26331536	0	I-PosReg
(	26331536	0	O
GOF	26331536	0	O
)	26331536	0	O
that	26331536	0	O
promotes	26331536	0	B-PosReg
cancer	26331536	0	B-Disease
.	26331536	0	O
Here	26331536	0	O
we	26331536	0	O
show	26331536	0	O
that	26331536	0	O
p53	26331536	0	B-Gene
GOF	26331536	0	B-PosReg
mutants	26331536	0	B-Var
bind	26331536	0	O
to	26331536	0	O
and	26331536	0	O
upregulate	26331536	0	B-PosReg
chromatin	26331536	0	B-Gene
regulatory	26331536	0	I-Gene
genes	26331536	0	I-Gene
,	26331536	0	O
including	26331536	0	O
the	26331536	0	O
methyltransferases	26331536	0	O
MLL1	26331536	0	O
(	26331536	0	O
also	26331536	0	O
known	26331536	0	O
as	26331536	0	O
KMT2A	26331536	0	O
)	26331536	0	O
,	26331536	0	O
MLL2	26331536	0	O
(	26331536	0	O
also	26331536	0	O
known	26331536	0	O
as	26331536	0	O
KMT2D	26331536	0	O
)	26331536	0	O
,	26331536	0	O
and	26331536	0	O
acetyltransferase	26331536	0	O
MOZ	26331536	0	O
(	26331536	0	O
also	26331536	0	O
known	26331536	0	O
as	26331536	0	O
KAT6A	26331536	0	O
or	26331536	0	O
MYST3	26331536	0	O
)	26331536	0	O
,	26331536	0	O
resulting	26331536	0	O
in	26331536	0	O
genome	26331536	0	O
-	26331536	0	O
wide	26331536	0	O
increases	26331536	0	B-PosReg
of	26331536	0	O
histone	26331536	0	O
methylation	26331536	0	O
and	26331536	0	O
acetylation	26331536	0	O
.	26331536	0	O
Analysis	26331536	0	O
of	26331536	0	O
The	26331536	0	O
Cancer	26331536	0	O
Genome	26331536	0	O
Atlas	26331536	0	O
shows	26331536	0	O
specific	26331536	0	O
upregulation	26331536	0	B-PosReg
of	26331536	0	O
MLL1	26331536	0	O
,	26331536	0	O
MLL2	26331536	0	O
,	26331536	0	O
and	26331536	0	O
MOZ	26331536	0	O
in	26331536	0	O
p53	26331536	0	B-Gene
GOF	26331536	0	B-Var
patient	26331536	0	O
-	26331536	0	O
derived	26331536	0	O
tumours	26331536	0	O
,	26331536	0	O
but	26331536	0	O
not	26331536	0	O
in	26331536	0	O
wild	26331536	0	O
-	26331536	0	O
type	26331536	0	O
p53	26331536	0	O
or	26331536	0	O
p53	26331536	0	O
null	26331536	0	O
tumours	26331536	0	O
.	26331536	0	O
Our	26331536	0	O
study	26331536	0	O
reveals	26331536	0	O
a	26331536	0	O
novel	26331536	0	O
chromatin	26331536	0	O
mechanism	26331536	0	O
underlying	26331536	0	O
the	26331536	0	O
progression	26331536	0	O
of	26331536	0	O
tumours	26331536	0	O
with	26331536	0	O
GOF	26331536	0	O
p53	26331536	0	O
,	26331536	0	O
and	26331536	0	O
suggests	26331536	0	O
new	26331536	0	O
possibilities	26331536	0	O
for	26331536	0	O
designing	26331536	0	O
combinatorial	26331536	0	O
chromatin	26331536	0	O
-	26331536	0	O
based	26331536	0	O
therapies	26331536	0	O
for	26331536	0	O
treating	26331536	0	O
individual	26331536	0	O
cancers	26331536	0	O
driven	26331536	0	O
by	26331536	0	O
prevalent	26331536	0	O
GOF	26331536	0	O
p53	26331536	0	O
mutations	26331536	0	O
.	26331536	0	O

DNA	26494468	0	O
damage	26494468	0	O
-	26494468	0	O
induced	26494468	0	O
ephrin	26494468	0	O
-	26494468	0	O
B2	26494468	0	O
reverse	26494468	0	O
signaling	26494468	0	O
promotes	26494468	0	O
chemoresistance	26494468	0	O
and	26494468	0	O
drives	26494468	0	O
EMT	26494468	0	O
in	26494468	0	O
colorectal	26494468	0	O
carcinoma	26494468	0	O
harboring	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
.	26494468	0	O
Mutation	26494468	0	O
in	26494468	0	O
the	26494468	0	O
TP53	26494468	0	O
gene	26494468	0	O
positively	26494468	0	O
correlates	26494468	0	O
with	26494468	0	O
increased	26494468	0	O
incidence	26494468	0	O
of	26494468	0	O
chemoresistance	26494468	0	O
in	26494468	0	O
different	26494468	0	O
cancers	26494468	0	O
.	26494468	0	O
In	26494468	0	O
this	26494468	0	O
study	26494468	0	O
,	26494468	0	O
we	26494468	0	O
investigated	26494468	0	O
the	26494468	0	O
mechanism	26494468	0	O
of	26494468	0	O
chemoresistance	26494468	0	O
and	26494468	0	O
epithelial	26494468	0	O
-	26494468	0	O
to	26494468	0	O
-	26494468	0	O
mesenchymal	26494468	0	O
transition	26494468	0	O
(	26494468	0	O
EMT	26494468	0	O
)	26494468	0	O
in	26494468	0	O
colorectal	26494468	0	O
cancer	26494468	0	O
involving	26494468	0	O
the	26494468	0	O
gain	26494468	0	O
-	26494468	0	O
of	26494468	0	O
-	26494468	0	O
function	26494468	0	O
(	26494468	0	O
GOF	26494468	0	O
)	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
/	26494468	0	O
ephrin	26494468	0	O
-	26494468	0	O
B2	26494468	0	O
signaling	26494468	0	O
axis	26494468	0	O
.	26494468	0	O
Bioinformatic	26494468	0	O
analysis	26494468	0	O
of	26494468	0	O
the	26494468	0	O
NCI-60	26494468	0	O
data	26494468	0	O
set	26494468	0	O
and	26494468	0	O
subsequent	26494468	0	O
hub	26494468	0	O
prediction	26494468	0	O
identified	26494468	0	O
EFNB2	26494468	0	O
as	26494468	0	O
a	26494468	0	O
possible	26494468	0	O
GOF	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
target	26494468	0	O
gene	26494468	0	O
,	26494468	0	O
responsible	26494468	0	O
for	26494468	0	O
chemoresistance	26494468	0	O
.	26494468	0	O
We	26494468	0	O
show	26494468	0	O
that	26494468	0	O
the	26494468	0	O
mutant	26494468	0	B-Var
p53	26494468	0	B-Gene
-	26494468	0	I-Gene
NF	26494468	0	I-Gene
-	26494468	0	I-Gene
Y	26494468	0	I-Gene
complex	26494468	0	O
transcriptionally	26494468	0	O
upregulates	26494468	0	B-PosReg
EFNB2	26494468	0	B-Gene
expression	26494468	0	O
in	26494468	0	O
response	26494468	0	O
to	26494468	0	O
DNA	26494468	0	O
damage	26494468	0	O
.	26494468	0	O
Moreover	26494468	0	O
,	26494468	0	O
the	26494468	0	O
acetylated	26494468	0	O
form	26494468	0	O
of	26494468	0	O
mutant	26494468	0	B-Var
p53	26494468	0	B-Gene
protein	26494468	0	O
is	26494468	0	O
recruited	26494468	0	B-PosReg
on	26494468	0	O
the	26494468	0	O
EFNB2	26494468	0	O
promoter	26494468	0	O
and	26494468	0	O
positively	26494468	0	O
regulates	26494468	0	B-Reg
its	26494468	0	O
expression	26494468	0	O
in	26494468	0	O
conjunction	26494468	0	O
with	26494468	0	O
coactivator	26494468	0	O
p300	26494468	0	O
.	26494468	0	O
In	26494468	0	O
vitro	26494468	0	O
cell	26494468	0	O
line	26494468	0	O
and	26494468	0	O
in	26494468	0	O
vivo	26494468	0	O
nude	26494468	0	O
mice	26494468	0	O
data	26494468	0	O
show	26494468	0	O
that	26494468	0	O
EFNB2	26494468	0	O
silencing	26494468	0	O
restores	26494468	0	O
chemosensitivity	26494468	0	O
in	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
-	26494468	0	O
harboring	26494468	0	O
tumors	26494468	0	O
.	26494468	0	O
In	26494468	0	O
the	26494468	0	O
course	26494468	0	O
of	26494468	0	O
deciphering	26494468	0	O
the	26494468	0	O
drug	26494468	0	O
resistance	26494468	0	O
mechanism	26494468	0	O
,	26494468	0	O
we	26494468	0	O
also	26494468	0	O
show	26494468	0	O
that	26494468	0	O
ephrin	26494468	0	O
-	26494468	0	O
B2	26494468	0	O
reverse	26494468	0	O
signaling	26494468	0	O
induces	26494468	0	B-PosReg
ABCG2	26494468	0	B-Gene
expression	26494468	0	O
after	26494468	0	O
drug	26494468	0	O
treatment	26494468	0	O
that	26494468	0	O
involves	26494468	0	O
JNK	26494468	0	O
-	26494468	0	O
c	26494468	0	O
-	26494468	0	O
Jun	26494468	0	O
signaling	26494468	0	O
in	26494468	0	O
mutant	26494468	0	B-Var
p53	26494468	0	B-Gene
cells	26494468	0	O
.	26494468	0	O
We	26494468	0	O
thus	26494468	0	O
conclude	26494468	0	O
that	26494468	0	O
targeting	26494468	0	O
ephrin	26494468	0	O
-	26494468	0	O
B2	26494468	0	O
might	26494468	0	O
enhance	26494468	0	O
the	26494468	0	O
therapeutic	26494468	0	O
potential	26494468	0	O
of	26494468	0	O
DNA	26494468	0	O
-	26494468	0	O
damaging	26494468	0	O
chemotherapeutic	26494468	0	O
agents	26494468	0	O
in	26494468	0	O
mutant	26494468	0	O
p53	26494468	0	O
-	26494468	0	O
bearing	26494468	0	O
human	26494468	0	O
tumors	26494468	0	O
.	26494468	0	O

A	26545172	4	O
recurrent	26545172	4	B-Var
germline	26545172	4	I-Var
mutation	26545172	4	I-Var
in	26545172	4	O
the	26545172	4	O
PIGA	26545172	4	B-Gene
gene	26545172	4	O
causes	26545172	4	B-Reg
Simpson	26545172	4	B-Disease
-	26545172	4	I-Disease
Golabi	26545172	4	I-Disease
-	26545172	4	I-Disease
Behmel	26545172	4	I-Disease
syndrome	26545172	4	I-Disease
type	26545172	4	I-Disease
2	26545172	4	I-Disease
.	26545172	4	O
Hypomorphic	26545172	4	O
germline	26545172	4	O
mutations	26545172	4	O
in	26545172	4	O
the	26545172	4	O
PIGA	26545172	4	O
(	26545172	4	O
phosphatidylinositol	26545172	4	O
glycan	26545172	4	O
class	26545172	4	O
A	26545172	4	O
)	26545172	4	O
gene	26545172	4	O
recently	26545172	4	O
were	26545172	4	O
recognized	26545172	4	O
as	26545172	4	O
the	26545172	4	O
cause	26545172	4	O
of	26545172	4	O
a	26545172	4	O
clinically	26545172	4	O
heterogeneous	26545172	4	O
spectrum	26545172	4	O
of	26545172	4	O
X	26545172	4	O
-	26545172	4	O
linked	26545172	4	O
disorders	26545172	4	O
including	26545172	4	O
(	26545172	4	O
i	26545172	4	O
)	26545172	4	O
early	26545172	4	O
onset	26545172	4	O
epileptic	26545172	4	O
encephalopathy	26545172	4	O
with	26545172	4	O
severe	26545172	4	O
muscular	26545172	4	O
hypotonia	26545172	4	O
,	26545172	4	O
dysmorphism	26545172	4	O
,	26545172	4	O
multiple	26545172	4	O
congenital	26545172	4	O
anomalies	26545172	4	O
,	26545172	4	O
and	26545172	4	O
early	26545172	4	O
death	26545172	4	O
(	26545172	4	O
"	26545172	4	O
MCAHS2	26545172	4	O
"	26545172	4	O
)	26545172	4	O
,	26545172	4	O
(	26545172	4	O
ii	26545172	4	O
)	26545172	4	O
neurodegenerative	26545172	4	O
encephalopathy	26545172	4	O
with	26545172	4	O
systemic	26545172	4	O
iron	26545172	4	O
overload	26545172	4	O
(	26545172	4	O
ferro	26545172	4	O
-	26545172	4	O
cerebro	26545172	4	O
-	26545172	4	O
cutaneous	26545172	4	O
syndrome	26545172	4	O
,	26545172	4	O
"	26545172	4	O
FCCS	26545172	4	O
"	26545172	4	O
)	26545172	4	O
,	26545172	4	O
and	26545172	4	O
(	26545172	4	O
iii	26545172	4	O
)	26545172	4	O
intellectual	26545172	4	O
disability	26545172	4	O
and	26545172	4	O
seizures	26545172	4	O
without	26545172	4	O
dysmorphism	26545172	4	O
.	26545172	4	O
Previous	26545172	4	O
studies	26545172	4	O
showed	26545172	4	O
that	26545172	4	O
the	26545172	4	O
recurrent	26545172	4	O
PIGA	26545172	4	O
germline	26545172	4	O
mutation	26545172	4	O
c.1234	26545172	4	O
C	26545172	4	O
>	26545172	4	O
T	26545172	4	O
(	26545172	4	O
p.Arg412*	26545172	4	O
)	26545172	4	O
leads	26545172	4	O
to	26545172	4	O
a	26545172	4	O
clinical	26545172	4	O
phenotype	26545172	4	O
at	26545172	4	O
the	26545172	4	O
most	26545172	4	O
severe	26545172	4	O
end	26545172	4	O
of	26545172	4	O
the	26545172	4	O
spectrum	26545172	4	O
associated	26545172	4	O
with	26545172	4	O
early	26545172	4	O
infantile	26545172	4	O
lethality	26545172	4	O
.	26545172	4	O
We	26545172	4	O
identified	26545172	4	O
three	26545172	4	O
additional	26545172	4	O
individuals	26545172	4	O
from	26545172	4	O
two	26545172	4	O
unrelated	26545172	4	O
families	26545172	4	O
with	26545172	4	O
the	26545172	4	O
same	26545172	4	O
PIGA	26545172	4	O
mutation	26545172	4	O
.	26545172	4	O
We	26545172	4	O
were	26545172	4	O
able	26545172	4	O
to	26545172	4	O
confirm	26545172	4	O
the	26545172	4	O
same	26545172	4	O
c.1234	26545172	4	O
C	26545172	4	O
>	26545172	4	O
T	26545172	4	O
(	26545172	4	O
p.Arg412*	26545172	4	O
)	26545172	4	O
mutation	26545172	4	O
in	26545172	4	O
the	26545172	4	O
DNA	26545172	4	O
sample	26545172	4	O
from	26545172	4	O
an	26545172	4	O
affected	26545172	4	O
fetus	26545172	4	O
of	26545172	4	O
the	26545172	4	O
original	26545172	4	O
family	26545172	4	O
affected	26545172	4	O
with	26545172	4	O
SGBS2	26545172	4	O
.	26545172	4	O
We	26545172	4	O
conclude	26545172	4	O
that	26545172	4	O
the	26545172	4	O
recurrent	26545172	4	O
PIGA	26545172	4	B-Gene
germline	26545172	4	O
mutation	26545172	4	O
c.1234	26545172	4	B-Var
C	26545172	4	I-Var
>	26545172	4	I-Var
T	26545172	4	I-Var
leads	26545172	4	B-Reg
to	26545172	4	I-Reg
a	26545172	4	O
recognizable	26545172	4	O
clinical	26545172	4	O
phenotype	26545172	4	O
with	26545172	4	O
a	26545172	4	O
poor	26545172	4	O
prognosis	26545172	4	O
and	26545172	4	O
is	26545172	4	O
the	26545172	4	O
cause	26545172	4	B-Reg
of	26545172	4	O
SGBS2	26545172	4	B-Disease
.	26545172	4	O

Whereas	26586530	3	O
PCSK9	26586530	3	B-Gene
gain	26586530	3	B-PosReg
-	26586530	3	I-PosReg
of	26586530	3	I-PosReg
-	26586530	3	I-PosReg
function	26586530	3	I-PosReg
(	26586530	3	O
GOF	26586530	3	O
)	26586530	3	O
mutations	26586530	3	B-Var
are	26586530	3	O
associated	26586530	3	O
with	26586530	3	O
autosomal	26586530	3	B-Disease
dominant	26586530	3	I-Disease
hypercholesterolemia	26586530	3	I-Disease
(	26586530	3	O
ADH	26586530	3	O
)	26586530	3	O
and	26586530	3	O
premature	26586530	3	B-Disease
atherosclerosis	26586530	3	I-Disease
,	26586530	3	O
PCSK9	26586530	3	B-Gene
loss	26586530	3	B-NegReg
-	26586530	3	I-NegReg
of	26586530	3	I-NegReg
-	26586530	3	I-NegReg
function	26586530	3	I-NegReg
(	26586530	3	O
LOF	26586530	3	O
)	26586530	3	O
mutations	26586530	3	B-Var
have	26586530	3	B-PosReg
a	26586530	3	O
cardio	26586530	3	O
-	26586530	3	O
protective	26586530	3	O
effect	26586530	3	O
and	26586530	3	O
in	26586530	3	O
some	26586530	3	O
cases	26586530	3	O
can	26586530	3	O
lead	26586530	3	O
to	26586530	3	O
familial	26586530	3	B-Disease
hypobetalipoproteinemia	26586530	3	I-Disease
(	26586530	3	O
FHBL	26586530	3	O
)	26586530	3	O
.	26586530	3	O
However	26586530	3	O
,	26586530	3	O
limitations	26586530	3	O
of	26586530	3	O
the	26586530	3	O
currently	26586530	3	O
available	26586530	3	O
cellular	26586530	3	O
models	26586530	3	O
preclude	26586530	3	O
deciphering	26586530	3	O
the	26586530	3	O
consequences	26586530	3	O
of	26586530	3	O
PCSK9	26586530	3	O
mutation	26586530	3	O
further	26586530	3	O
.	26586530	3	O
Compared	26586530	3	O
to	26586530	3	O
control	26586530	3	O
cells	26586530	3	O
,	26586530	3	O
cells	26586530	3	O
originally	26586530	3	O
derived	26586530	3	O
from	26586530	3	O
an	26586530	3	O
individual	26586530	3	O
with	26586530	3	O
ADH	26586530	3	O
(	26586530	3	O
HLC	26586530	3	O
-	26586530	3	O
S127R	26586530	3	O
)	26586530	3	O
secreted	26586530	3	O
less	26586530	3	O
PCSK9	26586530	3	O
in	26586530	3	O
the	26586530	3	O
media	26586530	3	O
(	26586530	3	O
-	26586530	3	O
38.5%	26586530	3	O
;	26586530	3	O
P	26586530	3	O
=	26586530	3	O
0.038	26586530	3	O
)	26586530	3	O
and	26586530	3	O
had	26586530	3	O
a	26586530	3	O
71%	26586530	3	O
decrease	26586530	3	O
(	26586530	3	O
P	26586530	3	O
<	26586530	3	O
0.001	26586530	3	O
)	26586530	3	O
of	26586530	3	O
low	26586530	3	O
-	26586530	3	O
density	26586530	3	O
lipoprotein	26586530	3	O
(	26586530	3	O
LDL	26586530	3	O
)	26586530	3	O
uptake	26586530	3	O
,	26586530	3	O
whereas	26586530	3	O
cells	26586530	3	O
originally	26586530	3	O
derived	26586530	3	O
from	26586530	3	O
an	26586530	3	O
individual	26586530	3	O
with	26586530	3	O
FHBL	26586530	3	O
(	26586530	3	O
HLC	26586530	3	O
-	26586530	3	O
R104C	26586530	3	O
/	26586530	3	O
V114A	26586530	3	O
)	26586530	3	O
displayed	26586530	3	O
a	26586530	3	O
strong	26586530	3	O
decrease	26586530	3	O
in	26586530	3	O
PCSK9	26586530	3	O
secretion	26586530	3	O
(	26586530	3	O
-	26586530	3	O
89.7%	26586530	3	O
;	26586530	3	O
P	26586530	3	O
<	26586530	3	O
0.001	26586530	3	O
)	26586530	3	O
and	26586530	3	O
had	26586530	3	O
a	26586530	3	O
106%	26586530	3	O
increase	26586530	3	O
(	26586530	3	O
P	26586530	3	O
=	26586530	3	O
0.0104	26586530	3	O
)	26586530	3	O
of	26586530	3	O
LDL	26586530	3	O
uptake	26586530	3	O
.	26586530	3	O
Pravastatin	26586530	3	O
treatment	26586530	3	O
significantly	26586530	3	O
enhanced	26586530	3	O
LDL	26586530	3	O
receptor	26586530	3	O
(	26586530	3	O
LDLR	26586530	3	O
)	26586530	3	O
and	26586530	3	O
PCSK9	26586530	3	O
mRNA	26586530	3	O
gene	26586530	3	O
expression	26586530	3	O
,	26586530	3	O
as	26586530	3	O
well	26586530	3	O
as	26586530	3	O
PCSK9	26586530	3	O
secretion	26586530	3	O
and	26586530	3	O
LDL	26586530	3	O
uptake	26586530	3	O
in	26586530	3	O
both	26586530	3	O
control	26586530	3	O
and	26586530	3	O
S127R	26586530	3	O
HLCs	26586530	3	O
.	26586530	3	O
Pravastatin	26586530	3	O
treatment	26586530	3	O
of	26586530	3	O
multiple	26586530	3	O
clones	26586530	3	O
led	26586530	3	O
to	26586530	3	O
an	26586530	3	O
average	26586530	3	O
increase	26586530	3	O
of	26586530	3	O
LDL	26586530	3	O
uptake	26586530	3	O
of	26586530	3	O
2.19	26586530	3	O
0.77	26586530	3	O
-	26586530	3	O
fold	26586530	3	O
in	26586530	3	O
HLC	26586530	3	O
-	26586530	3	O
S127R	26586530	3	O
compared	26586530	3	O
to	26586530	3	O
1.38	26586530	3	O
0.49	26586530	3	O
fold	26586530	3	O
in	26586530	3	O
control	26586530	3	O
HLCs	26586530	3	O
(	26586530	3	O
P	26586530	3	O
<	26586530	3	O
0.01	26586530	3	O
)	26586530	3	O
,	26586530	3	O
in	26586530	3	O
line	26586530	3	O
with	26586530	3	O
the	26586530	3	O
good	26586530	3	O
response	26586530	3	O
to	26586530	3	O
statin	26586530	3	O
treatment	26586530	3	O
of	26586530	3	O
individuals	26586530	3	O
carrying	26586530	3	O
the	26586530	3	O
S127R	26586530	3	O
mutation	26586530	3	O
(	26586530	3	O
mean	26586530	3	O
LDL	26586530	3	O
cholesterol	26586530	3	O
reduction	26586530	3	O
=	26586530	3	O
60.4%	26586530	3	O
,	26586530	3	O
n	26586530	3	O
=	26586530	3	O
5	26586530	3	O
)	26586530	3	O
.	26586530	3	O
In	26586530	3	O
conclusion	26586530	3	O
,	26586530	3	O
urine	26586530	3	O
samples	26586530	3	O
provide	26586530	3	O
an	26586530	3	O
attractive	26586530	3	O
and	26586530	3	O
convenient	26586530	3	O
source	26586530	3	O
of	26586530	3	O
somatic	26586530	3	O
cells	26586530	3	O
for	26586530	3	O
reprogramming	26586530	3	O
and	26586530	3	O
hepatocyte	26586530	3	O
differentiation	26586530	3	O
,	26586530	3	O
but	26586530	3	O
also	26586530	3	O
a	26586530	3	O
powerful	26586530	3	O
tool	26586530	3	O
to	26586530	3	O
further	26586530	3	O
decipher	26586530	3	O
PCSK9	26586530	3	O
mutations	26586530	3	O
and	26586530	3	O
function	26586530	3	O
.	26586530	3	O

Recurrent	26637668	1	O
MLK4	26637668	1	B-Gene
Loss	26637668	1	B-NegReg
-	26637668	1	I-NegReg
of	26637668	1	I-NegReg
-	26637668	1	I-NegReg
Function	26637668	1	I-NegReg
Mutations	26637668	1	B-Var
Suppress	26637668	1	B-NegReg
JNK	26637668	1	O
Signaling	26637668	1	O
to	26637668	1	O
Promote	26637668	1	B-PosReg
Colon	26637668	1	B-Disease
Tumorigenesis	26637668	1	I-Disease
.	26637668	1	O
MLK4	26637668	1	O
mutations	26637668	1	O
have	26637668	1	O
been	26637668	1	O
identified	26637668	1	O
in	26637668	1	O
various	26637668	1	O
human	26637668	1	O
cancers	26637668	1	O
,	26637668	1	O
including	26637668	1	O
frequently	26637668	1	O
in	26637668	1	O
colorectal	26637668	1	O
cancer	26637668	1	O
,	26637668	1	O
where	26637668	1	O
their	26637668	1	O
function	26637668	1	O
and	26637668	1	O
pathobiological	26637668	1	O
importance	26637668	1	O
have	26637668	1	O
been	26637668	1	O
uncertain	26637668	1	O
.	26637668	1	O
In	26637668	1	O
this	26637668	1	O
study	26637668	1	O
,	26637668	1	O
we	26637668	1	O
assessed	26637668	1	O
the	26637668	1	O
functional	26637668	1	O
consequences	26637668	1	O
of	26637668	1	O
MLK4	26637668	1	O
mutations	26637668	1	O
in	26637668	1	O
colon	26637668	1	O
tumorigenesis	26637668	1	O
.	26637668	1	O
Biochemical	26637668	1	O
data	26637668	1	O
indicated	26637668	1	O
that	26637668	1	O
a	26637668	1	O
majority	26637668	1	O
of	26637668	1	O
MLK4	26637668	1	B-Gene
mutations	26637668	1	B-Var
are	26637668	1	O
loss	26637668	1	B-NegReg
-	26637668	1	I-NegReg
of	26637668	1	I-NegReg
-	26637668	1	I-NegReg
function	26637668	1	I-NegReg
(	26637668	1	O
LOF	26637668	1	O
)	26637668	1	O
mutations	26637668	1	O
that	26637668	1	O
can	26637668	1	O
exert	26637668	1	O
dominant	26637668	1	O
-	26637668	1	O
negative	26637668	1	O
effects	26637668	1	O
.	26637668	1	O
In	26637668	1	O
seeking	26637668	1	O
to	26637668	1	O
understand	26637668	1	O
the	26637668	1	O
abrogated	26637668	1	O
activity	26637668	1	O
of	26637668	1	O
these	26637668	1	O
mutants	26637668	1	O
,	26637668	1	O
we	26637668	1	O
elucidated	26637668	1	O
a	26637668	1	O
new	26637668	1	O
MLK4	26637668	1	O
catalytic	26637668	1	O
domain	26637668	1	O
structure	26637668	1	O
.	26637668	1	O
To	26637668	1	O
determine	26637668	1	O
whether	26637668	1	O
MLK4	26637668	1	O
is	26637668	1	O
required	26637668	1	O
to	26637668	1	O
maintain	26637668	1	O
tumorigenic	26637668	1	O
phenotypes	26637668	1	O
,	26637668	1	O
we	26637668	1	O
reconstituted	26637668	1	O
its	26637668	1	O
signaling	26637668	1	O
axis	26637668	1	O
in	26637668	1	O
colon	26637668	1	O
cancer	26637668	1	O
cells	26637668	1	O
harboring	26637668	1	O
MLK4	26637668	1	O
-	26637668	1	O
inactivating	26637668	1	O
mutations	26637668	1	O
.	26637668	1	O
Our	26637668	1	O
work	26637668	1	O
indicates	26637668	1	O
that	26637668	1	O
MLK4	26637668	1	B-Gene
is	26637668	1	O
a	26637668	1	O
novel	26637668	1	O
tumor	26637668	1	O
-	26637668	1	O
suppressing	26637668	1	O
kinase	26637668	1	O
harboring	26637668	1	O
frequent	26637668	1	O
LOF	26637668	1	B-NegReg
mutations	26637668	1	B-Var
that	26637668	1	O
lead	26637668	1	O
to	26637668	1	O
diminished	26637668	1	B-NegReg
signaling	26637668	1	O
in	26637668	1	O
the	26637668	1	O
JNK	26637668	1	O
pathway	26637668	1	O
and	26637668	1	O
enhanced	26637668	1	B-PosReg
proliferation	26637668	1	O
in	26637668	1	O
colon	26637668	1	O
cancer	26637668	1	O
.	26637668	1	O

Transcriptome	27114909	0	O
profiling	27114909	0	O
identifies	27114909	0	O
genes	27114909	0	O
and	27114909	0	O
pathways	27114909	0	O
deregulated	27114909	0	O
upon	27114909	0	O
floxuridine	27114909	0	O
treatment	27114909	0	O
in	27114909	0	O
colorectal	27114909	0	O
cancer	27114909	0	O
cells	27114909	0	O
harboring	27114909	0	O
GOF	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
.	27114909	0	O
Mutation	27114909	0	O
in	27114909	0	O
TP53	27114909	0	O
is	27114909	0	O
a	27114909	0	O
common	27114909	0	O
genetic	27114909	0	O
alteration	27114909	0	O
in	27114909	0	O
human	27114909	0	O
cancers	27114909	0	O
.	27114909	0	O
Certain	27114909	0	O
tumor	27114909	0	O
associated	27114909	0	O
p53	27114909	0	B-Gene
missense	27114909	0	B-Var
mutants	27114909	0	I-Var
acquire	27114909	0	O
gain	27114909	0	B-PosReg
-	27114909	0	I-PosReg
of	27114909	0	I-PosReg
-	27114909	0	I-PosReg
function	27114909	0	I-PosReg
(	27114909	0	O
GOF	27114909	0	O
)	27114909	0	O
properties	27114909	0	O
and	27114909	0	O
confer	27114909	0	O
oncogenic	27114909	0	O
phenotypes	27114909	0	O
including	27114909	0	O
enhanced	27114909	0	B-PosReg
chemoresistance	27114909	0	O
.	27114909	0	O
The	27114909	0	O
colorectal	27114909	0	O
cancers	27114909	0	O
(	27114909	0	O
CRC	27114909	0	O
)	27114909	0	O
harboring	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
are	27114909	0	O
generally	27114909	0	O
aggressive	27114909	0	O
in	27114909	0	O
nature	27114909	0	O
and	27114909	0	O
difficult	27114909	0	O
to	27114909	0	O
treat	27114909	0	O
.	27114909	0	O
To	27114909	0	O
identify	27114909	0	O
a	27114909	0	O
potential	27114909	0	O
gene	27114909	0	O
expression	27114909	0	O
signature	27114909	0	O
of	27114909	0	O
GOF	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
-	27114909	0	O
driven	27114909	0	O
acquired	27114909	0	O
chemoresistance	27114909	0	O
in	27114909	0	O
CRC	27114909	0	O
,	27114909	0	O
we	27114909	0	O
performed	27114909	0	O
transcriptome	27114909	0	O
profiling	27114909	0	O
of	27114909	0	O
floxuridine	27114909	0	O
(	27114909	0	O
FUdR	27114909	0	O
)	27114909	0	O
treated	27114909	0	O
SW480	27114909	0	O
cells	27114909	0	O
expressing	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
(	27114909	0	O
R273H	27114909	0	O
)	27114909	0	O
(	27114909	0	O
GEO	27114909	0	O
:	27114909	0	O
GSE77533	27114909	0	O
)	27114909	0	O
.	27114909	0	O
Our	27114909	0	O
data	27114909	0	O
suggest	27114909	0	O
that	27114909	0	O
in	27114909	0	O
response	27114909	0	O
to	27114909	0	O
chemotherapeutics	27114909	0	O
treatment	27114909	0	O
,	27114909	0	O
cancer	27114909	0	O
cells	27114909	0	O
with	27114909	0	O
GOF	27114909	0	B-PosReg
mutant	27114909	0	B-Var
p53	27114909	0	B-Gene
can	27114909	0	O
modulate	27114909	0	B-Reg
key	27114909	0	O
cellular	27114909	0	O
pathways	27114909	0	O
to	27114909	0	O
withstand	27114909	0	O
the	27114909	0	O
cytotoxic	27114909	0	O
effect	27114909	0	O
of	27114909	0	O
the	27114909	0	O
drugs	27114909	0	O
.	27114909	0	O
The	27114909	0	O
genes	27114909	0	O
and	27114909	0	O
pathways	27114909	0	O
identified	27114909	0	O
in	27114909	0	O
the	27114909	0	O
present	27114909	0	O
study	27114909	0	O
can	27114909	0	O
be	27114909	0	O
further	27114909	0	O
validated	27114909	0	O
and	27114909	0	O
targeted	27114909	0	O
for	27114909	0	O
better	27114909	0	O
chemotherapy	27114909	0	O
response	27114909	0	O
in	27114909	0	O
colorectal	27114909	0	O
cancer	27114909	0	O
patients	27114909	0	O
harboring	27114909	0	O
mutant	27114909	0	O
p53	27114909	0	O
.	27114909	0	O

ASD	27325115	1	O
genes	27325115	1	O
with	27325115	1	O
adjacent	27325115	1	O
cortical	27325115	1	O
TBR1	27325115	1	O
ChIP	27325115	1	O
-	27325115	1	O
seq	27325115	1	O
peaks	27325115	1	O
also	27325115	1	O
showed	27325115	1	O
unusually	27325115	1	O
low	27325115	1	O
levels	27325115	1	O
of	27325115	1	O
LoF	27325115	1	O
mutations	27325115	1	O
in	27325115	1	O
a	27325115	1	O
reference	27325115	1	O
human	27325115	1	O
population	27325115	1	O
and	27325115	1	O
among	27325115	1	O
Icelanders	27325115	1	O
.	27325115	1	O
Our	27325115	1	O
findings	27325115	1	O
highlight	27325115	1	O
a	27325115	1	O
TBR1	27325115	1	O
-	27325115	1	O
regulated	27325115	1	O
network	27325115	1	O
of	27325115	1	O
ASD	27325115	1	O
genes	27325115	1	O
in	27325115	1	O
the	27325115	1	O
developing	27325115	1	O
neocortex	27325115	1	O
that	27325115	1	O
are	27325115	1	O
relatively	27325115	1	O
intolerant	27325115	1	O
to	27325115	1	O
LoF	27325115	1	O
mutations	27325115	1	O
,	27325115	1	O
indicating	27325115	1	O
that	27325115	1	O
these	27325115	1	O
genes	27325115	1	O
may	27325115	1	O
play	27325115	1	O
critical	27325115	1	O
roles	27325115	1	O
in	27325115	1	O
normal	27325115	1	O
cortical	27325115	1	O
development	27325115	1	O
.	27325115	1	O

A	27341992	0	O
rare	27341992	0	O
DNA	27341992	0	O
contact	27341992	0	O
mutation	27341992	0	B-Var
in	27341992	0	O
cancer	27341992	0	O
confers	27341992	0	B-PosReg
p53	27341992	0	B-Gene
gain	27341992	0	B-PosReg
-	27341992	0	I-PosReg
of	27341992	0	I-PosReg
-	27341992	0	I-PosReg
function	27341992	0	I-PosReg
and	27341992	0	O
tumor	27341992	0	O
cell	27341992	0	O
survival	27341992	0	O
via	27341992	0	O
TNFAIP8	27341992	0	B-Gene
induction	27341992	0	O
.	27341992	0	O
Mutations	27341992	0	B-Var
in	27341992	0	O
the	27341992	0	O
coding	27341992	0	O
sequence	27341992	0	O
of	27341992	0	O
p53	27341992	0	B-Gene
occur	27341992	0	O
frequently	27341992	0	O
in	27341992	0	O
human	27341992	0	O
cancer	27341992	0	O
and	27341992	0	O
often	27341992	0	O
result	27341992	0	B-Reg
in	27341992	0	I-Reg
single	27341992	0	B-Var
amino	27341992	0	I-Var
acid	27341992	0	I-Var
substitutions	27341992	0	I-Var
(	27341992	0	I-Var
missense	27341992	0	I-Var
mutations	27341992	0	I-Var
)	27341992	0	I-Var
in	27341992	0	I-Var
the	27341992	0	I-Var
DNA	27341992	0	I-Var
binding	27341992	0	I-Var
domain	27341992	0	I-Var
(	27341992	0	O
DBD	27341992	0	O
)	27341992	0	O
,	27341992	0	O
blocking	27341992	0	B-NegReg
normal	27341992	0	O
tumor	27341992	0	O
suppressive	27341992	0	O
functions	27341992	0	O
.	27341992	0	O
In	27341992	0	O
addition	27341992	0	O
to	27341992	0	O
the	27341992	0	O
loss	27341992	0	O
of	27341992	0	O
canonical	27341992	0	O
functions	27341992	0	O
,	27341992	0	O
some	27341992	0	O
missense	27341992	0	B-Var
mutations	27341992	0	I-Var
in	27341992	0	O
p53	27341992	0	B-Gene
confer	27341992	0	O
gain	27341992	0	B-PosReg
-	27341992	0	I-PosReg
of	27341992	0	I-PosReg
-	27341992	0	I-PosReg
function	27341992	0	I-PosReg
(	27341992	0	O
GOF	27341992	0	O
)	27341992	0	O
activities	27341992	0	O
to	27341992	0	O
tumor	27341992	0	O
cells	27341992	0	O
.	27341992	0	O
While	27341992	0	O
many	27341992	0	O
missense	27341992	0	O
mutations	27341992	0	O
in	27341992	0	O
p53	27341992	0	O
cluster	27341992	0	O
at	27341992	0	O
six	27341992	0	O
"	27341992	0	O
hotspot	27341992	0	O
"	27341992	0	O
amino	27341992	0	O
acids	27341992	0	O
,	27341992	0	O
the	27341992	0	O
majority	27341992	0	O
of	27341992	0	O
mutations	27341992	0	O
in	27341992	0	O
human	27341992	0	O
cancer	27341992	0	O
occur	27341992	0	O
elsewhere	27341992	0	O
in	27341992	0	O
the	27341992	0	O
DBD	27341992	0	O
and	27341992	0	O
at	27341992	0	O
a	27341992	0	O
much	27341992	0	O
lower	27341992	0	O
frequency	27341992	0	O
.	27341992	0	O
We	27341992	0	O
report	27341992	0	O
here	27341992	0	O
that	27341992	0	O
mutations	27341992	0	B-Var
at	27341992	0	I-Var
K120	27341992	0	I-Var
,	27341992	0	O
a	27341992	0	O
non	27341992	0	O
-	27341992	0	O
hotspot	27341992	0	O
DNA	27341992	0	O
contact	27341992	0	O
residue	27341992	0	O
,	27341992	0	O
confer	27341992	0	B-PosReg
p53	27341992	0	B-Gene
with	27341992	0	O
the	27341992	0	O
previously	27341992	0	O
unrecognized	27341992	0	O
ability	27341992	0	O
to	27341992	0	O
bind	27341992	0	O
and	27341992	0	O
activate	27341992	0	B-PosReg
the	27341992	0	O
transcription	27341992	0	O
of	27341992	0	O
the	27341992	0	O
pro	27341992	0	O
-	27341992	0	O
survival	27341992	0	O
TNFAIP8	27341992	0	B-Gene
gene	27341992	0	O
.	27341992	0	O
Mutant	27341992	0	O
K120	27341992	0	O
p53	27341992	0	O
binds	27341992	0	O
the	27341992	0	O
TNFAIP8	27341992	0	O
locus	27341992	0	O
at	27341992	0	O
a	27341992	0	O
cryptic	27341992	0	O
p53	27341992	0	O
response	27341992	0	O
element	27341992	0	O
that	27341992	0	O
is	27341992	0	O
not	27341992	0	O
occupied	27341992	0	O
by	27341992	0	O
wild	27341992	0	O
-	27341992	0	O
type	27341992	0	O
p53	27341992	0	O
.	27341992	0	O
Furthermore	27341992	0	O
,	27341992	0	O
induction	27341992	0	O
of	27341992	0	O
TNFAIP8	27341992	0	O
is	27341992	0	O
critical	27341992	0	O
for	27341992	0	O
the	27341992	0	O
evasion	27341992	0	O
of	27341992	0	O
apoptosis	27341992	0	O
by	27341992	0	O
tumor	27341992	0	O
cells	27341992	0	O
expressing	27341992	0	O
the	27341992	0	O
K120R	27341992	0	O
variant	27341992	0	O
of	27341992	0	O
p53	27341992	0	O
.	27341992	0	O
These	27341992	0	O
findings	27341992	0	O
identify	27341992	0	O
induction	27341992	0	O
of	27341992	0	O
pro	27341992	0	O
-	27341992	0	O
survival	27341992	0	O
targets	27341992	0	O
as	27341992	0	O
a	27341992	0	O
mechanism	27341992	0	O
of	27341992	0	O
gain	27341992	0	B-PosReg
-	27341992	0	I-PosReg
of	27341992	0	I-PosReg
-	27341992	0	I-PosReg
function	27341992	0	I-PosReg
activity	27341992	0	O
for	27341992	0	O
mutant	27341992	0	B-Var
p53	27341992	0	B-Gene
and	27341992	0	O
will	27341992	0	O
likely	27341992	0	O
broaden	27341992	0	O
our	27341992	0	O
understanding	27341992	0	O
of	27341992	0	O
this	27341992	0	O
phenomenon	27341992	0	O
beyond	27341992	0	O
the	27341992	0	O
limited	27341992	0	O
number	27341992	0	O
of	27341992	0	O
GOF	27341992	0	O
activities	27341992	0	O
currently	27341992	0	O
reported	27341992	0	O
for	27341992	0	O
hotspot	27341992	0	O
mutants	27341992	0	O
.	27341992	0	O

De	27545680	1	O
Novo	27545680	1	O
Mutations	27545680	1	B-Var
in	27545680	1	O
SON	27545680	1	B-Gene
Disrupt	27545680	1	O
RNA	27545680	1	O
Splicing	27545680	1	O
of	27545680	1	O
Genes	27545680	1	O
Essential	27545680	1	O
for	27545680	1	O
Brain	27545680	1	O
Development	27545680	1	O
and	27545680	1	O
Metabolism	27545680	1	O
,	27545680	1	O
Causing	27545680	1	B-Reg
an	27545680	1	O
Intellectual	27545680	1	B-Disease
-	27545680	1	I-Disease
Disability	27545680	1	I-Disease
Syndrome	27545680	1	I-Disease
.	27545680	1	O
Here	27545680	1	O
,	27545680	1	O
we	27545680	1	O
report	27545680	1	O
on	27545680	1	O
an	27545680	1	O
ID	27545680	1	B-Disease
syndrome	27545680	1	I-Disease
caused	27545680	1	O
by	27545680	1	O
de	27545680	1	O
novo	27545680	1	O
heterozygous	27545680	1	O
loss	27545680	1	B-NegReg
-	27545680	1	I-NegReg
of	27545680	1	I-NegReg
-	27545680	1	I-NegReg
function	27545680	1	I-NegReg
(	27545680	1	O
LoF	27545680	1	O
)	27545680	1	O
mutations	27545680	1	B-Var
in	27545680	1	O
SON	27545680	1	B-Gene
.	27545680	1	O

OBJECTIVE	27662822	0	O
:	27662822	0	O
To	27662822	0	O
determine	27662822	0	O
the	27662822	0	O
effect	27662822	0	O
of	27662822	0	O
(	27662822	0	O
1	27662822	0	O
)	27662822	0	O
an	27662822	0	O
oral	27662822	0	O
fat	27662822	0	O
load	27662822	0	O
and	27662822	0	O
(	27662822	0	O
2	27662822	0	O
)	27662822	0	O
pro	27662822	0	O
-	27662822	0	O
protein	27662822	0	O
convertase	27662822	0	O
subtilisin	27662822	0	O
/	27662822	0	O
kexin	27662822	0	O
type	27662822	0	O
(	27662822	0	O
PCSK	27662822	0	O
)	27662822	0	O
9	27662822	0	O
loss	27662822	0	B-NegReg
-	27662822	0	I-NegReg
of	27662822	0	I-NegReg
-	27662822	0	I-NegReg
function	27662822	0	I-NegReg
(	27662822	0	O
LOF	27662822	0	O
)	27662822	0	O
variant	27662822	0	B-Var
status	27662822	0	O
on	27662822	0	O
the	27662822	0	O
ability	27662822	0	O
of	27662822	0	O
peripheral	27662822	0	O
blood	27662822	0	O
mononuclear	27662822	0	O
cells	27662822	0	O
(	27662822	0	O
PBMC	27662822	0	O
)	27662822	0	O
to	27662822	0	O
inhibit	27662822	0	B-NegReg
human	27662822	0	O
adipogenesis	27662822	0	O
.	27662822	0	O
METHODS	27662822	0	O
:	27662822	0	O
PBMC	27662822	0	O
from	27662822	0	O
subjects	27662822	0	O
with	27662822	0	O
one	27662822	0	O
or	27662822	0	O
more	27662822	0	O
PCSK9	27662822	0	O
LOF	27662822	0	O
variants	27662822	0	O
versus	27662822	0	O
non	27662822	0	O
-	27662822	0	O
variant	27662822	0	O
controls	27662822	0	O
were	27662822	0	O
compared	27662822	0	O
in	27662822	0	O
the	27662822	0	O
fasting	27662822	0	O
state	27662822	0	O
and	27662822	0	O
after	27662822	0	O
an	27662822	0	O
oral	27662822	0	O
fat	27662822	0	O
load	27662822	0	O
.	27662822	0	O
RESULTS	27662822	0	O
:	27662822	0	O
Fasting	27662822	0	O
triglyceride	27662822	0	O
(	27662822	0	O
TG	27662822	0	O
)	27662822	0	O
levels	27662822	0	O
were	27662822	0	O
lower	27662822	0	O
in	27662822	0	O
the	27662822	0	O
LOF	27662822	0	O
variant	27662822	0	O
versus	27662822	0	O
non	27662822	0	O
-	27662822	0	O
variant	27662822	0	O
group	27662822	0	O
but	27662822	0	O
rose	27662822	0	O
to	27662822	0	O
the	27662822	0	O
same	27662822	0	O
level	27662822	0	O
after	27662822	0	O
the	27662822	0	O
oral	27662822	0	O
fat	27662822	0	O
load	27662822	0	O
.	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
CM	27662822	0	O
-	27662822	0	O
PP	27662822	0	O
from	27662822	0	O
non	27662822	0	O
-	27662822	0	O
variant	27662822	0	O
controls	27662822	0	O
inhibited	27662822	0	O
adipogenesis	27662822	0	O
of	27662822	0	O
human	27662822	0	O
preadipocytes	27662822	0	O
more	27662822	0	O
than	27662822	0	O
did	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
CM	27662822	0	O
-	27662822	0	O
F.	27662822	0	O
In	27662822	0	O
contrast	27662822	0	O
,	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
CM	27662822	0	O
-	27662822	0	O
F	27662822	0	O
or	27662822	0	O
-	27662822	0	O
PP	27662822	0	O
from	27662822	0	O
PCSK9	27662822	0	B-Gene
LOF	27662822	0	B-NegReg
variant	27662822	0	B-Var
subjects	27662822	0	O
had	27662822	0	O
no	27662822	0	O
effect	27662822	0	O
on	27662822	0	O
adipogenesis	27662822	0	O
.	27662822	0	O
After	27662822	0	O
the	27662822	0	O
oral	27662822	0	O
fat	27662822	0	O
load	27662822	0	O
,	27662822	0	O
PBMC	27662822	0	O
from	27662822	0	O
PCSK9	27662822	0	B-Gene
LOF	27662822	0	B-NegReg
variant	27662822	0	B-Var
subjects	27662822	0	O
showed	27662822	0	O
significant	27662822	0	O
increases	27662822	0	B-PosReg
in	27662822	0	O
mRNA	27662822	0	O
levels	27662822	0	O
of	27662822	0	O
interleukin-1	27662822	0	O
	27662822	0	O
,	27662822	0	O
tumor	27662822	0	O
necrosis	27662822	0	O
factor	27662822	0	O
-	27662822	0	O
	27662822	0	O
,	27662822	0	O
sterol	27662822	0	O
regulatory	27662822	0	O
element	27662822	0	O
binding	27662822	0	O
protein-1	27662822	0	O
c	27662822	0	O
,	27662822	0	O
CD36	27662822	0	O
,	27662822	0	O
and	27662822	0	O
monocyte	27662822	0	O
chemoattractant	27662822	0	O
protein-1	27662822	0	O
(	27662822	0	O
MCP-1	27662822	0	O
)	27662822	0	O
,	27662822	0	O
only	27662822	0	O
MCP-1	27662822	0	O
mRNA	27662822	0	O
levels	27662822	0	O
increased	27662822	0	O
in	27662822	0	O
PBMC	27662822	0	O
from	27662822	0	O
non	27662822	0	O
-	27662822	0	O
variant	27662822	0	O
controls	27662822	0	O
.	27662822	0	O
CONCLUSIONS	27662822	0	O
:	27662822	0	O
The	27662822	0	O
absence	27662822	0	B-NegReg
of	27662822	0	O
anti	27662822	0	O
-	27662822	0	O
adipogenic	27662822	0	O
action	27662822	0	O
of	27662822	0	O
PBMC	27662822	0	O
from	27662822	0	O
PCSK9	27662822	0	B-Gene
LOF	27662822	0	O
variant	27662822	0	B-Var
subjects	27662822	0	O
points	27662822	0	O
to	27662822	0	O
a	27662822	0	O
novel	27662822	0	B-PosReg
role	27662822	0	I-PosReg
for	27662822	0	O
PCSK9	27662822	0	O
in	27662822	0	O
PBMC	27662822	0	O
-	27662822	0	O
adipose	27662822	0	O
cell	27662822	0	O
interactions	27662822	0	O
.	27662822	0	O

The	27678121	1	O
extensive	27678121	1	B-Var
genetic	27678121	1	I-Var
variation	27678121	1	I-Var
in	27678121	1	O
this	27678121	1	O
gene	27678121	1	O
,	27678121	1	O
especially	27678121	1	O
common	27678121	1	O
loss	27678121	1	B-NegReg
-	27678121	1	I-NegReg
of	27678121	1	I-NegReg
-	27678121	1	I-NegReg
function	27678121	1	I-NegReg
(	27678121	1	O
LoF	27678121	1	O
)	27678121	1	O
mutations	27678121	1	B-Var
,	27678121	1	O
has	27678121	1	O
been	27678121	1	O
established	27678121	1	O
as	27678121	1	O
primary	27678121	1	O
risk	27678121	1	O
factors	27678121	1	O
for	27678121	1	O
atopic	27678121	1	B-Disease
dermatitis	27678121	1	I-Disease
.	27678121	1	O

Importantly	27975164	4	O
,	27975164	4	O
we	27975164	4	O
identified	27975164	4	O
52	27975164	4	O
novel	27975164	4	O
probably	27975164	4	O
pathogenic	27975164	4	O
loss	27975164	4	O
-	27975164	4	O
of	27975164	4	O
-	27975164	4	O
function	27975164	4	O
(	27975164	4	O
LOF	27975164	4	O
)	27975164	4	O
variants	27975164	4	O
(	27975164	4	O
20	27975164	4	O
nonsense	27975164	4	O
,	27975164	4	O
16	27975164	4	O
frameshift	27975164	4	O
,	27975164	4	O
14	27975164	4	O
splice	27975164	4	O
sites	27975164	4	O
,	27975164	4	O
one	27975164	4	O
stop	27975164	4	O
-	27975164	4	O
loss	27975164	4	O
,	27975164	4	O
one	27975164	4	O
initiation	27975164	4	O
codon	27975164	4	O
)	27975164	4	O
in	27975164	4	O
11.06%	27975164	4	O
(	27975164	4	O
50	27975164	4	O
/	27975164	4	O
452	27975164	4	O
)	27975164	4	O
AD	27975164	4	O
patients	27975164	4	O
,	27975164	4	O
which	27975164	4	O
were	27975164	4	O
absent	27975164	4	O
in	27975164	4	O
163	27975164	4	O
controls	27975164	4	O
(	27975164	4	O
P	27975164	4	O
=	27975164	4	O
2.5	27975164	4	O
10	27975164	4	O
(	27975164	4	O
-	27975164	4	O
5	27975164	4	O
)	27975164	4	O
)	27975164	4	O
.	27975164	4	O

BACKGROUND	28011069	3	O
:	28011069	3	O
Germline	28011069	3	B-Var
heterozygous	28011069	3	I-Var
mutations	28011069	3	I-Var
in	28011069	3	O
human	28011069	3	O
signal	28011069	3	B-Gene
transducer	28011069	3	I-Gene
and	28011069	3	O
activator	28011069	3	B-Gene
of	28011069	3	I-Gene
transcription	28011069	3	I-Gene
1	28011069	3	I-Gene
(	28011069	3	O
STAT1	28011069	3	O
)	28011069	3	O
can	28011069	3	O
cause	28011069	3	O
loss	28011069	3	B-NegReg
of	28011069	3	I-NegReg
function	28011069	3	I-NegReg
(	28011069	3	O
LOF	28011069	3	O
)	28011069	3	O
,	28011069	3	O
as	28011069	3	O
in	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
Mendelian	28011069	3	O
susceptibility	28011069	3	O
to	28011069	3	O
mycobacterial	28011069	3	B-Disease
diseases	28011069	3	I-Disease
,	28011069	3	O
or	28011069	3	O
gain	28011069	3	B-PosReg
of	28011069	3	I-PosReg
function	28011069	3	I-PosReg
(	28011069	3	O
GOF	28011069	3	O
)	28011069	3	O
,	28011069	3	O
as	28011069	3	O
in	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
chronic	28011069	3	B-Disease
mucocutaneous	28011069	3	I-Disease
candidiasis	28011069	3	I-Disease
.	28011069	3	O
LOF	28011069	3	O
and	28011069	3	O
GOF	28011069	3	O
mutations	28011069	3	B-Var
are	28011069	3	O
equally	28011069	3	O
rare	28011069	3	O
and	28011069	3	O
can	28011069	3	O
affect	28011069	3	B-Reg
the	28011069	3	O
same	28011069	3	O
domains	28011069	3	O
of	28011069	3	O
STAT1	28011069	3	B-Gene
,	28011069	3	O
especially	28011069	3	O
the	28011069	3	O
coiled	28011069	3	O
-	28011069	3	O
coil	28011069	3	O
domain	28011069	3	O
(	28011069	3	O
CCD	28011069	3	O
)	28011069	3	O
and	28011069	3	O
DNA	28011069	3	O
-	28011069	3	O
binding	28011069	3	O
domain	28011069	3	O
(	28011069	3	O
DBD	28011069	3	O
)	28011069	3	O
.	28011069	3	O
Moreover	28011069	3	O
,	28011069	3	O
6%	28011069	3	O
of	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
chronic	28011069	3	O
mucocutaneous	28011069	3	O
candidiasis	28011069	3	O
with	28011069	3	O
a	28011069	3	O
GOF	28011069	3	O
STAT1	28011069	3	O
mutation	28011069	3	O
have	28011069	3	O
mycobacterial	28011069	3	O
disease	28011069	3	O
,	28011069	3	O
obscuring	28011069	3	O
the	28011069	3	O
functional	28011069	3	O
significance	28011069	3	O
of	28011069	3	O
the	28011069	3	O
identified	28011069	3	O
STAT1	28011069	3	O
mutations	28011069	3	O
.	28011069	3	O
Current	28011069	3	O
computational	28011069	3	O
approaches	28011069	3	O
,	28011069	3	O
such	28011069	3	O
as	28011069	3	O
combined	28011069	3	O
annotation	28011069	3	O
-	28011069	3	O
dependent	28011069	3	O
depletion	28011069	3	O
,	28011069	3	O
do	28011069	3	O
not	28011069	3	O
distinguish	28011069	3	O
LOF	28011069	3	O
and	28011069	3	O
GOF	28011069	3	O
variants	28011069	3	O
.	28011069	3	O
METHODS	28011069	3	O
:	28011069	3	O
We	28011069	3	O
mutagenized	28011069	3	O
342	28011069	3	O
individual	28011069	3	O
wild	28011069	3	O
-	28011069	3	O
type	28011069	3	O
amino	28011069	3	O
acids	28011069	3	O
in	28011069	3	O
the	28011069	3	O
CCD	28011069	3	O
/	28011069	3	O
DBD	28011069	3	O
(	28011069	3	O
45.6%	28011069	3	O
of	28011069	3	O
full	28011069	3	O
-	28011069	3	O
length	28011069	3	O
STAT1	28011069	3	O
)	28011069	3	O
to	28011069	3	O
alanine	28011069	3	O
and	28011069	3	O
tested	28011069	3	O
the	28011069	3	O
mutants	28011069	3	O
for	28011069	3	O
STAT1	28011069	3	O
transcriptional	28011069	3	O
activity	28011069	3	O
.	28011069	3	O
RESULTS	28011069	3	O
:	28011069	3	O
Of	28011069	3	O
these	28011069	3	O
342	28011069	3	O
mutants	28011069	3	O
,	28011069	3	O
201	28011069	3	O
were	28011069	3	O
neutral	28011069	3	O
,	28011069	3	O
30	28011069	3	O
were	28011069	3	O
LOF	28011069	3	O
,	28011069	3	O
and	28011069	3	O
111	28011069	3	O
were	28011069	3	O
GOF	28011069	3	O
mutations	28011069	3	O
in	28011069	3	O
a	28011069	3	O
luciferase	28011069	3	O
assay	28011069	3	O
.	28011069	3	O
This	28011069	3	O
assay	28011069	3	O
system	28011069	3	O
correctly	28011069	3	O
estimated	28011069	3	O
all	28011069	3	O
previously	28011069	3	O
reported	28011069	3	O
LOF	28011069	3	O
mutations	28011069	3	O
(	28011069	3	O
100%	28011069	3	O
)	28011069	3	O
and	28011069	3	O
slightly	28011069	3	O
fewer	28011069	3	O
GOF	28011069	3	O
mutations	28011069	3	O
(	28011069	3	O
78.1%	28011069	3	O
)	28011069	3	O
in	28011069	3	O
the	28011069	3	O
CCD	28011069	3	O
/	28011069	3	O
DBD	28011069	3	O
of	28011069	3	O
STAT1	28011069	3	O
.	28011069	3	O
We	28011069	3	O
found	28011069	3	O
that	28011069	3	O
GOF	28011069	3	O
alanine	28011069	3	O
mutants	28011069	3	O
occurred	28011069	3	O
at	28011069	3	O
the	28011069	3	O
interface	28011069	3	O
of	28011069	3	O
the	28011069	3	O
antiparallel	28011069	3	O
STAT1	28011069	3	O
dimer	28011069	3	O
,	28011069	3	O
suggesting	28011069	3	O
that	28011069	3	O
they	28011069	3	O
destabilize	28011069	3	O
this	28011069	3	O
dimer	28011069	3	O
.	28011069	3	O
This	28011069	3	O
assay	28011069	3	O
also	28011069	3	O
precisely	28011069	3	O
predicted	28011069	3	O
the	28011069	3	O
effect	28011069	3	O
of	28011069	3	O
2	28011069	3	O
hypomorphic	28011069	3	O
and	28011069	3	O
dominant	28011069	3	O
negative	28011069	3	O
mutations	28011069	3	O
,	28011069	3	O
E157K	28011069	3	O
and	28011069	3	O
G250E	28011069	3	O
,	28011069	3	O
in	28011069	3	O
the	28011069	3	O
CCD	28011069	3	O
of	28011069	3	O
STAT1	28011069	3	O
that	28011069	3	O
we	28011069	3	O
found	28011069	3	O
in	28011069	3	O
2	28011069	3	O
unrelated	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
Mendelian	28011069	3	O
susceptibility	28011069	3	O
to	28011069	3	O
mycobacterial	28011069	3	O
diseases	28011069	3	O
.	28011069	3	O
CONCLUSION	28011069	3	O
:	28011069	3	O
The	28011069	3	O
systematic	28011069	3	O
alanine	28011069	3	O
-	28011069	3	O
scanning	28011069	3	O
assay	28011069	3	O
is	28011069	3	O
a	28011069	3	O
useful	28011069	3	O
tool	28011069	3	O
to	28011069	3	O
estimate	28011069	3	O
the	28011069	3	O
GOF	28011069	3	O
or	28011069	3	O
LOF	28011069	3	O
status	28011069	3	O
and	28011069	3	O
the	28011069	3	O
effect	28011069	3	O
of	28011069	3	O
heterozygous	28011069	3	O
missense	28011069	3	O
mutations	28011069	3	O
in	28011069	3	O
STAT1	28011069	3	O
identified	28011069	3	O
in	28011069	3	O
patients	28011069	3	O
with	28011069	3	O
severe	28011069	3	O
infectious	28011069	3	O
diseases	28011069	3	O
,	28011069	3	O
including	28011069	3	O
mycobacterial	28011069	3	O
and	28011069	3	O
fungal	28011069	3	O
diseases	28011069	3	O
.	28011069	3	O

Ruxolitinib	28139313	2	O
reverses	28139313	2	O
dysregulated	28139313	2	O
T	28139313	2	O
helper	28139313	2	O
cell	28139313	2	O
responses	28139313	2	O
and	28139313	2	O
controls	28139313	2	O
autoimmunity	28139313	2	O
caused	28139313	2	O
by	28139313	2	O
a	28139313	2	O
novel	28139313	2	O
signal	28139313	2	O
transducer	28139313	2	O
and	28139313	2	O
activator	28139313	2	O
of	28139313	2	O
transcription	28139313	2	O
1	28139313	2	O
(	28139313	2	O
STAT1	28139313	2	O
)	28139313	2	O
gain	28139313	2	O
-	28139313	2	O
of	28139313	2	O
-	28139313	2	O
function	28139313	2	O
mutation	28139313	2	O
.	28139313	2	O
BACKGROUND	28139313	2	O
:	28139313	2	O
Gain	28139313	2	B-PosReg
-	28139313	2	I-PosReg
of	28139313	2	I-PosReg
-	28139313	2	I-PosReg
function	28139313	2	I-PosReg
(	28139313	2	O
GOF	28139313	2	O
)	28139313	2	O
mutations	28139313	2	B-Var
in	28139313	2	O
the	28139313	2	O
human	28139313	2	B-Gene
signal	28139313	2	I-Gene
transducer	28139313	2	I-Gene
and	28139313	2	I-Gene
activator	28139313	2	I-Gene
of	28139313	2	I-Gene
transcription	28139313	2	I-Gene
1	28139313	2	I-Gene
(	28139313	2	O
STAT1	28139313	2	O
)	28139313	2	O
manifest	28139313	2	O
in	28139313	2	O
immunodeficiency	28139313	2	O
and	28139313	2	O
autoimmunity	28139313	2	O
with	28139313	2	O
impaired	28139313	2	B-NegReg
TH17	28139313	2	O
cell	28139313	2	O
differentiation	28139313	2	O
and	28139313	2	O
exaggerated	28139313	2	B-PosReg
responsiveness	28139313	2	O
to	28139313	2	O
type	28139313	2	O
I	28139313	2	O
and	28139313	2	O
II	28139313	2	O
interferons	28139313	2	O
.	28139313	2	O
OBJECTIVE	28139313	2	O
:	28139313	2	O
We	28139313	2	O
sought	28139313	2	O
to	28139313	2	O
define	28139313	2	O
the	28139313	2	O
effect	28139313	2	O
of	28139313	2	O
increased	28139313	2	O
STAT1	28139313	2	O
activity	28139313	2	O
on	28139313	2	O
T	28139313	2	O
helper	28139313	2	O
cell	28139313	2	O
polarization	28139313	2	O
and	28139313	2	O
to	28139313	2	O
investigate	28139313	2	O
the	28139313	2	O
therapeutic	28139313	2	O
potential	28139313	2	O
of	28139313	2	O
ruxolitinib	28139313	2	O
in	28139313	2	O
treating	28139313	2	O
autoimmunity	28139313	2	O
secondary	28139313	2	O
to	28139313	2	O
STAT1	28139313	2	O
GOF	28139313	2	O
mutations	28139313	2	O
.	28139313	2	O
RESULTS	28139313	2	O
:	28139313	2	O
We	28139313	2	O
report	28139313	2	O
a	28139313	2	O
child	28139313	2	O
with	28139313	2	O
a	28139313	2	O
novel	28139313	2	O
mutation	28139313	2	B-Var
in	28139313	2	I-Var
the	28139313	2	I-Var
linker	28139313	2	I-Var
domain	28139313	2	I-Var
of	28139313	2	O
STAT1	28139313	2	B-Gene
who	28139313	2	O
had	28139313	2	O
life	28139313	2	O
-	28139313	2	O
threatening	28139313	2	O
autoimmune	28139313	2	O
cytopenias	28139313	2	O
and	28139313	2	O
chronic	28139313	2	O
mucocutaneous	28139313	2	O
candidiasis	28139313	2	O
.	28139313	2	O
The	28139313	2	O
mutation	28139313	2	B-Var
augmented	28139313	2	B-PosReg
cytokine	28139313	2	O
-	28139313	2	O
induced	28139313	2	O
STAT1	28139313	2	O
phosphorylation	28139313	2	O
without	28139313	2	O
affecting	28139313	2	O
dephosphorylation	28139313	2	O
kinetics	28139313	2	O
.	28139313	2	O
CONCLUSIONS	28139313	2	O
:	28139313	2	O
Autoimmunity	28139313	2	O
and	28139313	2	O
infection	28139313	2	O
caused	28139313	2	O
by	28139313	2	O
STAT1	28139313	2	B-Gene
GOF	28139313	2	B-PosReg
mutations	28139313	2	B-Var
are	28139313	2	O
the	28139313	2	O
result	28139313	2	O
of	28139313	2	O
dysregulated	28139313	2	O
T	28139313	2	O
helper	28139313	2	O
cell	28139313	2	O
responses	28139313	2	O
.	28139313	2	O

Conformational	28167755	4	O
disruption	28167755	4	O
of	28167755	4	O
PI3K	28167755	4	O
regulation	28167755	4	O
by	28167755	4	O
immunodeficiency	28167755	4	O
mutations	28167755	4	O
in	28167755	4	O
PIK3CD	28167755	4	O
and	28167755	4	O
PIK3R1	28167755	4	O
.	28167755	4	O
Activated	28167755	4	B-Disease
PI3K	28167755	4	I-Disease
Delta	28167755	4	I-Disease
Syndrome	28167755	4	I-Disease
(	28167755	4	O
APDS	28167755	4	O
)	28167755	4	O
is	28167755	4	O
a	28167755	4	O
primary	28167755	4	O
immunodeficiency	28167755	4	O
disease	28167755	4	O
caused	28167755	4	B-Reg
by	28167755	4	O
activating	28167755	4	O
mutations	28167755	4	B-Var
in	28167755	4	O
either	28167755	4	O
the	28167755	4	O
leukocyte	28167755	4	O
-	28167755	4	O
restricted	28167755	4	O
p110	28167755	4	O
catalytic	28167755	4	O
(	28167755	4	B-Gene
PIK3CD	28167755	4	I-Gene
)	28167755	4	I-Gene
subunit	28167755	4	O
or	28167755	4	O
the	28167755	4	O
ubiquitously	28167755	4	O
expressed	28167755	4	O
p85	28167755	4	O
regulatory	28167755	4	O
(	28167755	4	O
PIK3R1	28167755	4	O
)	28167755	4	O
subunit	28167755	4	O
of	28167755	4	O
class	28167755	4	O
IA	28167755	4	O
phosphoinositide	28167755	4	O
3	28167755	4	O
-	28167755	4	O
kinases	28167755	4	O
(	28167755	4	O
PI3Ks	28167755	4	O
)	28167755	4	O
.	28167755	4	O
There	28167755	4	O
are	28167755	4	O
two	28167755	4	O
classes	28167755	4	O
of	28167755	4	O
APDS	28167755	4	O
:	28167755	4	O
APDS1	28167755	4	O
that	28167755	4	O
arises	28167755	4	O
from	28167755	4	O
p110	28167755	4	O
mutations	28167755	4	O
that	28167755	4	O
are	28167755	4	O
analogous	28167755	4	O
to	28167755	4	O
oncogenic	28167755	4	O
mutations	28167755	4	O
found	28167755	4	O
in	28167755	4	O
the	28167755	4	O
broadly	28167755	4	O
expressed	28167755	4	O
p110	28167755	4	O
subunit	28167755	4	O
and	28167755	4	O
APDS2	28167755	4	O
that	28167755	4	O
occurs	28167755	4	O
from	28167755	4	O
a	28167755	4	O
splice	28167755	4	O
mutation	28167755	4	O
resulting	28167755	4	O
in	28167755	4	O
p85	28167755	4	O
with	28167755	4	O
a	28167755	4	O
central	28167755	4	O
deletion	28167755	4	O
(	28167755	4	O
434-475	28167755	4	O
)	28167755	4	O
.	28167755	4	O
As	28167755	4	O
p85	28167755	4	O
regulatory	28167755	4	O
subunits	28167755	4	O
associate	28167755	4	O
with	28167755	4	O
and	28167755	4	O
inhibit	28167755	4	O
all	28167755	4	O
class	28167755	4	O
IA	28167755	4	O
catalytic	28167755	4	O
subunits	28167755	4	O
,	28167755	4	O
APDS2	28167755	4	O
mutations	28167755	4	O
are	28167755	4	O
expected	28167755	4	O
to	28167755	4	O
similarly	28167755	4	O
activate	28167755	4	O
p110	28167755	4	O
,	28167755	4	O
	28167755	4	O
,	28167755	4	O
and	28167755	4	O
	28167755	4	O
,	28167755	4	O
yet	28167755	4	O
APDS2	28167755	4	O
largely	28167755	4	O
phenocopies	28167755	4	O
APDS1	28167755	4	O
without	28167755	4	O
dramatic	28167755	4	O
effects	28167755	4	O
outside	28167755	4	O
the	28167755	4	O
immune	28167755	4	O
system	28167755	4	O
.	28167755	4	O
We	28167755	4	O
have	28167755	4	O
examined	28167755	4	O
the	28167755	4	O
molecular	28167755	4	O
mechanism	28167755	4	O
of	28167755	4	O
activation	28167755	4	O
of	28167755	4	O
both	28167755	4	O
classes	28167755	4	O
of	28167755	4	O
APDS	28167755	4	O
mutations	28167755	4	O
using	28167755	4	O
a	28167755	4	O
combination	28167755	4	O
of	28167755	4	O
biochemical	28167755	4	O
assays	28167755	4	O
and	28167755	4	O
hydrogen	28167755	4	O
-	28167755	4	O
deuterium	28167755	4	O
exchange	28167755	4	O
mass	28167755	4	O
spectrometry	28167755	4	O
.	28167755	4	O
Intriguingly	28167755	4	O
,	28167755	4	O
we	28167755	4	O
find	28167755	4	O
that	28167755	4	O
an	28167755	4	O
APDS2	28167755	4	B-Gene
mutation	28167755	4	B-Var
in	28167755	4	O
p85	28167755	4	O
leads	28167755	4	O
to	28167755	4	O
substantial	28167755	4	O
basal	28167755	4	O
activation	28167755	4	B-PosReg
of	28167755	4	O
p110	28167755	4	O
(	28167755	4	O
>	28167755	4	O
300	28167755	4	O
-	28167755	4	O
fold	28167755	4	O
)	28167755	4	O
and	28167755	4	O
disrupts	28167755	4	B-NegReg
inhibitory	28167755	4	O
interactions	28167755	4	O
from	28167755	4	O
the	28167755	4	O
nSH2	28167755	4	O
,	28167755	4	O
iSH2	28167755	4	O
,	28167755	4	O
and	28167755	4	O
cSH2	28167755	4	O
domains	28167755	4	O
of	28167755	4	O
p85	28167755	4	O
,	28167755	4	O
whereas	28167755	4	O
p110	28167755	4	O
is	28167755	4	O
only	28167755	4	O
minimally	28167755	4	O
basally	28167755	4	O
activated	28167755	4	O
(	28167755	4	O
2	28167755	4	O
-	28167755	4	O
fold	28167755	4	O
)	28167755	4	O
when	28167755	4	O
associated	28167755	4	O
with	28167755	4	O
mutated	28167755	4	O
p85	28167755	4	O
.	28167755	4	O
APDS1	28167755	4	O
mutations	28167755	4	O
in	28167755	4	O
p110	28167755	4	O
(	28167755	4	O
N334K	28167755	4	O
,	28167755	4	O
E525K	28167755	4	O
,	28167755	4	O
E1021K	28167755	4	O
)	28167755	4	O
mimic	28167755	4	O
the	28167755	4	O
activation	28167755	4	O
mechanisms	28167755	4	O
previously	28167755	4	O
discovered	28167755	4	O
for	28167755	4	O
oncogenic	28167755	4	O
mutations	28167755	4	O
in	28167755	4	O
p110	28167755	4	O
.	28167755	4	O
All	28167755	4	O
APDS	28167755	4	O
mutations	28167755	4	O
were	28167755	4	O
potently	28167755	4	O
inhibited	28167755	4	O
by	28167755	4	O
the	28167755	4	O
Food	28167755	4	O
and	28167755	4	O
Drug	28167755	4	O
Administration	28167755	4	O
-	28167755	4	O
approved	28167755	4	O
p110	28167755	4	O
inhibitor	28167755	4	O
idelalisib	28167755	4	O
.	28167755	4	O
Our	28167755	4	O
results	28167755	4	O
define	28167755	4	O
the	28167755	4	O
molecular	28167755	4	O
basis	28167755	4	O
of	28167755	4	O
how	28167755	4	O
PIK3CD	28167755	4	O
and	28167755	4	O
PIK3R1	28167755	4	O
mutations	28167755	4	O
result	28167755	4	O
in	28167755	4	O
APDS	28167755	4	O
and	28167755	4	O
reveal	28167755	4	O
a	28167755	4	O
potential	28167755	4	O
path	28167755	4	O
to	28167755	4	O
treatment	28167755	4	O
for	28167755	4	O
all	28167755	4	O
APDS	28167755	4	O
patients	28167755	4	O
.	28167755	4	O

KIT	28270683	4	B-Gene
,	28270683	4	O
PDGFRA	28270683	4	B-Gene
,	28270683	4	O
NF1	28270683	4	B-Gene
and	28270683	4	O
SDH	28270683	4	B-Gene
mutations	28270683	4	B-Var
are	28270683	4	O
alternate	28270683	4	O
initiating	28270683	4	O
events	28270683	4	O
,	28270683	4	O
fostering	28270683	4	B-Reg
hyperplasia	28270683	4	O
in	28270683	4	O
gastrointestinal	28270683	4	O
stromal	28270683	4	O
tumours	28270683	4	O
(	28270683	4	O
GISTs	28270683	4	O
)	28270683	4	O
,	28270683	4	O
and	28270683	4	O
additional	28270683	4	O
genetic	28270683	4	O
alterations	28270683	4	O
are	28270683	4	O
required	28270683	4	O
for	28270683	4	O
progression	28270683	4	O
to	28270683	4	O
malignancy	28270683	4	O
.	28270683	4	O
Here	28270683	4	O
we	28270683	4	O
report	28270683	4	O
hemizygous	28270683	4	O
or	28270683	4	O
homozygous	28270683	4	O
inactivating	28270683	4	O
mutations	28270683	4	O
of	28270683	4	O
the	28270683	4	O
chromosome	28270683	4	O
14	28270683	4	O
q	28270683	4	O
MAX	28270683	4	O
gene	28270683	4	O
in	28270683	4	O
16	28270683	4	O
of	28270683	4	O
76	28270683	4	O
GISTs	28270683	4	O
(	28270683	4	O
21%	28270683	4	O
)	28270683	4	O
.	28270683	4	O
We	28270683	4	O
find	28270683	4	O
MAX	28270683	4	O
mutations	28270683	4	O
in	28270683	4	O
17%	28270683	4	O
and	28270683	4	O
50%	28270683	4	O
of	28270683	4	O
sporadic	28270683	4	O
and	28270683	4	O
NF1	28270683	4	O
-	28270683	4	O
syndromic	28270683	4	O
GISTs	28270683	4	O
,	28270683	4	O
respectively	28270683	4	O
,	28270683	4	O
and	28270683	4	O
we	28270683	4	O
find	28270683	4	O
loss	28270683	4	O
of	28270683	4	O
MAX	28270683	4	O
protein	28270683	4	O
expression	28270683	4	O
in	28270683	4	O
48%	28270683	4	O
and	28270683	4	O
90%	28270683	4	O
of	28270683	4	O
sporadic	28270683	4	O
and	28270683	4	O
NF1	28270683	4	O
-	28270683	4	O
syndromic	28270683	4	O
GISTs	28270683	4	O
,	28270683	4	O
respectively	28270683	4	O
,	28270683	4	O
and	28270683	4	O
in	28270683	4	O
three	28270683	4	O
of	28270683	4	O
eight	28270683	4	O
micro	28270683	4	O
-	28270683	4	O
GISTs	28270683	4	O
,	28270683	4	O
which	28270683	4	O
are	28270683	4	O
early	28270683	4	O
GISTs	28270683	4	O
.	28270683	4	O

Hydrocephalus	28460636	4	B-Disease
due	28460636	4	O
to	28460636	4	O
multiple	28460636	4	O
ependymal	28460636	4	O
malformations	28460636	4	O
is	28460636	4	O
caused	28460636	4	B-Reg
by	28460636	4	I-Reg
mutations	28460636	4	B-Var
in	28460636	4	O
the	28460636	4	O
MPDZ	28460636	4	B-Gene
gene	28460636	4	O
.	28460636	4	O
In	28460636	4	O
patients	28460636	4	O
with	28460636	4	O
isolated	28460636	4	B-Disease
hydrocephalus	28460636	4	I-Disease
,	28460636	4	O
L1CAM	28460636	4	B-Gene
mutations	28460636	4	B-Var
represent	28460636	4	O
the	28460636	4	O
most	28460636	4	O
common	28460636	4	B-Reg
aetiology	28460636	4	O
.	28460636	4	O
More	28460636	4	O
recently	28460636	4	O
,	28460636	4	O
a	28460636	4	O
founder	28460636	4	O
mutation	28460636	4	O
has	28460636	4	O
also	28460636	4	O
been	28460636	4	O
reported	28460636	4	O
in	28460636	4	O
the	28460636	4	O
MPDZ	28460636	4	O
gene	28460636	4	O
in	28460636	4	O
foetuses	28460636	4	O
presenting	28460636	4	O
massive	28460636	4	O
hydrocephalus	28460636	4	O
,	28460636	4	O
but	28460636	4	O
the	28460636	4	O
neuropathology	28460636	4	O
remains	28460636	4	O
unknown	28460636	4	O
.	28460636	4	O
We	28460636	4	O
describe	28460636	4	O
here	28460636	4	O
three	28460636	4	O
novel	28460636	4	O
homozygous	28460636	4	O
null	28460636	4	O
mutations	28460636	4	O
in	28460636	4	O
the	28460636	4	O
MPDZ	28460636	4	O
gene	28460636	4	O
in	28460636	4	O
foetuses	28460636	4	O
whose	28460636	4	O
post	28460636	4	O
-	28460636	4	O
mortem	28460636	4	O
examination	28460636	4	O
has	28460636	4	O
revealed	28460636	4	O
a	28460636	4	O
homogeneous	28460636	4	O
phenotype	28460636	4	O
characterized	28460636	4	O
by	28460636	4	O
multiple	28460636	4	O
ependymal	28460636	4	O
malformations	28460636	4	O
along	28460636	4	O
the	28460636	4	O
aqueduct	28460636	4	O
of	28460636	4	O
Sylvius	28460636	4	O
,	28460636	4	O
the	28460636	4	O
third	28460636	4	O
and	28460636	4	O
fourth	28460636	4	O
ventricles	28460636	4	O
as	28460636	4	O
well	28460636	4	O
as	28460636	4	O
the	28460636	4	O
central	28460636	4	O
canal	28460636	4	O
of	28460636	4	O
the	28460636	4	O
medulla	28460636	4	O
,	28460636	4	O
consisting	28460636	4	O
in	28460636	4	O
multifocal	28460636	4	O
rosettes	28460636	4	O
with	28460636	4	O
immature	28460636	4	O
cell	28460636	4	O
accumulation	28460636	4	O
in	28460636	4	O
the	28460636	4	O
vicinity	28460636	4	O
of	28460636	4	O
ependymal	28460636	4	O
lining	28460636	4	O
early	28460636	4	O
detached	28460636	4	O
from	28460636	4	O
the	28460636	4	O
ventricular	28460636	4	O
zone	28460636	4	O
.	28460636	4	O

Real	28507206	4	O
-	28507206	4	O
World	28507206	4	O
Data	28507206	4	O
on	28507206	4	O
Prognostic	28507206	4	O
Factors	28507206	4	O
for	28507206	4	O
Overall	28507206	4	O
Survival	28507206	4	O
in	28507206	4	O
EGFR	28507206	4	B-Gene
Mutation	28507206	4	B-Reg
-	28507206	4	I-Reg
Positive	28507206	4	I-Reg
Advanced	28507206	4	O
Non	28507206	4	B-Disease
-	28507206	4	I-Disease
Small	28507206	4	I-Disease
Cell	28507206	4	I-Disease
Lung	28507206	4	I-Disease
Cancer	28507206	4	I-Disease
Patients	28507206	4	O
Treated	28507206	4	O
with	28507206	4	O
First	28507206	4	O
-	28507206	4	O
Line	28507206	4	O
Gefitinib	28507206	4	O
.	28507206	4	O
BACKGROUND	28507206	4	O
:	28507206	4	O
This	28507206	4	O
study	28507206	4	O
aimed	28507206	4	O
to	28507206	4	O
identify	28507206	4	O
independent	28507206	4	O
prognostic	28507206	4	O
factors	28507206	4	O
for	28507206	4	O
overall	28507206	4	O
survival	28507206	4	O
(	28507206	4	O
OS	28507206	4	O
)	28507206	4	O
of	28507206	4	O
patients	28507206	4	O
with	28507206	4	O
advanced	28507206	4	O
non	28507206	4	O
-	28507206	4	O
small	28507206	4	O
cell	28507206	4	O
lung	28507206	4	O
cancer	28507206	4	O
(	28507206	4	O
NSCLC	28507206	4	O
)	28507206	4	O
harboring	28507206	4	O
an	28507206	4	O
activating	28507206	4	O
epidermal	28507206	4	O
growth	28507206	4	O
factor	28507206	4	O
receptor	28507206	4	O
(	28507206	4	O
EGFR	28507206	4	O
)	28507206	4	O
mutation	28507206	4	O
and	28507206	4	O
receiving	28507206	4	O
gefitinib	28507206	4	O
as	28507206	4	O
first	28507206	4	O
-	28507206	4	O
line	28507206	4	O
treatment	28507206	4	O
in	28507206	4	O
real	28507206	4	O
-	28507206	4	O
world	28507206	4	O
practice	28507206	4	O
.	28507206	4	O
CONCLUSION	28507206	4	O
:	28507206	4	O
HCV	28507206	4	O
infection	28507206	4	O
,	28507206	4	O
performance	28507206	4	O
status	28507206	4	O
(	28507206	4	O
ECOG	28507206	4	O
2	28507206	4	O
)	28507206	4	O
,	28507206	4	O
newly	28507206	4	O
diagnosed	28507206	4	O
advanced	28507206	4	O
NSCLC	28507206	4	O
without	28507206	4	O
prior	28507206	4	O
operation	28507206	4	O
,	28507206	4	O
and	28507206	4	O
liver	28507206	4	O
metastasis	28507206	4	O
predicted	28507206	4	O
poor	28507206	4	O
OS	28507206	4	O
in	28507206	4	O
EGFR	28507206	4	O
mutation	28507206	4	O
-	28507206	4	O
positive	28507206	4	O
advanced	28507206	4	O
NSCLC	28507206	4	O
patients	28507206	4	O
treated	28507206	4	O
with	28507206	4	O
first	28507206	4	O
-	28507206	4	O
line	28507206	4	O
gefitinib	28507206	4	O
;	28507206	4	O
however	28507206	4	O
,	28507206	4	O
neither	28507206	4	O
BM	28507206	4	O
at	28507206	4	O
initial	28507206	4	O
diagnosis	28507206	4	O
nor	28507206	4	O
intracranial	28507206	4	O
progression	28507206	4	O
during	28507206	4	O
gefitinib	28507206	4	O
treatment	28507206	4	O
had	28507206	4	O
an	28507206	4	O
impact	28507206	4	O
on	28507206	4	O
OS	28507206	4	O
.	28507206	4	O
The	28507206	4	O
Oncologist	28507206	4	O
2017	28507206	4	O
;	28507206	4	O
22	28507206	4	O
:	28507206	4	O
1	28507206	4	O
-	28507206	4	O
9	28507206	4	O
IMPLICATIONS	28507206	4	O
FOR	28507206	4	O
PRACTICE	28507206	4	O
:	28507206	4	O
The	28507206	4	O
finding	28507206	4	O
that	28507206	4	O
chronic	28507206	4	O
hepatitis	28507206	4	O
C	28507206	4	O
virus	28507206	4	O
(	28507206	4	O
HCV	28507206	4	O
)	28507206	4	O
infection	28507206	4	O
might	28507206	4	O
predict	28507206	4	O
poor	28507206	4	O
overall	28507206	4	O
survival	28507206	4	O
(	28507206	4	O
OS	28507206	4	O
)	28507206	4	O
in	28507206	4	O
epidermal	28507206	4	O
growth	28507206	4	O
factor	28507206	4	O
receptor	28507206	4	O
mutation	28507206	4	O
-	28507206	4	O
positive	28507206	4	O
advanced	28507206	4	O
non	28507206	4	O
-	28507206	4	O
small	28507206	4	O
cell	28507206	4	O
lung	28507206	4	O
cancer	28507206	4	O
(	28507206	4	O
NSCLC	28507206	4	O
)	28507206	4	O
patients	28507206	4	O
treated	28507206	4	O
with	28507206	4	O
first	28507206	4	O
-	28507206	4	O
line	28507206	4	O
gefitinib	28507206	4	O
may	28507206	4	O
raise	28507206	4	O
awareness	28507206	4	O
of	28507206	4	O
benefit	28507206	4	O
from	28507206	4	O
anti	28507206	4	O
-	28507206	4	O
HCV	28507206	4	O
treatment	28507206	4	O
in	28507206	4	O
this	28507206	4	O
patient	28507206	4	O
population	28507206	4	O
.	28507206	4	O

Extracellular	28708837	1	O
inhibitors	28708837	1	O
can	28708837	1	O
attenuate	28708837	1	O
tumorigenic	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
adenomatous	28708837	1	O
polyposis	28708837	1	O
coli	28708837	1	O
mutants	28708837	1	O
:	28708837	1	O
Predictions	28708837	1	O
of	28708837	1	O
a	28708837	1	O
validated	28708837	1	O
mathematical	28708837	1	O
model	28708837	1	O
.	28708837	1	O
BACKGROUND	28708837	1	O
:	28708837	1	O
Despite	28708837	1	O
considerable	28708837	1	O
investigational	28708837	1	O
efforts	28708837	1	O
,	28708837	1	O
no	28708837	1	O
method	28708837	1	O
to	28708837	1	O
overcome	28708837	1	O
the	28708837	1	O
pathogenesis	28708837	1	O
caused	28708837	1	O
by	28708837	1	O
loss	28708837	1	O
of	28708837	1	O
function	28708837	1	O
(	28708837	1	O
LoF	28708837	1	O
)	28708837	1	O
mutations	28708837	1	O
in	28708837	1	O
tumor	28708837	1	O
suppressor	28708837	1	O
genes	28708837	1	O
has	28708837	1	O
been	28708837	1	O
successfully	28708837	1	O
translated	28708837	1	O
to	28708837	1	O
the	28708837	1	O
clinic	28708837	1	O
.	28708837	1	O
The	28708837	1	O
most	28708837	1	O
frequent	28708837	1	O
LoF	28708837	1	B-NegReg
mutation	28708837	1	B-Var
in	28708837	1	O
human	28708837	1	O
cancers	28708837	1	O
is	28708837	1	O
Adenomatous	28708837	1	B-Gene
polyposis	28708837	1	I-Gene
coli	28708837	1	I-Gene
(	28708837	1	O
APC	28708837	1	O
)	28708837	1	O
,	28708837	1	O
causing	28708837	1	O
aberrant	28708837	1	O
activation	28708837	1	B-PosReg
of	28708837	1	O
the	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
.	28708837	1	O
OBJECTIVE	28708837	1	O
METHODS	28708837	1	O
:	28708837	1	O
Here	28708837	1	O
,	28708837	1	O
we	28708837	1	O
tested	28708837	1	O
the	28708837	1	O
hypothesis	28708837	1	O
that	28708837	1	O
extracellular	28708837	1	O
inhibitors	28708837	1	O
of	28708837	1	O
the	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
,	28708837	1	O
although	28708837	1	O
acting	28708837	1	O
upstream	28708837	1	O
of	28708837	1	O
the	28708837	1	O
APC	28708837	1	O
mutation	28708837	1	O
,	28708837	1	O
can	28708837	1	O
restore	28708837	1	O
normal	28708837	1	O
levels	28708837	1	O
of	28708837	1	O
pathway	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
colon	28708837	1	O
cancer	28708837	1	O
cells	28708837	1	O
.	28708837	1	O
To	28708837	1	O
this	28708837	1	O
end	28708837	1	O
,	28708837	1	O
we	28708837	1	O
developed	28708837	1	O
and	28708837	1	O
simulated	28708837	1	O
a	28708837	1	O
mathematical	28708837	1	O
model	28708837	1	O
for	28708837	1	O
the	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
in	28708837	1	O
different	28708837	1	O
APC	28708837	1	O
mutants	28708837	1	O
,	28708837	1	O
with	28708837	1	O
or	28708837	1	O
without	28708837	1	O
the	28708837	1	O
effects	28708837	1	O
of	28708837	1	O
the	28708837	1	O
extracellular	28708837	1	O
inhibitors	28708837	1	O
,	28708837	1	O
Secreted	28708837	1	O
Frizzled	28708837	1	O
-	28708837	1	O
Related	28708837	1	O
Protein1	28708837	1	O
(	28708837	1	O
sFRP1	28708837	1	O
)	28708837	1	O
and	28708837	1	O
Dickhopf1	28708837	1	O
(	28708837	1	O
Dkk1	28708837	1	O
)	28708837	1	O
.	28708837	1	O
RESULTS	28708837	1	O
:	28708837	1	O
Our	28708837	1	O
model	28708837	1	O
accurately	28708837	1	O
predicts	28708837	1	O
T	28708837	1	O
-	28708837	1	O
cell	28708837	1	O
factor	28708837	1	O
(	28708837	1	O
TCF	28708837	1	O
)	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
mutant	28708837	1	O
cells	28708837	1	O
that	28708837	1	O
vary	28708837	1	O
in	28708837	1	O
APC	28708837	1	O
mutation	28708837	1	O
.	28708837	1	O
Model	28708837	1	O
simulations	28708837	1	O
suggest	28708837	1	O
that	28708837	1	O
both	28708837	1	O
sFRP1	28708837	1	O
and	28708837	1	O
DKK1	28708837	1	O
can	28708837	1	O
reduce	28708837	1	O
TCF	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
APC1638N	28708837	1	O
/	28708837	1	O
1572	28708837	1	O
T	28708837	1	O
and	28708837	1	O
Apcmin	28708837	1	O
/	28708837	1	O
min	28708837	1	O
mutants	28708837	1	O
,	28708837	1	O
but	28708837	1	O
restoration	28708837	1	O
of	28708837	1	O
normal	28708837	1	O
activity	28708837	1	O
levels	28708837	1	O
is	28708837	1	O
possible	28708837	1	O
only	28708837	1	O
in	28708837	1	O
the	28708837	1	O
former	28708837	1	O
.	28708837	1	O
Overall	28708837	1	O
,	28708837	1	O
re	28708837	1	O
-	28708837	1	O
establishment	28708837	1	O
of	28708837	1	O
normal	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
activity	28708837	1	O
is	28708837	1	O
predicted	28708837	1	O
for	28708837	1	O
every	28708837	1	O
APC	28708837	1	O
mutant	28708837	1	O
in	28708837	1	O
whom	28708837	1	O
TCF	28708837	1	O
activity	28708837	1	O
is	28708837	1	O
increased	28708837	1	O
by	28708837	1	O
up	28708837	1	O
to	28708837	1	O
11	28708837	1	O
fold	28708837	1	O
.	28708837	1	O
CONCLUSIONS	28708837	1	O
:	28708837	1	O
Our	28708837	1	O
work	28708837	1	O
suggests	28708837	1	O
that	28708837	1	O
extracellular	28708837	1	O
inhibitors	28708837	1	O
can	28708837	1	O
effectively	28708837	1	O
restore	28708837	1	O
normal	28708837	1	O
Wnt	28708837	1	O
pathway	28708837	1	O
activity	28708837	1	O
in	28708837	1	O
APC	28708837	1	O
-	28708837	1	O
truncated	28708837	1	O
cancer	28708837	1	O
cells	28708837	1	O
,	28708837	1	O
even	28708837	1	O
though	28708837	1	O
these	28708837	1	O
LoF	28708837	1	O
mutations	28708837	1	O
occur	28708837	1	O
downstream	28708837	1	O
of	28708837	1	O
the	28708837	1	O
inhibitory	28708837	1	O
action	28708837	1	O
.	28708837	1	O
This	28708837	1	O
new	28708837	1	O
concept	28708837	1	O
of	28708837	1	O
upstream	28708837	1	O
intervention	28708837	1	O
to	28708837	1	O
control	28708837	1	O
the	28708837	1	O
effects	28708837	1	O
of	28708837	1	O
downstream	28708837	1	O
mutations	28708837	1	O
may	28708837	1	O
be	28708837	1	O
considered	28708837	1	O
also	28708837	1	O
for	28708837	1	O
other	28708837	1	O
partial	28708837	1	O
LoF	28708837	1	O
mutations	28708837	1	O
in	28708837	1	O
other	28708837	1	O
signaling	28708837	1	O
pathways	28708837	1	O
.	28708837	1	O

BACKGROUND	28717663	1	O
:	28717663	1	O
Alstrm	28717663	1	O
syndrome	28717663	1	O
(	28717663	1	O
AS	28717663	1	O
)	28717663	1	O
,	28717663	1	O
featuring	28717663	1	O
retinal	28717663	1	O
dystrophy	28717663	1	O
,	28717663	1	O
neuronal	28717663	1	O
deafness	28717663	1	O
,	28717663	1	O
cardiomyopathy	28717663	1	O
,	28717663	1	O
metabolic	28717663	1	O
syndrome	28717663	1	O
,	28717663	1	O
and	28717663	1	O
diffuse	28717663	1	O
fibrosis	28717663	1	O
,	28717663	1	O
is	28717663	1	O
caused	28717663	1	O
by	28717663	1	O
biallelic	28717663	1	O
mutations	28717663	1	O
in	28717663	1	O
the	28717663	1	O
centrosomal	28717663	1	O
protein	28717663	1	O
ALMS1	28717663	1	O
.	28717663	1	O
Exome	28717663	1	O
sequencing	28717663	1	O
was	28717663	1	O
used	28717663	1	O
in	28717663	1	O
two	28717663	1	O
participants	28717663	1	O
without	28717663	1	O
convincing	28717663	1	O
biallelic	28717663	1	O
ALMS1	28717663	1	O
mutations	28717663	1	O
,	28717663	1	O
and	28717663	1	O
BBS2	28717663	1	O
(	28717663	1	O
Bardet	28717663	1	O
-	28717663	1	O
Biedl	28717663	1	O
syndrome	28717663	1	O
2	28717663	1	O
)	28717663	1	O
protein	28717663	1	O
expression	28717663	1	O
was	28717663	1	O
assessed	28717663	1	O
in	28717663	1	O
one	28717663	1	O
patient	28717663	1	O
with	28717663	1	O
biallelic	28717663	1	O
BBS2	28717663	1	O
mutations	28717663	1	O
.	28717663	1	O
RESULTS	28717663	1	O
:	28717663	1	O
In	28717663	1	O
16	28717663	1	O
of	28717663	1	O
the	28717663	1	O
patient	28717663	1	O
cell	28717663	1	O
lines	28717663	1	O
examined	28717663	1	O
,	28717663	1	O
ALMS1	28717663	1	B-Gene
protein	28717663	1	O
was	28717663	1	O
undetectable	28717663	1	B-NegReg
(	28717663	1	O
14	28717663	1	O
with	28717663	1	O
biallelic	28717663	1	O
loss	28717663	1	B-NegReg
-	28717663	1	I-NegReg
of	28717663	1	I-NegReg
-	28717663	1	I-NegReg
function	28717663	1	I-NegReg
(	28717663	1	O
LoF	28717663	1	O
)	28717663	1	O
mutations	28717663	1	B-Var
)	28717663	1	I-Var
,	28717663	1	O
and	28717663	1	O
in	28717663	1	O
two	28717663	1	O
,	28717663	1	O
ALMS1	28717663	1	O
staining	28717663	1	O
was	28717663	1	O
equivocal	28717663	1	O
(	28717663	1	O
one	28717663	1	O
with	28717663	1	O
biallelic	28717663	1	O
LoF	28717663	1	O
mutations	28717663	1	O
)	28717663	1	O
.	28717663	1	O
In	28717663	1	O
five	28717663	1	O
lines	28717663	1	O
,	28717663	1	O
ALMS1	28717663	1	O
expression	28717663	1	O
was	28717663	1	O
normal	28717663	1	O
using	28717663	1	O
at	28717663	1	O
least	28717663	1	O
one	28717663	1	O
fixation	28717663	1	O
method	28717663	1	O
(	28717663	1	O
one	28717663	1	O
with	28717663	1	O
biallelic	28717663	1	O
LoF	28717663	1	O
mutations	28717663	1	O
)	28717663	1	O
.	28717663	1	O
Exome	28717663	1	O
sequencing	28717663	1	O
of	28717663	1	O
two	28717663	1	O
participants	28717663	1	O
with	28717663	1	O
normal	28717663	1	O
ALMS1	28717663	1	O
expression	28717663	1	O
identified	28717663	1	O
biallelic	28717663	1	O
LoF	28717663	1	O
BBS2	28717663	1	O
mutations	28717663	1	O
in	28717663	1	O
one	28717663	1	O
.	28717663	1	O
No	28717663	1	O
second	28717663	1	O
,	28717663	1	O
known	28717663	1	O
ciliopathy	28717663	1	O
mutation	28717663	1	O
was	28717663	1	O
found	28717663	1	O
in	28717663	1	O
the	28717663	1	O
other	28717663	1	O
patient	28717663	1	O
,	28717663	1	O
who	28717663	1	O
had	28717663	1	O
one	28717663	1	O
LoF	28717663	1	O
ALMS1	28717663	1	O
mutation	28717663	1	O
.	28717663	1	O
All	28717663	1	O
cells	28717663	1	O
studied	28717663	1	O
developed	28717663	1	O
normal	28717663	1	O
cilia	28717663	1	O
,	28717663	1	O
ALMS1	28717663	1	O
and	28717663	1	O
BBS2	28717663	1	O
mutant	28717663	1	O
cells	28717663	1	O
showed	28717663	1	O
normal	28717663	1	O
Hedgehog	28717663	1	O
-	28717663	1	O
induced	28717663	1	O
upregulation	28717663	1	O
of	28717663	1	O
GLI1	28717663	1	O
expression	28717663	1	O
,	28717663	1	O
and	28717663	1	O
PDGFA	28717663	1	O
signaling	28717663	1	O
was	28717663	1	O
normal	28717663	1	O
in	28717663	1	O
ALMS1	28717663	1	O
-	28717663	1	O
deficient	28717663	1	O
cells	28717663	1	O
.	28717663	1	O
A	28717663	1	O
subgroup	28717663	1	O
of	28717663	1	O
patients	28717663	1	O
with	28717663	1	O
bona	28717663	1	O
fide	28717663	1	O
ALMS1	28717663	1	O
defects	28717663	1	O
have	28717663	1	O
milder	28717663	1	O
phenotypes	28717663	1	O
due	28717663	1	O
to	28717663	1	O
residual	28717663	1	O
ALMS1	28717663	1	O
expression	28717663	1	O
,	28717663	1	O
which	28717663	1	O
may	28717663	1	O
be	28717663	1	O
more	28717663	1	O
important	28717663	1	O
than	28717663	1	O
mutation	28717663	1	O
site	28717663	1	O
.	28717663	1	O

To	28720827	0	O
study	28720827	0	O
the	28720827	0	O
mechanism	28720827	0	O
of	28720827	0	O
neuronal	28720827	0	O
necrosis	28720827	0	O
,	28720827	0	O
we	28720827	0	O
previously	28720827	0	O
established	28720827	0	O
a	28720827	0	O
Drosophila	28720827	0	O
genetic	28720827	0	O
model	28720827	0	O
of	28720827	0	O
neuronal	28720827	0	O
necrosis	28720827	0	O
by	28720827	0	O
calcium	28720827	0	O
overloading	28720827	0	O
through	28720827	0	O
expression	28720827	0	O
of	28720827	0	O
a	28720827	0	O
constitutively	28720827	0	O
opened	28720827	0	O
cation	28720827	0	O
channel	28720827	0	O
mutant	28720827	0	O
.	28720827	0	O
We	28720827	0	O
found	28720827	0	O
that	28720827	0	O
loss	28720827	0	B-Var
-	28720827	0	I-Var
of	28720827	0	I-Var
-	28720827	0	I-Var
function	28720827	0	I-Var
(	28720827	0	O
LOF	28720827	0	O
)	28720827	0	O
CG17259	28720827	0	B-Gene
activated	28720827	0	B-PosReg
eIF2	28720827	0	O
phosphorylation	28720827	0	O
and	28720827	0	O
subsequent	28720827	0	O
up	28720827	0	B-PosReg
-	28720827	0	I-PosReg
regulation	28720827	0	I-PosReg
of	28720827	0	O
chaperons	28720827	0	O
(	28720827	0	O
Hsp26	28720827	0	O
and	28720827	0	O
Hsp27	28720827	0	O
)	28720827	0	O
and	28720827	0	O
autophagy	28720827	0	O
.	28720827	0	O
Genetically	28720827	0	O
,	28720827	0	O
down	28720827	0	B-NegReg
-	28720827	0	I-NegReg
regulation	28720827	0	I-NegReg
of	28720827	0	O
eIF2	28720827	0	O
phosphorylation	28720827	0	O
,	28720827	0	O
Hsp26	28720827	0	O
/	28720827	0	O
Hsp27	28720827	0	O
or	28720827	0	O
autophagy	28720827	0	O
reduced	28720827	0	B-NegReg
the	28720827	0	O
protective	28720827	0	O
effect	28720827	0	O
of	28720827	0	O
LOF	28720827	0	B-Var
CG17259	28720827	0	B-Gene
,	28720827	0	O
indicating	28720827	0	O
they	28720827	0	O
function	28720827	0	O
downstream	28720827	0	O
of	28720827	0	O
CG17259	28720827	0	O
.	28720827	0	O

A	28726812	4	O
patient	28726812	4	O
with	28726812	4	O
germ	28726812	4	O
-	28726812	4	O
line	28726812	4	O
gain	28726812	4	O
-	28726812	4	O
of	28726812	4	O
-	28726812	4	O
function	28726812	4	O
PDGFRB	28726812	4	O
p.N666H	28726812	4	O
mutation	28726812	4	O
and	28726812	4	O
marked	28726812	4	O
clinical	28726812	4	O
response	28726812	4	O
to	28726812	4	O
imatinib	28726812	4	O
.	28726812	4	O
PurposeHeterozygous	28726812	4	O
germ	28726812	4	O
-	28726812	4	O
line	28726812	4	O
activating	28726812	4	O
mutations	28726812	4	B-Var
in	28726812	4	O
PDGFRB	28726812	4	B-Gene
cause	28726812	4	B-Reg
Kosaki	28726812	4	B-Disease
and	28726812	4	I-Disease
Penttinen	28726812	4	I-Disease
syndromes	28726812	4	I-Disease
and	28726812	4	O
myofibromatosis	28726812	4	B-Disease
.	28726812	4	O
We	28726812	4	O
describe	28726812	4	O
a	28726812	4	O
10	28726812	4	O
-	28726812	4	O
year	28726812	4	O
-	28726812	4	O
old	28726812	4	O
child	28726812	4	O
with	28726812	4	O
a	28726812	4	O
germ	28726812	4	O
-	28726812	4	O
line	28726812	4	O
PDGFRB	28726812	4	B-Gene
p.N666H	28726812	4	B-Var
mutation	28726812	4	O
who	28726812	4	O
responded	28726812	4	O
to	28726812	4	O
the	28726812	4	O
tyrosine	28726812	4	O
kinase	28726812	4	O
inhibitor	28726812	4	O
imatinib	28726812	4	O
by	28726812	4	O
inhibition	28726812	4	B-NegReg
of	28726812	4	O
PDGFRB	28726812	4	B-Gene
.	28726812	4	I-Gene
MethodsThe	28726812	4	I-Gene
impact	28726812	4	O
of	28726812	4	O
p.N666H	28726812	4	O
on	28726812	4	O
PDGFRB	28726812	4	O
function	28726812	4	O
and	28726812	4	O
sensitivity	28726812	4	O
to	28726812	4	O
imatinib	28726812	4	O
was	28726812	4	O
studied	28726812	4	O
in	28726812	4	O
cell	28726812	4	O
culture	28726812	4	O
.	28726812	4	O
ResultsCells	28726812	4	O
expressing	28726812	4	O
the	28726812	4	O
p.N666H	28726812	4	O
mutation	28726812	4	O
showed	28726812	4	O
constitutive	28726812	4	O
PDGFRB	28726812	4	O
tyrosine	28726812	4	O
phosphorylation	28726812	4	O
.	28726812	4	O
ConclusionTo	28726812	4	O
our	28726812	4	O
knowledge	28726812	4	O
,	28726812	4	O
this	28726812	4	O
is	28726812	4	O
one	28726812	4	O
of	28726812	4	O
the	28726812	4	O
first	28726812	4	O
personalized	28726812	4	O
treatments	28726812	4	O
of	28726812	4	O
a	28726812	4	O
congenital	28726812	4	O
disorder	28726812	4	O
caused	28726812	4	O
by	28726812	4	O
a	28726812	4	O
germ	28726812	4	O
-	28726812	4	O
line	28726812	4	O
PDGF	28726812	4	O
receptor	28726812	4	O
mutation	28726812	4	O
with	28726812	4	O
a	28726812	4	O
PDGFRB	28726812	4	O
inhibitor	28726812	4	O
.	28726812	4	O

However	28741757	4	O
,	28741757	4	O
while	28741757	4	O
mutations	28741757	4	B-Var
in	28741757	4	O
FOXP2	28741757	4	B-Gene
lead	28741757	4	B-Reg
to	28741757	4	I-Reg
a	28741757	4	O
speech	28741757	4	O
/	28741757	4	O
language	28741757	4	O
disorder	28741757	4	O
characterized	28741757	4	O
by	28741757	4	O
childhood	28741757	4	B-Disease
apraxia	28741757	4	I-Disease
of	28741757	4	I-Disease
speech	28741757	4	I-Disease
(	28741757	4	O
CAS	28741757	4	O
)	28741757	4	O
,	28741757	4	O
the	28741757	4	O
clinical	28741757	4	O
profile	28741757	4	O
of	28741757	4	O
FOXP1	28741757	4	B-Gene
variants	28741757	4	B-Var
includes	28741757	4	B-Reg
a	28741757	4	O
broader	28741757	4	O
neurodevelopmental	28741757	4	O
phenotype	28741757	4	O
with	28741757	4	O
global	28741757	4	B-Disease
developmental	28741757	4	I-Disease
delay	28741757	4	I-Disease
,	28741757	4	O
intellectual	28741757	4	B-Disease
disability	28741757	4	I-Disease
,	28741757	4	O
and	28741757	4	O
speech	28741757	4	B-Disease
/	28741757	4	I-Disease
language	28741757	4	I-Disease
impairment	28741757	4	I-Disease
.	28741757	4	O
The	28741757	4	O
variant	28741757	4	O
,	28741757	4	O
p.R514H	28741757	4	O
,	28741757	4	O
is	28741757	4	O
located	28741757	4	O
in	28741757	4	O
the	28741757	4	O
forkhead	28741757	4	O
-	28741757	4	O
box	28741757	4	O
DNA	28741757	4	O
-	28741757	4	O
binding	28741757	4	O
domain	28741757	4	O
and	28741757	4	O
is	28741757	4	O
equivalent	28741757	4	O
to	28741757	4	O
the	28741757	4	O
well	28741757	4	O
-	28741757	4	O
studied	28741757	4	O
p.R553H	28741757	4	O
FOXP2	28741757	4	O
variant	28741757	4	O
that	28741757	4	O
cosegregates	28741757	4	O
with	28741757	4	O
CAS	28741757	4	O
in	28741757	4	O
a	28741757	4	O
large	28741757	4	O
UK	28741757	4	O
family	28741757	4	O
.	28741757	4	O
We	28741757	4	O
present	28741757	4	O
here	28741757	4	O
for	28741757	4	O
the	28741757	4	O
first	28741757	4	O
time	28741757	4	O
a	28741757	4	O
direct	28741757	4	O
comparison	28741757	4	O
of	28741757	4	O
the	28741757	4	O
molecular	28741757	4	O
and	28741757	4	O
clinical	28741757	4	O
consequences	28741757	4	O
of	28741757	4	O
the	28741757	4	O
same	28741757	4	O
mutation	28741757	4	O
affecting	28741757	4	O
the	28741757	4	O
equivalent	28741757	4	O
residue	28741757	4	O
in	28741757	4	O
FOXP1	28741757	4	O
and	28741757	4	O
FOXP2	28741757	4	O
.	28741757	4	O
Nonetheless	28741757	4	O
,	28741757	4	O
clinical	28741757	4	O
manifestations	28741757	4	O
were	28741757	4	O
broader	28741757	4	O
and	28741757	4	O
more	28741757	4	O
severe	28741757	4	O
in	28741757	4	O
the	28741757	4	O
three	28741757	4	O
cases	28741757	4	O
carrying	28741757	4	O
the	28741757	4	O
p.R514H	28741757	4	O
FOXP1	28741757	4	O
variant	28741757	4	O
than	28741757	4	O
in	28741757	4	O
individuals	28741757	4	O
with	28741757	4	O
the	28741757	4	O
p.R553H	28741757	4	O
variant	28741757	4	O
related	28741757	4	O
to	28741757	4	O
CAS	28741757	4	O
,	28741757	4	O
highlighting	28741757	4	O
divergent	28741757	4	O
roles	28741757	4	O
of	28741757	4	O
FOXP2	28741757	4	O
and	28741757	4	O
FOXP1	28741757	4	O
in	28741757	4	O
neurodevelopment	28741757	4	O
.	28741757	4	O

In	28749435	4	O
some	28749435	4	O
cases	28749435	4	O
,	28749435	4	O
more	28749435	4	O
than	28749435	4	O
one	28749435	4	O
genetic	28749435	4	O
variant	28749435	4	O
is	28749435	4	O
identified	28749435	4	O
in	28749435	4	O
the	28749435	4	O
same	28749435	4	O
(	28749435	4	O
compound	28749435	4	O
heterozygosity	28749435	4	O
)	28749435	4	O
or	28749435	4	O
different	28749435	4	O
(	28749435	4	O
digenic	28749435	4	O
heterozygosity	28749435	4	O
)	28749435	4	O
genes	28749435	4	O
,	28749435	4	O
and	28749435	4	O
subjects	28749435	4	O
with	28749435	4	O
multiple	28749435	4	O
pathogenic	28749435	4	O
mutations	28749435	4	O
may	28749435	4	O
have	28749435	4	O
a	28749435	4	O
more	28749435	4	O
severe	28749435	4	O
disease	28749435	4	O
.	28749435	4	O
Therefore	28749435	4	O
,	28749435	4	O
it	28749435	4	O
is	28749435	4	O
important	28749435	4	O
to	28749435	4	O
distinguish	28749435	4	O
between	28749435	4	O
pathogenic	28749435	4	O
mutations	28749435	4	O
and	28749435	4	O
benign	28749435	4	O
rare	28749435	4	O
variants	28749435	4	O
.	28749435	4	O
We	28749435	4	O
identified	28749435	4	O
four	28749435	4	O
genetic	28749435	4	O
variants	28749435	4	O
(	28749435	4	O
KCNQ1	28749435	4	O
-	28749435	4	O
p.R583H	28749435	4	O
,	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.C108Y	28749435	4	O
,	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.K897T	28749435	4	O
,	28749435	4	O
and	28749435	4	O
KCNE1	28749435	4	O
-	28749435	4	O
p.G38S	28749435	4	O
)	28749435	4	O
in	28749435	4	O
an	28749435	4	O
LQTS	28749435	4	O
family	28749435	4	O
.	28749435	4	O
On	28749435	4	O
the	28749435	4	O
basis	28749435	4	O
of	28749435	4	O
in	28749435	4	O
silico	28749435	4	O
analysis	28749435	4	O
,	28749435	4	O
clinical	28749435	4	O
data	28749435	4	O
from	28749435	4	O
our	28749435	4	O
family	28749435	4	O
,	28749435	4	O
and	28749435	4	O
the	28749435	4	O
evidence	28749435	4	O
from	28749435	4	O
previous	28749435	4	O
studies	28749435	4	O
,	28749435	4	O
we	28749435	4	O
analyzed	28749435	4	O
two	28749435	4	O
mutated	28749435	4	O
channels	28749435	4	O
,	28749435	4	O
KCNQ1	28749435	4	O
-	28749435	4	O
p.R583H	28749435	4	O
and	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.C108Y	28749435	4	O
,	28749435	4	O
using	28749435	4	O
the	28749435	4	O
whole	28749435	4	O
-	28749435	4	O
cell	28749435	4	O
patch	28749435	4	O
clamp	28749435	4	O
technique	28749435	4	O
.	28749435	4	O
We	28749435	4	O
found	28749435	4	O
that	28749435	4	O
KCNQ1	28749435	4	O
-	28749435	4	O
p.R583H	28749435	4	O
was	28749435	4	O
not	28749435	4	O
associated	28749435	4	O
with	28749435	4	O
a	28749435	4	O
severe	28749435	4	O
functional	28749435	4	O
impairment	28749435	4	O
,	28749435	4	O
whereas	28749435	4	O
KCNH2	28749435	4	B-Var
-	28749435	4	I-Var
p.C108Y	28749435	4	I-Var
,	28749435	4	O
a	28749435	4	O
novel	28749435	4	O
variant	28749435	4	O
,	28749435	4	O
encoded	28749435	4	B-Reg
a	28749435	4	O
non	28749435	4	O
-	28749435	4	O
functional	28749435	4	O
channel	28749435	4	O
that	28749435	4	O
exerts	28749435	4	O
dominant	28749435	4	B-NegReg
-	28749435	4	I-NegReg
negative	28749435	4	I-NegReg
effects	28749435	4	O
on	28749435	4	O
the	28749435	4	O
wild	28749435	4	O
-	28749435	4	O
type	28749435	4	O
.	28749435	4	O
Notably	28749435	4	O
,	28749435	4	O
the	28749435	4	O
common	28749435	4	O
variants	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.K897T	28749435	4	O
and	28749435	4	O
KCNE1	28749435	4	O
-	28749435	4	O
p.G38S	28749435	4	O
were	28749435	4	O
previously	28749435	4	O
reported	28749435	4	O
to	28749435	4	O
produce	28749435	4	O
more	28749435	4	O
severe	28749435	4	O
phenotypes	28749435	4	O
when	28749435	4	O
combined	28749435	4	O
with	28749435	4	O
disease	28749435	4	O
-	28749435	4	O
causing	28749435	4	O
alleles	28749435	4	O
.	28749435	4	O
Our	28749435	4	O
results	28749435	4	O
indicate	28749435	4	O
that	28749435	4	O
the	28749435	4	O
novel	28749435	4	O
KCNH2	28749435	4	B-Var
-	28749435	4	I-Var
C108Y	28749435	4	I-Var
variant	28749435	4	O
can	28749435	4	O
be	28749435	4	O
a	28749435	4	O
pathogenic	28749435	4	B-Reg
LQTS	28749435	4	B-Disease
mutation	28749435	4	O
,	28749435	4	O
whereas	28749435	4	O
KCNQ1	28749435	4	O
-	28749435	4	O
p.R583H	28749435	4	O
,	28749435	4	O
KCNH2	28749435	4	O
-	28749435	4	O
p.K897T	28749435	4	O
,	28749435	4	O
and	28749435	4	O
KCNE1	28749435	4	O
-	28749435	4	O
p.G38S	28749435	4	O
could	28749435	4	O
be	28749435	4	O
LQTS	28749435	4	O
modifiers	28749435	4	O
.	28749435	4	O

Klotho	28798354	4	O
is	28798354	4	O
a	28798354	4	O
well	28798354	4	O
-	28798354	4	O
known	28798354	4	O
anti	28798354	4	O
-	28798354	4	O
aging	28798354	4	O
factor	28798354	4	O
that	28798354	4	O
regulates	28798354	4	O
phosphate	28798354	4	O
metabolism	28798354	4	O
:	28798354	4	O
mice	28798354	4	O
mutant	28798354	4	O
or	28798354	4	O
deficient	28798354	4	O
in	28798354	4	O
Klotho	28798354	4	O
exhibit	28798354	4	O
phenotypes	28798354	4	O
resembling	28798354	4	O
human	28798354	4	O
aging	28798354	4	O
.	28798354	4	O
Loss	28798354	4	B-Var
-	28798354	4	I-Var
of	28798354	4	I-Var
-	28798354	4	I-Var
function	28798354	4	I-Var
Enpp1	28798354	4	B-Gene
(	28798354	4	O
ttw	28798354	4	O
/	28798354	4	O
ttw	28798354	4	O
)	28798354	4	O
mice	28798354	4	O
under	28798354	4	O
phosphate	28798354	4	O
overload	28798354	4	O
conditions	28798354	4	O
exhibited	28798354	4	B-Reg
phenotypes	28798354	4	O
resembling	28798354	4	O
human	28798354	4	O
aging	28798354	4	O
and	28798354	4	O
Klotho	28798354	4	O
mutants	28798354	4	O
,	28798354	4	O
such	28798354	4	O
as	28798354	4	O
short	28798354	4	O
life	28798354	4	O
span	28798354	4	O
,	28798354	4	O
arteriosclerosis	28798354	4	B-Disease
and	28798354	4	O
osteoporosis	28798354	4	B-Disease
,	28798354	4	O
with	28798354	4	O
elevated	28798354	4	B-PosReg
serum	28798354	4	O
1	28798354	4	O
,	28798354	4	O
25	28798354	4	O
(	28798354	4	O
OH	28798354	4	O
)	28798354	4	O
2	28798354	4	O
D3	28798354	4	O
levels	28798354	4	O
.	28798354	4	O

ARHGAP29	28817352	1	O
Mutation	28817352	1	O
Is	28817352	1	O
Associated	28817352	1	O
with	28817352	1	O
Abnormal	28817352	1	O
Oral	28817352	1	O
Epithelial	28817352	1	O
Adhesions	28817352	1	O
.	28817352	1	O
Previous	28817352	1	O
studies	28817352	1	O
identified	28817352	1	O
mutations	28817352	1	B-Var
in	28817352	1	O
ARHGAP29	28817352	1	B-Gene
associated	28817352	1	B-Reg
with	28817352	1	O
an	28817352	1	O
increased	28817352	1	O
risk	28817352	1	O
for	28817352	1	O
NSCL	28817352	1	B-Disease
/	28817352	1	I-Disease
P.	28817352	1	I-Disease
To	28817352	1	O
investigate	28817352	1	O
the	28817352	1	O
effects	28817352	1	O
of	28817352	1	O
ARHGAP29	28817352	1	O
in	28817352	1	O
vivo	28817352	1	O
,	28817352	1	O
we	28817352	1	O
generated	28817352	1	O
a	28817352	1	O
novel	28817352	1	O
murine	28817352	1	O
allele	28817352	1	O
by	28817352	1	O
inserting	28817352	1	O
a	28817352	1	O
point	28817352	1	O
mutation	28817352	1	O
identified	28817352	1	O
in	28817352	1	O
a	28817352	1	O
patient	28817352	1	O
with	28817352	1	O
NSCL	28817352	1	O
/	28817352	1	O
P.	28817352	1	O
This	28817352	1	O
single	28817352	1	B-Var
-	28817352	1	I-Var
nucleotide	28817352	1	I-Var
variation	28817352	1	I-Var
of	28817352	1	O
ARHGAP29	28817352	1	B-Gene
translates	28817352	1	O
to	28817352	1	O
an	28817352	1	O
early	28817352	1	O
nonsense	28817352	1	O
mutation	28817352	1	O
(	28817352	1	B-Var
K326X	28817352	1	I-Var
)	28817352	1	I-Var
,	28817352	1	O
presumably	28817352	1	O
resulting	28817352	1	O
in	28817352	1	O
loss	28817352	1	B-NegReg
-	28817352	1	I-NegReg
of	28817352	1	I-NegReg
-	28817352	1	I-NegReg
function	28817352	1	I-NegReg
(	28817352	1	O
LoF	28817352	1	O
)	28817352	1	O
.	28817352	1	O
Embryos	28817352	1	O
from	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
/	28817352	1	O
)	28817352	1	O
intercrosses	28817352	1	O
were	28817352	1	O
harvested	28817352	1	O
at	28817352	1	O
various	28817352	1	O
time	28817352	1	O
points	28817352	1	O
.	28817352	1	O
No	28817352	1	O
homozygous	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
)	28817352	1	O
animals	28817352	1	O
were	28817352	1	O
found	28817352	1	O
in	28817352	1	O
the	28817352	1	O
45	28817352	1	O
analyzed	28817352	1	O
litters	28817352	1	O
,	28817352	1	O
assessed	28817352	1	O
as	28817352	1	O
early	28817352	1	O
as	28817352	1	O
embryonic	28817352	1	O
day	28817352	1	O
8.5	28817352	1	O
(	28817352	1	O
e8.5	28817352	1	O
)	28817352	1	O
.	28817352	1	O
Coronal	28817352	1	O
sectioning	28817352	1	O
of	28817352	1	O
e13.5	28817352	1	O
and	28817352	1	O
e14.5	28817352	1	O
heads	28817352	1	O
revealed	28817352	1	O
that	28817352	1	O
59%	28817352	1	O
of	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
/	28817352	1	O
)	28817352	1	O
mice	28817352	1	O
(	28817352	1	O
n	28817352	1	O
=	28817352	1	O
37	28817352	1	O
)	28817352	1	O
exhibited	28817352	1	O
improper	28817352	1	O
epithelial	28817352	1	O
contact	28817352	1	O
between	28817352	1	O
developing	28817352	1	O
oral	28817352	1	O
structures	28817352	1	O
,	28817352	1	O
while	28817352	1	O
none	28817352	1	O
were	28817352	1	O
observed	28817352	1	O
in	28817352	1	O
wild	28817352	1	O
types	28817352	1	O
(	28817352	1	O
n	28817352	1	O
=	28817352	1	O
10	28817352	1	O
)	28817352	1	O
.	28817352	1	O
In	28817352	1	O
addition	28817352	1	O
,	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
/	28817352	1	O
)	28817352	1	O
embryos	28817352	1	O
exhibited	28817352	1	O
a	28817352	1	O
significantly	28817352	1	O
higher	28817352	1	O
percentage	28817352	1	O
of	28817352	1	O
maxillary	28817352	1	O
epithelium	28817352	1	O
in	28817352	1	O
contact	28817352	1	O
with	28817352	1	O
mandibular	28817352	1	O
epithelium	28817352	1	O
.	28817352	1	O
Oral	28817352	1	O
adhesions	28817352	1	O
did	28817352	1	O
not	28817352	1	O
appear	28817352	1	O
to	28817352	1	O
impair	28817352	1	O
palatogenesis	28817352	1	O
,	28817352	1	O
as	28817352	1	O
all	28817352	1	O
analyzed	28817352	1	O
Arhgap29	28817352	1	O
(	28817352	1	O
K326X	28817352	1	O
/	28817352	1	O
)	28817352	1	O
embryos	28817352	1	O
showed	28817352	1	O
confluent	28817352	1	O
palatal	28817352	1	O
mesenchyme	28817352	1	O
and	28817352	1	O
epithelium	28817352	1	O
at	28817352	1	O
e18.5	28817352	1	O
(	28817352	1	O
n	28817352	1	O
=	28817352	1	O
16	28817352	1	O
)	28817352	1	O
,	28817352	1	O
and	28817352	1	O
no	28817352	1	O
mice	28817352	1	O
were	28817352	1	O
found	28817352	1	O
with	28817352	1	O
a	28817352	1	O
cleft	28817352	1	O
at	28817352	1	O
birth	28817352	1	O
.	28817352	1	O
In	28817352	1	O
conclusion	28817352	1	O
,	28817352	1	O
we	28817352	1	O
validate	28817352	1	O
the	28817352	1	O
LoF	28817352	1	B-NegReg
nature	28817352	1	O
of	28817352	1	O
the	28817352	1	O
human	28817352	1	O
K326X	28817352	1	B-Var
mutation	28817352	1	I-Var
in	28817352	1	O
vivo	28817352	1	O
and	28817352	1	O
reveal	28817352	1	O
a	28817352	1	O
previously	28817352	1	O
unknown	28817352	1	O
effect	28817352	1	O
of	28817352	1	O
Arhgap29	28817352	1	B-Gene
in	28817352	1	O
murine	28817352	1	O
craniofacial	28817352	1	O
development	28817352	1	O
.	28817352	1	O

Deciphering	28826751	4	O
the	28826751	4	O
molecular	28826751	4	O
basis	28826751	4	O
of	28826751	4	O
ferroportin	28826751	4	O
resistance	28826751	4	O
to	28826751	4	O
hepcidin	28826751	4	O
:	28826751	4	O
Structure	28826751	4	O
/	28826751	4	O
function	28826751	4	O
analysis	28826751	4	O
of	28826751	4	O
rare	28826751	4	O
SLC40A1	28826751	4	B-Gene
missense	28826751	4	B-Var
mutations	28826751	4	I-Var
found	28826751	4	B-Reg
in	28826751	4	O
suspected	28826751	4	O
hemochromatosis	28826751	4	B-Disease
type	28826751	4	I-Disease
4	28826751	4	I-Disease
patients	28826751	4	O
.	28826751	4	O
The	28826751	4	O
model	28826751	4	O
enabled	28826751	4	O
study	28826751	4	O
of	28826751	4	O
disease	28826751	4	O
-	28826751	4	O
associated	28826751	4	O
mutations	28826751	4	O
,	28826751	4	O
and	28826751	4	O
guided	28826751	4	O
mutagenesis	28826751	4	O
experiments	28826751	4	O
to	28826751	4	O
determine	28826751	4	O
the	28826751	4	O
role	28826751	4	O
of	28826751	4	O
conserved	28826751	4	O
residues	28826751	4	O
in	28826751	4	O
protein	28826751	4	O
stability	28826751	4	O
and	28826751	4	O
iron	28826751	4	O
transport	28826751	4	O
.	28826751	4	O
Here	28826751	4	O
,	28826751	4	O
we	28826751	4	O
propose	28826751	4	O
a	28826751	4	O
strategy	28826751	4	O
that	28826751	4	O
is	28826751	4	O
not	28826751	4	O
limited	28826751	4	O
to	28826751	4	O
structure	28826751	4	O
analysis	28826751	4	O
,	28826751	4	O
but	28826751	4	O
integrates	28826751	4	O
information	28826751	4	O
from	28826751	4	O
different	28826751	4	O
sources	28826751	4	O
,	28826751	4	O
including	28826751	4	O
human	28826751	4	O
disease	28826751	4	O
-	28826751	4	O
associated	28826751	4	O
mutations	28826751	4	O
and	28826751	4	O
functional	28826751	4	O
in	28826751	4	O
vitro	28826751	4	O
assays	28826751	4	O
.	28826751	4	O

Particularly	28860350	4	O
,	28860350	4	O
we	28860350	4	O
identified	28860350	4	O
a	28860350	4	O
novel	28860350	4	O
mutational	28860350	4	O
signature	28860350	4	O
similar	28860350	4	O
to	28860350	4	O
Catalogue	28860350	4	O
Of	28860350	4	O
Somatic	28860350	4	O
Mutations	28860350	4	O
In	28860350	4	O
Cancer	28860350	4	O
(	28860350	4	O
COSMIC	28860350	4	O
)	28860350	4	O
signature	28860350	4	O
16	28860350	4	O
,	28860350	4	O
which	28860350	4	O
has	28860350	4	O
prognostic	28860350	4	O
value	28860350	4	O
in	28860350	4	O
OSCC	28860350	4	O
.	28860350	4	O

Heterozygous	28890134	1	O
loss	28890134	1	B-NegReg
-	28890134	1	I-NegReg
of	28890134	1	I-NegReg
-	28890134	1	I-NegReg
function	28890134	1	I-NegReg
(	28890134	1	O
LOF	28890134	1	O
)	28890134	1	O
mutations	28890134	1	B-Var
in	28890134	1	O
the	28890134	1	O
human	28890134	1	O
progranulin	28890134	1	O
gene	28890134	1	O
(	28890134	1	B-Gene
GRN	28890134	1	I-Gene
)	28890134	1	I-Gene
cause	28890134	1	O
frontotemporal	28890134	1	B-Disease
lobar	28890134	1	I-Disease
degeneration	28890134	1	I-Disease
(	28890134	1	O
FTLD	28890134	1	O
)	28890134	1	O
by	28890134	1	O
a	28890134	1	O
mechanism	28890134	1	O
of	28890134	1	O
haploinsufficiency	28890134	1	O
.	28890134	1	O
Multiple	28890134	1	O
studies	28890134	1	O
have	28890134	1	O
demonstrated	28890134	1	O
the	28890134	1	O
heterogeneity	28890134	1	O
in	28890134	1	O
clinical	28890134	1	O
presentation	28890134	1	O
and	28890134	1	O
wide	28890134	1	O
variability	28890134	1	O
in	28890134	1	O
age	28890134	1	O
of	28890134	1	O
onset	28890134	1	O
in	28890134	1	O
patients	28890134	1	O
carrying	28890134	1	O
a	28890134	1	O
GRN	28890134	1	O
LOF	28890134	1	O
mutation	28890134	1	O
.	28890134	1	O

Effect	28993478	0	B-Reg
of	28993478	0	O
Mutant	28993478	0	B-Var
p53	28993478	0	B-Gene
Proteins	28993478	0	O
on	28993478	0	O
Glycolysis	28993478	0	O
and	28993478	0	O
Mitochondrial	28993478	0	O
Metabolism	28993478	0	O
.	28993478	0	O
Unlike	28993478	0	O
other	28993478	0	O
tumor	28993478	0	O
suppressors	28993478	0	O
that	28993478	0	O
are	28993478	0	O
frequently	28993478	0	O
deleted	28993478	0	O
or	28993478	0	O
acquire	28993478	0	O
loss	28993478	0	O
-	28993478	0	O
of	28993478	0	O
-	28993478	0	O
function	28993478	0	O
mutations	28993478	0	O
,	28993478	0	O
the	28993478	0	O
majority	28993478	0	O
of	28993478	0	O
TP53	28993478	0	B-Gene
mutations	28993478	0	B-Var
in	28993478	0	O
tumors	28993478	0	O
are	28993478	0	O
missense	28993478	0	B-Var
substitutions	28993478	0	I-Var
,	28993478	0	O
which	28993478	0	O
lead	28993478	0	O
to	28993478	0	O
the	28993478	0	O
expression	28993478	0	O
of	28993478	0	O
full	28993478	0	O
-	28993478	0	O
length	28993478	0	O
mutant	28993478	0	B-Var
proteins	28993478	0	O
that	28993478	0	O
accumulate	28993478	0	B-PosReg
in	28993478	0	O
cancer	28993478	0	O
cells	28993478	0	O
and	28993478	0	O
may	28993478	0	O
confer	28993478	0	O
unique	28993478	0	O
gain	28993478	0	B-PosReg
-	28993478	0	I-PosReg
of	28993478	0	I-PosReg
-	28993478	0	I-PosReg
function	28993478	0	I-PosReg
(	28993478	0	O
GOF	28993478	0	O
)	28993478	0	O
activities	28993478	0	O
to	28993478	0	O
promote	28993478	0	B-PosReg
tumorigenic	28993478	0	O
events	28993478	0	O
.	28993478	0	O
Recently	28993478	0	O
,	28993478	0	O
mutant	28993478	0	B-Var
p53	28993478	0	B-Gene
proteins	28993478	0	O
have	28993478	0	O
been	28993478	0	O
shown	28993478	0	O
to	28993478	0	O
mediate	28993478	0	O
metabolic	28993478	0	O
changes	28993478	0	O
as	28993478	0	O
a	28993478	0	O
novel	28993478	0	O
GOF	28993478	0	B-PosReg
to	28993478	0	O
promote	28993478	0	B-PosReg
tumor	28993478	0	O
development	28993478	0	O
.	28993478	0	O
There	28993478	0	O
is	28993478	0	O
a	28993478	0	O
strong	28993478	0	O
rationale	28993478	0	O
that	28993478	0	O
the	28993478	0	O
GOF	28993478	0	O
activities	28993478	0	O
,	28993478	0	O
including	28993478	0	O
alterations	28993478	0	O
in	28993478	0	O
cellular	28993478	0	O
metabolism	28993478	0	O
,	28993478	0	O
might	28993478	0	O
vary	28993478	0	O
between	28993478	0	O
the	28993478	0	O
different	28993478	0	O
p53	28993478	0	O
mutants	28993478	0	O
.	28993478	0	O
Accordingly	28993478	0	O
,	28993478	0	O
the	28993478	0	O
effect	28993478	0	O
of	28993478	0	O
different	28993478	0	O
mutant	28993478	0	O
p53	28993478	0	O
proteins	28993478	0	O
on	28993478	0	O
cancer	28993478	0	O
cell	28993478	0	O
metabolism	28993478	0	O
is	28993478	0	O
largely	28993478	0	O
unknown	28993478	0	O
.	28993478	0	O
In	28993478	0	O
this	28993478	0	O
study	28993478	0	O
,	28993478	0	O
we	28993478	0	O
have	28993478	0	O
metabolically	28993478	0	O
profiled	28993478	0	O
several	28993478	0	O
individual	28993478	0	O
frequently	28993478	0	O
occurring	28993478	0	O
p53	28993478	0	O
mutants	28993478	0	O
in	28993478	0	O
cancers	28993478	0	O
,	28993478	0	O
focusing	28993478	0	O
on	28993478	0	O
glycolytic	28993478	0	O
and	28993478	0	O
mitochondrial	28993478	0	O
oxidative	28993478	0	O
phosphorylation	28993478	0	O
pathways	28993478	0	O
.	28993478	0	O
Our	28993478	0	O
investigation	28993478	0	O
highlights	28993478	0	O
the	28993478	0	O
diversity	28993478	0	O
of	28993478	0	O
different	28993478	0	O
p53	28993478	0	O
mutants	28993478	0	O
in	28993478	0	O
terms	28993478	0	O
of	28993478	0	O
their	28993478	0	O
effect	28993478	0	O
on	28993478	0	O
metabolism	28993478	0	O
,	28993478	0	O
which	28993478	0	O
might	28993478	0	O
provide	28993478	0	O
a	28993478	0	O
foundation	28993478	0	O
for	28993478	0	O
the	28993478	0	O
development	28993478	0	O
of	28993478	0	O
more	28993478	0	O
effective	28993478	0	O
targeted	28993478	0	O
pharmacological	28993478	0	O
approaches	28993478	0	O
toward	28993478	0	O
variants	28993478	0	O
of	28993478	0	O
mutant	28993478	0	O
p53	28993478	0	O
.	28993478	0	O

For	29203834	4	O
the	29203834	4	O
putative	29203834	4	O
splice	29203834	4	O
variant	29203834	4	O
c.11322	29203834	4	B-Var
-	29203834	4	I-Var
1	29203834	4	I-Var
G	29203834	4	I-Var
>	29203834	4	I-Var
A	29203834	4	I-Var
,	29203834	4	O
we	29203834	4	O
showed	29203834	4	O
that	29203834	4	O
it	29203834	4	O
led	29203834	4	O
to	29203834	4	O
only	29203834	4	O
one	29203834	4	O
nucleotide	29203834	4	O
deletion	29203834	4	O
and	29203834	4	O
loss	29203834	4	B-NegReg
of	29203834	4	O
the	29203834	4	O
C	29203834	4	O
-	29203834	4	O
terminal	29203834	4	O
part	29203834	4	O
of	29203834	4	O
the	29203834	4	O
protein	29203834	4	O
.	29203834	4	O
For	29203834	4	O
two	29203834	4	O
studied	29203834	4	O
KMT2A	29203834	4	B-Gene
missense	29203834	4	O
variants	29203834	4	O
,	29203834	4	O
c.3460	29203834	4	B-Var
C	29203834	4	I-Var
>	29203834	4	I-Var
T	29203834	4	I-Var
(	29203834	4	O
p.(Arg1154Trp)	29203834	4	O
)	29203834	4	O
and	29203834	4	O
c.8558	29203834	4	B-Var
T	29203834	4	I-Var
>	29203834	4	I-Var
G	29203834	4	I-Var
(	29203834	4	O
p.(Met2853Arg)	29203834	4	O
)	29203834	4	O
,	29203834	4	O
located	29203834	4	O
at	29203834	4	O
the	29203834	4	O
cysteine	29203834	4	O
-	29203834	4	O
rich	29203834	4	O
CXXC	29203834	4	O
domain	29203834	4	O
and	29203834	4	O
the	29203834	4	O
transactivation	29203834	4	O
domain	29203834	4	O
of	29203834	4	O
the	29203834	4	O
protein	29203834	4	O
,	29203834	4	O
respectively	29203834	4	O
,	29203834	4	O
we	29203834	4	O
found	29203834	4	O
altered	29203834	4	B-Reg
KMT2A	29203834	4	O
target	29203834	4	O
genes	29203834	4	O
expression	29203834	4	O
in	29203834	4	O
patient	29203834	4	O
'	29203834	4	O
s	29203834	4	O
fibroblasts	29203834	4	O
compared	29203834	4	O
to	29203834	4	O
controls	29203834	4	O
.	29203834	4	O
Furthermore	29203834	4	O
,	29203834	4	O
we	29203834	4	O
found	29203834	4	O
a	29203834	4	O
disturbed	29203834	4	B-Reg
subcellular	29203834	4	O
distribution	29203834	4	O
of	29203834	4	O
KMT2A	29203834	4	B-Gene
for	29203834	4	O
the	29203834	4	O
c.3460	29203834	4	B-Var
C	29203834	4	I-Var
>	29203834	4	I-Var
T	29203834	4	I-Var
mutant	29203834	4	O
.	29203834	4	O

METHODS	29224215	4	O
:	29224215	4	O
DNA	29224215	4	O
sequencing	29224215	4	O
assays	29224215	4	O
were	29224215	4	O
developed	29224215	4	O
for	29224215	4	O
two	29224215	4	O
previously	29224215	4	O
identified	29224215	4	O
functional	29224215	4	O
missense	29224215	4	O
variants	29224215	4	O
,	29224215	4	O
namely	29224215	4	O
p.R2330C	29224215	4	B-Var
and	29224215	4	O
p.R2513H	29224215	4	B-Var
,	29224215	4	O
and	29224215	4	O
all	29224215	4	O
21	29224215	4	O
exons	29224215	4	O
of	29224215	4	O
DCHS1	29224215	4	B-Gene
.	29224215	4	O
RESULTS	29224215	4	O
:	29224215	4	O
p.R2330C	29224215	4	O
and	29224215	4	O
p.R2513H	29224215	4	O
were	29224215	4	O
not	29224215	4	O
identified	29224215	4	O
in	29224215	4	O
this	29224215	4	O
cohort	29224215	4	O
.	29224215	4	O
This	29224215	4	O
includes	29224215	4	O
one	29224215	4	O
novel	29224215	4	O
variant	29224215	4	O
(	29224215	4	O
p.A2464P	29224215	4	O
)	29224215	4	O
and	29224215	4	O
two	29224215	4	O
rare	29224215	4	O
variants	29224215	4	O
(	29224215	4	O
p.R2770Q	29224215	4	O
and	29224215	4	O
p.R2462Q	29224215	4	O
)	29224215	4	O
.	29224215	4	O
These	29224215	4	O
variants	29224215	4	O
are	29224215	4	O
predicted	29224215	4	O
to	29224215	4	O
be	29224215	4	O
deleterious	29224215	4	O
with	29224215	4	O
combined	29224215	4	O
annotation	29224215	4	O
-	29224215	4	O
dependent	29224215	4	O
depletion	29224215	4	O
(	29224215	4	O
CADD	29224215	4	O
)	29224215	4	O
scores	29224215	4	O
greater	29224215	4	O
than	29224215	4	O
25	29224215	4	O
,	29224215	4	O
which	29224215	4	O
are	29224215	4	O
in	29224215	4	O
the	29224215	4	O
same	29224215	4	O
range	29224215	4	O
as	29224215	4	O
p.R2330C	29224215	4	O
(	29224215	4	O
CADD	29224215	4	O
=	29224215	4	O
28.0	29224215	4	O
)	29224215	4	O
and	29224215	4	O
p.R2513H	29224215	4	O
(	29224215	4	O
CADD	29224215	4	O
=	29224215	4	O
24.3	29224215	4	O
)	29224215	4	O
.	29224215	4	O

Primary	29240891	4	B-Disease
Ovarian	29240891	4	I-Disease
Insufficiency	29240891	4	I-Disease
and	29240891	4	O
Azoospermia	29240891	4	B-Disease
in	29240891	4	O
Carriers	29240891	4	B-Reg
of	29240891	4	O
a	29240891	4	O
Homozygous	29240891	4	O
PSMC3IP	29240891	4	B-Gene
Stop	29240891	4	O
Gain	29240891	4	O
Mutation	29240891	4	B-Var
.	29240891	4	O
Results	29240891	4	O
:	29240891	4	O
The	29240891	4	O
sisters	29240891	4	O
shared	29240891	4	O
a	29240891	4	O
homozygous	29240891	4	O
stop	29240891	4	O
gain	29240891	4	O
mutation	29240891	4	O
in	29240891	4	O
exon	29240891	4	O
6	29240891	4	O
of	29240891	4	O
PSMC3IP	29240891	4	O
(	29240891	4	O
c.489	29240891	4	O
C	29240891	4	O
>	29240891	4	O
G	29240891	4	O
,	29240891	4	O
p.Tyr163Ter	29240891	4	O
)	29240891	4	O
and	29240891	4	O
a	29240891	4	O
missense	29240891	4	O
variant	29240891	4	O
in	29240891	4	O
exon	29240891	4	O
1	29240891	4	O
of	29240891	4	O
CLPP	29240891	4	O
(	29240891	4	B-Var
c.100	29240891	4	I-Var
C	29240891	4	I-Var
>	29240891	4	I-Var
T	29240891	4	I-Var
,	29240891	4	O
p.Pro34Ser	29240891	4	O
)	29240891	4	O
.	29240891	4	O
The	29240891	4	O
affected	29240891	4	O
brother	29240891	4	O
also	29240891	4	O
carried	29240891	4	O
the	29240891	4	O
homozygous	29240891	4	O
PSMC3IP	29240891	4	O
mutation	29240891	4	O
.	29240891	4	O
Functional	29240891	4	O
studies	29240891	4	O
demonstrated	29240891	4	B-Reg
mitochondrial	29240891	4	O
fragmentation	29240891	4	O
in	29240891	4	O
cells	29240891	4	O
infected	29240891	4	O
with	29240891	4	O
the	29240891	4	O
CLPP	29240891	4	B-Gene
mutation	29240891	4	B-Var
.	29240891	4	O
Conclusions	29240891	4	O
:	29240891	4	O
The	29240891	4	O
PSMC3IP	29240891	4	O
mutation	29240891	4	O
provides	29240891	4	O
additional	29240891	4	O
evidence	29240891	4	O
that	29240891	4	O
mutations	29240891	4	O
in	29240891	4	O
meiotic	29240891	4	O
homologous	29240891	4	O
recombination	29240891	4	O
and	29240891	4	O
DNA	29240891	4	O
repair	29240891	4	O
genes	29240891	4	O
result	29240891	4	O
in	29240891	4	O
distinct	29240891	4	O
female	29240891	4	O
and	29240891	4	O
male	29240891	4	O
reproductive	29240891	4	O
phenotypes	29240891	4	O
,	29240891	4	O
including	29240891	4	O
delayed	29240891	4	O
puberty	29240891	4	O
and	29240891	4	O
primary	29240891	4	O
amenorrhea	29240891	4	O
caused	29240891	4	O
by	29240891	4	O
POI	29240891	4	O
(	29240891	4	O
XX	29240891	4	O
gonadal	29240891	4	O
dysgenesis	29240891	4	O
)	29240891	4	O
in	29240891	4	O
females	29240891	4	O
but	29240891	4	O
isolated	29240891	4	O
azoospermia	29240891	4	O
with	29240891	4	O
normal	29240891	4	O
pubertal	29240891	4	O
development	29240891	4	O
in	29240891	4	O
males	29240891	4	O
.	29240891	4	O
The	29240891	4	O
findings	29240891	4	O
also	29240891	4	O
suggest	29240891	4	O
that	29240891	4	O
the	29240891	4	O
N	29240891	4	O
-	29240891	4	O
terminal	29240891	4	O
missense	29240891	4	O
mutation	29240891	4	O
in	29240891	4	O
CLPP	29240891	4	O
does	29240891	4	O
not	29240891	4	O
cause	29240891	4	O
substantial	29240891	4	O
mitochondrial	29240891	4	O
dysfunction	29240891	4	O
or	29240891	4	O
contribute	29240891	4	O
to	29240891	4	O
ovarian	29240891	4	O
insufficiency	29240891	4	O
in	29240891	4	O
an	29240891	4	O
oligogenic	29240891	4	O
manner	29240891	4	O
.	29240891	4	O

Internal	29372308	4	B-Var
tandem	29372308	4	I-Var
duplication	29372308	4	I-Var
mutations	29372308	4	I-Var
in	29372308	4	O
the	29372308	4	O
tyrosine	29372308	4	O
kinase	29372308	4	O
domain	29372308	4	O
of	29372308	4	O
FLT3	29372308	4	B-Gene
display	29372308	4	O
a	29372308	4	O
higher	29372308	4	B-PosReg
oncogenic	29372308	4	O
potential	29372308	4	O
than	29372308	4	O
the	29372308	4	O
activation	29372308	4	O
loop	29372308	4	O
D835Y	29372308	4	O
mutation	29372308	4	O
.	29372308	4	O
Mutations	29372308	4	B-Var
in	29372308	4	O
FMS	29372308	4	O
-	29372308	4	O
like	29372308	4	O
tyrosine	29372308	4	O
kinase	29372308	4	O
3	29372308	4	O
(	29372308	4	B-Gene
FLT3	29372308	4	I-Gene
)	29372308	4	I-Gene
is	29372308	4	O
one	29372308	4	O
of	29372308	4	O
the	29372308	4	O
most	29372308	4	O
prevalent	29372308	4	B-Reg
findings	29372308	4	O
in	29372308	4	O
this	29372308	4	O
heterogeneous	29372308	4	O
disease	29372308	4	O
.	29372308	4	O
The	29372308	4	O
major	29372308	4	O
types	29372308	4	O
of	29372308	4	O
mutations	29372308	4	O
in	29372308	4	O
FLT3	29372308	4	O
can	29372308	4	O
be	29372308	4	O
categorized	29372308	4	O
as	29372308	4	O
internal	29372308	4	O
tandem	29372308	4	O
duplications	29372308	4	O
(	29372308	4	O
ITD	29372308	4	O
)	29372308	4	O
and	29372308	4	O
point	29372308	4	O
mutations	29372308	4	O
.	29372308	4	O
For	29372308	4	O
this	29372308	4	O
reason	29372308	4	O
,	29372308	4	O
we	29372308	4	O
compared	29372308	4	O
ITD	29372308	4	O
mutations	29372308	4	O
in	29372308	4	O
the	29372308	4	O
juxtamembrane	29372308	4	O
domain	29372308	4	O
with	29372308	4	O
those	29372308	4	O
in	29372308	4	O
the	29372308	4	O
tyrosine	29372308	4	O
kinase	29372308	4	O
domain	29372308	4	O
,	29372308	4	O
as	29372308	4	O
well	29372308	4	O
as	29372308	4	O
with	29372308	4	O
the	29372308	4	O
most	29372308	4	O
common	29372308	4	O
activating	29372308	4	O
point	29372308	4	O
mutation	29372308	4	O
in	29372308	4	O
the	29372308	4	O
tyrosine	29372308	4	O
kinase	29372308	4	O
domain	29372308	4	O
,	29372308	4	O
D835Y	29372308	4	O
.	29372308	4	O
The	29372308	4	O
purpose	29372308	4	O
of	29372308	4	O
this	29372308	4	O
study	29372308	4	O
was	29372308	4	O
to	29372308	4	O
understand	29372308	4	O
whether	29372308	4	O
it	29372308	4	O
is	29372308	4	O
the	29372308	4	O
nature	29372308	4	O
of	29372308	4	O
the	29372308	4	O
mutation	29372308	4	O
or	29372308	4	O
the	29372308	4	O
location	29372308	4	O
of	29372308	4	O
the	29372308	4	O
mutation	29372308	4	O
that	29372308	4	O
plays	29372308	4	O
the	29372308	4	O
main	29372308	4	O
role	29372308	4	O
in	29372308	4	O
leukemogenesis	29372308	4	O
.	29372308	4	O
The	29372308	4	O
various	29372308	4	O
FLT3	29372308	4	O
mutants	29372308	4	O
were	29372308	4	O
expressed	29372308	4	O
in	29372308	4	O
the	29372308	4	O
murine	29372308	4	O
pro	29372308	4	O
-	29372308	4	O
B	29372308	4	O
cell	29372308	4	O
line	29372308	4	O
Ba	29372308	4	O
/	29372308	4	O
F3	29372308	4	O
and	29372308	4	O
examined	29372308	4	O
for	29372308	4	O
their	29372308	4	O
capacity	29372308	4	O
to	29372308	4	O
form	29372308	4	O
colonies	29372308	4	O
in	29372308	4	O
semisolid	29372308	4	O
medium	29372308	4	O
.	29372308	4	O
The	29372308	4	O
size	29372308	4	O
and	29372308	4	O
number	29372308	4	O
of	29372308	4	O
colonies	29372308	4	O
formed	29372308	4	O
by	29372308	4	O
Ba	29372308	4	O
/	29372308	4	O
F3	29372308	4	O
cells	29372308	4	O
expressing	29372308	4	O
either	29372308	4	O
the	29372308	4	O
internal	29372308	4	O
tandem	29372308	4	O
duplication	29372308	4	O
within	29372308	4	O
juxtamembrane	29372308	4	O
domain	29372308	4	O
of	29372308	4	O
the	29372308	4	O
receptor	29372308	4	O
(	29372308	4	O
JMD	29372308	4	O
-	29372308	4	O
ITD	29372308	4	O
)	29372308	4	O
or	29372308	4	O
the	29372308	4	O
tyrosine	29372308	4	O
kinase	29372308	4	O
domain	29372308	4	O
(	29372308	4	O
TKD	29372308	4	O
)	29372308	4	O
-	29372308	4	O
ITD	29372308	4	O
were	29372308	4	O
indistinguishable	29372308	4	O
,	29372308	4	O
while	29372308	4	O
Ba	29372308	4	O
/	29372308	4	O
F3	29372308	4	O
cells	29372308	4	O
expressing	29372308	4	O
D835Y	29372308	4	O
/	29372308	4	O
FLT3	29372308	4	O
failed	29372308	4	O
to	29372308	4	O
form	29372308	4	O
colonies	29372308	4	O
.	29372308	4	O
Cell	29372308	4	O
proliferation	29372308	4	O
and	29372308	4	O
cell	29372308	4	O
survival	29372308	4	O
was	29372308	4	O
also	29372308	4	O
significantly	29372308	4	O
higher	29372308	4	B-PosReg
in	29372308	4	O
TKD	29372308	4	B-Var
-	29372308	4	I-Var
ITD	29372308	4	I-Var
expressing	29372308	4	O
cells	29372308	4	O
,	29372308	4	O
compared	29372308	4	O
to	29372308	4	O
cells	29372308	4	O
expressing	29372308	4	O
D835Y	29372308	4	O
/	29372308	4	O
FLT3	29372308	4	O
.	29372308	4	O
Furthermore	29372308	4	O
,	29372308	4	O
TKD	29372308	4	B-Var
-	29372308	4	I-Var
ITD	29372308	4	I-Var
is	29372308	4	O
capable	29372308	4	O
of	29372308	4	O
inducing	29372308	4	B-PosReg
phosphorylation	29372308	4	O
of	29372308	4	O
STAT5	29372308	4	O
,	29372308	4	O
while	29372308	4	O
D835Y	29372308	4	O
/	29372308	4	O
FLT3	29372308	4	O
fails	29372308	4	O
to	29372308	4	O
induce	29372308	4	O
tyrosine	29372308	4	O
phosphorylation	29372308	4	O
of	29372308	4	O
STAT5	29372308	4	O
.	29372308	4	O
Other	29372308	4	O
signal	29372308	4	O
transduction	29372308	4	O
pathways	29372308	4	O
such	29372308	4	O
as	29372308	4	O
the	29372308	4	O
RAS	29372308	4	O
/	29372308	4	O
ERK	29372308	4	O
and	29372308	4	O
the	29372308	4	O
PI3K	29372308	4	O
/	29372308	4	O
AKT	29372308	4	O
pathways	29372308	4	O
were	29372308	4	O
activated	29372308	4	O
to	29372308	4	O
the	29372308	4	O
same	29372308	4	O
level	29372308	4	O
in	29372308	4	O
TKD	29372308	4	O
-	29372308	4	O
ITD	29372308	4	O
cells	29372308	4	O
as	29372308	4	O
compared	29372308	4	O
to	29372308	4	O
D835Y	29372308	4	O
/	29372308	4	O
FLT3	29372308	4	O
expressing	29372308	4	O
cells	29372308	4	O
.	29372308	4	O
Taken	29372308	4	O
together	29372308	4	O
,	29372308	4	O
our	29372308	4	O
data	29372308	4	O
suggest	29372308	4	O
that	29372308	4	O
TKD	29372308	4	O
-	29372308	4	O
ITD	29372308	4	O
displays	29372308	4	O
similar	29372308	4	O
oncogenic	29372308	4	O
potential	29372308	4	O
to	29372308	4	O
the	29372308	4	O
JMD	29372308	4	O
-	29372308	4	O
ITD	29372308	4	O
but	29372308	4	O
a	29372308	4	O
higher	29372308	4	O
oncogenic	29372308	4	O
potential	29372308	4	O
than	29372308	4	O
the	29372308	4	O
D835Y	29372308	4	O
point	29372308	4	O
mutation	29372308	4	O
.	29372308	4	O

Loss	29432562	4	O
-	29432562	4	O
of	29432562	4	O
-	29432562	4	O
function	29432562	4	O
and	29432562	4	O
gain	29432562	4	O
-	29432562	4	O
of	29432562	4	O
-	29432562	4	O
function	29432562	4	O
mutations	29432562	4	O
in	29432562	4	O
PPP3CA	29432562	4	O
cause	29432562	4	O
two	29432562	4	O
distinct	29432562	4	O
disorders	29432562	4	O
.	29432562	4	O
Here	29432562	4	O
,	29432562	4	O
we	29432562	4	O
report	29432562	4	O
six	29432562	4	O
heterozygous	29432562	4	O
mutations	29432562	4	O
in	29432562	4	O
a	29432562	4	O
gene	29432562	4	O
encoding	29432562	4	O
the	29432562	4	O
alpha	29432562	4	O
isoform	29432562	4	O
of	29432562	4	O
the	29432562	4	O
calcineurin	29432562	4	O
catalytic	29432562	4	O
subunit	29432562	4	O
(	29432562	4	O
PPP3CA	29432562	4	O
)	29432562	4	O
.	29432562	4	O
Notably	29432562	4	O
,	29432562	4	O
mutations	29432562	4	O
were	29432562	4	O
observed	29432562	4	O
in	29432562	4	O
different	29432562	4	O
functional	29432562	4	O
domains	29432562	4	O
:	29432562	4	O
in	29432562	4	O
addition	29432562	4	O
to	29432562	4	O
three	29432562	4	O
catalytic	29432562	4	O
domain	29432562	4	O
mutations	29432562	4	O
,	29432562	4	O
two	29432562	4	O
missense	29432562	4	O
mutations	29432562	4	O
were	29432562	4	O
found	29432562	4	O
in	29432562	4	O
the	29432562	4	O
auto	29432562	4	O
-	29432562	4	O
inhibitory	29432562	4	O
(	29432562	4	O
AI	29432562	4	O
)	29432562	4	O
domain	29432562	4	O
.	29432562	4	O
Detailed	29432562	4	O
clinical	29432562	4	O
evaluation	29432562	4	O
of	29432562	4	O
the	29432562	4	O
six	29432562	4	O
individuals	29432562	4	O
revealed	29432562	4	O
clinically	29432562	4	O
unexpected	29432562	4	O
consequences	29432562	4	O
of	29432562	4	O
the	29432562	4	O
PPP3CA	29432562	4	B-Gene
mutations	29432562	4	O
.	29432562	4	O
First	29432562	4	O
,	29432562	4	O
the	29432562	4	O
catalytic	29432562	4	B-Var
domain	29432562	4	I-Var
mutations	29432562	4	I-Var
and	29432562	4	O
frameshift	29432562	4	B-Var
mutation	29432562	4	I-Var
were	29432562	4	O
consistently	29432562	4	O
found	29432562	4	B-Reg
in	29432562	4	O
patients	29432562	4	O
with	29432562	4	O
nonsyndromic	29432562	4	B-Disease
early	29432562	4	I-Disease
onset	29432562	4	I-Disease
epileptic	29432562	4	I-Disease
encephalopathy	29432562	4	I-Disease
.	29432562	4	O
In	29432562	4	O
contrast	29432562	4	O
,	29432562	4	O
the	29432562	4	O
AI	29432562	4	B-Var
domain	29432562	4	I-Var
mutations	29432562	4	I-Var
were	29432562	4	O
associated	29432562	4	B-Reg
with	29432562	4	O
multiple	29432562	4	B-Disease
congenital	29432562	4	I-Disease
abnormalities	29432562	4	I-Disease
including	29432562	4	O
craniofacial	29432562	4	B-Disease
dysmorphism	29432562	4	I-Disease
,	29432562	4	O
arthrogryposis	29432562	4	B-Disease
and	29432562	4	O
short	29432562	4	B-Disease
stature	29432562	4	I-Disease
.	29432562	4	O
Using	29432562	4	O
a	29432562	4	O
yeast	29432562	4	O
model	29432562	4	O
system	29432562	4	O
,	29432562	4	O
we	29432562	4	O
showed	29432562	4	O
that	29432562	4	O
the	29432562	4	O
catalytic	29432562	4	O
and	29432562	4	O
AI	29432562	4	B-Var
domain	29432562	4	I-Var
mutations	29432562	4	I-Var
visibly	29432562	4	O
result	29432562	4	O
in	29432562	4	O
decreased	29432562	4	O
and	29432562	4	O
increased	29432562	4	B-PosReg
calcineurin	29432562	4	O
signaling	29432562	4	O
,	29432562	4	O
respectively	29432562	4	O
.	29432562	4	O
These	29432562	4	O
findings	29432562	4	O
indicate	29432562	4	O
that	29432562	4	O
different	29432562	4	O
functional	29432562	4	O
effects	29432562	4	O
of	29432562	4	O
PPP3CA	29432562	4	B-Gene
mutations	29432562	4	O
are	29432562	4	O
associated	29432562	4	O
with	29432562	4	O
two	29432562	4	O
distinct	29432562	4	O
disorders	29432562	4	O
and	29432562	4	O
suggest	29432562	4	O
that	29432562	4	O
functional	29432562	4	O
approaches	29432562	4	O
using	29432562	4	O
a	29432562	4	O
simple	29432562	4	O
cellular	29432562	4	O
system	29432562	4	O
provide	29432562	4	O
a	29432562	4	O
tool	29432562	4	O
for	29432562	4	O
resolving	29432562	4	O
complex	29432562	4	O
genotype	29432562	4	O
-	29432562	4	O
phenotype	29432562	4	O
correlations	29432562	4	O
.	29432562	4	O

We	29449720	4	O
present	29449720	4	O
three	29449720	4	O
unrelated	29449720	4	O
families	29449720	4	O
in	29449720	4	O
which	29449720	4	O
whole	29449720	4	O
-	29449720	4	O
exome	29449720	4	O
sequencing	29449720	4	O
identified	29449720	4	O
the	29449720	4	O
homozygous	29449720	4	O
non	29449720	4	O
-	29449720	4	O
sense	29449720	4	O
variants	29449720	4	O
c.430	29449720	4	B-Var
[	29449720	4	I-Var
C	29449720	4	I-Var
>	29449720	4	I-Var
T	29449720	4	I-Var
]	29449720	4	I-Var
;	29449720	4	I-Var
[	29449720	4	I-Var
C	29449720	4	I-Var
>	29449720	4	I-Var
T	29449720	4	I-Var
]	29449720	4	I-Var
p.(Arg144*)	29449720	4	I-Var
,	29449720	4	O
c.1219	29449720	4	B-Var
[	29449720	4	I-Var
C	29449720	4	I-Var
>	29449720	4	I-Var
T	29449720	4	I-Var
]	29449720	4	I-Var
;	29449720	4	I-Var
[	29449720	4	I-Var
C	29449720	4	I-Var
>	29449720	4	I-Var
T	29449720	4	I-Var
]	29449720	4	I-Var
p.(Gln407*)	29449720	4	I-Var
and	29449720	4	O
c.1408	29449720	4	B-Var
[	29449720	4	I-Var
C	29449720	4	I-Var
>	29449720	4	I-Var
T	29449720	4	I-Var
]	29449720	4	I-Var
;	29449720	4	I-Var
[	29449720	4	I-Var
C	29449720	4	I-Var
>	29449720	4	I-Var
T	29449720	4	I-Var
]	29449720	4	I-Var
p.(Arg470*)	29449720	4	I-Var
in	29449720	4	O
GTPBP2	29449720	4	B-Gene
.	29449720	4	O

We	29478779	4	O
identified	29478779	4	O
heterozygous	29478779	4	O
frameshift	29478779	4	O
mutations	29478779	4	O
in	29478779	4	O
NR2F2	29478779	4	B-Gene
,	29478779	4	O
encoding	29478779	4	O
COUP	29478779	4	O
-	29478779	4	O
TF2	29478779	4	O
,	29478779	4	O
in	29478779	4	O
three	29478779	4	O
children	29478779	4	O
.	29478779	4	O
One	29478779	4	O
carried	29478779	4	O
a	29478779	4	O
c.103	29478779	4	O
_109delGGCGCCC	29478779	4	O
(	29478779	4	B-Var
p.Gly35Argfs	29478779	4	I-Var
75	29478779	4	I-Var
)	29478779	4	I-Var
mutation	29478779	4	O
,	29478779	4	O
while	29478779	4	O
two	29478779	4	O
others	29478779	4	O
carried	29478779	4	O
a	29478779	4	O
c.97	29478779	4	O
_103delCCGCCCG	29478779	4	O
(	29478779	4	B-Var
p.Pro33Alafs	29478779	4	I-Var
77	29478779	4	I-Var
)	29478779	4	I-Var
mutation	29478779	4	O
.	29478779	4	O
In	29478779	4	O
two	29478779	4	O
of	29478779	4	O
three	29478779	4	O
children	29478779	4	O
the	29478779	4	O
mutation	29478779	4	O
was	29478779	4	O
de	29478779	4	O
novo	29478779	4	O
.	29478779	4	O
We	29478779	4	O
demonstrate	29478779	4	O
a	29478779	4	O
highly	29478779	4	O
significant	29478779	4	O
association	29478779	4	O
between	29478779	4	O
the	29478779	4	O
NR2F2	29478779	4	B-Gene
loss	29478779	4	B-NegReg
-	29478779	4	I-NegReg
of	29478779	4	I-NegReg
-	29478779	4	I-NegReg
function	29478779	4	I-NegReg
mutations	29478779	4	B-Var
and	29478779	4	O
this	29478779	4	O
syndromic	29478779	4	B-Disease
form	29478779	4	I-Disease
of	29478779	4	I-Disease
DSD	29478779	4	I-Disease
(	29478779	4	O
p	29478779	4	O
=	29478779	4	O
2.44	29478779	4	O
10	29478779	4	O
-	29478779	4	O
8	29478779	4	O
)	29478779	4	O
.	29478779	4	O

In	29507057	4	O
a	29507057	4	O
genetic	29507057	4	O
screen	29507057	4	O
to	29507057	4	O
identify	29507057	4	O
genes	29507057	4	O
that	29507057	4	O
promote	29507057	4	O
GLP-1	29507057	4	O
/	29507057	4	O
Notch	29507057	4	O
signaling	29507057	4	O
in	29507057	4	O
Caenorhabditis	29507057	4	O
elegans	29507057	4	O
germline	29507057	4	O
stem	29507057	4	O
cells	29507057	4	O
,	29507057	4	O
we	29507057	4	O
found	29507057	4	O
a	29507057	4	O
single	29507057	4	O
mutation	29507057	4	O
,	29507057	4	O
om40	29507057	4	O
,	29507057	4	O
defining	29507057	4	O
a	29507057	4	O
gene	29507057	4	O
called	29507057	4	O
ego-3	29507057	4	O
.	29507057	4	O
hsp-90	29507057	4	O
(	29507057	4	O
om40	29507057	4	O
)	29507057	4	O
is	29507057	4	O
an	29507057	4	O
I	29507057	4	O
N	29507057	4	O
conservative	29507057	4	O
missense	29507057	4	O
mutation	29507057	4	O
of	29507057	4	O
a	29507057	4	O
highly	29507057	4	O
conserved	29507057	4	O
residue	29507057	4	O
in	29507057	4	O
the	29507057	4	O
middle	29507057	4	O
domain	29507057	4	O
of	29507057	4	O
HSP-90	29507057	4	O
RNA	29507057	4	O
interference	29507057	4	O
-	29507057	4	O
mediated	29507057	4	O
knockdown	29507057	4	O
of	29507057	4	O
hsp-90	29507057	4	O
expression	29507057	4	O
partially	29507057	4	O
phenocopied	29507057	4	O
hsp-90	29507057	4	O
(	29507057	4	O
om40	29507057	4	O
)	29507057	4	O
,	29507057	4	O
confirming	29507057	4	O
the	29507057	4	O
loss	29507057	4	O
-	29507057	4	O
of	29507057	4	O
-	29507057	4	O
function	29507057	4	O
nature	29507057	4	O
of	29507057	4	O
hsp-90	29507057	4	O
(	29507057	4	O
om40	29507057	4	O
)	29507057	4	O
Furthermore	29507057	4	O
,	29507057	4	O
reduced	29507057	4	O
HSP-90	29507057	4	O
activity	29507057	4	O
enhanced	29507057	4	O
the	29507057	4	O
effect	29507057	4	O
of	29507057	4	O
reduced	29507057	4	O
function	29507057	4	O
of	29507057	4	O
both	29507057	4	O
the	29507057	4	O
GLP-1	29507057	4	O
receptor	29507057	4	O
and	29507057	4	O
the	29507057	4	O
downstream	29507057	4	O
LAG-1	29507057	4	O
transcription	29507057	4	O
factor	29507057	4	O
.	29507057	4	O

We	29653316	4	O
previously	29653316	4	O
reported	29653316	4	B-Reg
a	29653316	4	O
granulin	29653316	4	O
(	29653316	4	B-Gene
GRN	29653316	4	I-Gene
)	29653316	4	I-Gene
null	29653316	4	O
mutation	29653316	4	B-Var
,	29653316	4	O
originating	29653316	4	O
from	29653316	4	O
a	29653316	4	O
common	29653316	4	O
founder	29653316	4	O
,	29653316	4	O
in	29653316	4	O
multiple	29653316	4	O
Belgian	29653316	4	O
families	29653316	4	O
with	29653316	4	O
frontotemporal	29653316	4	B-Disease
dementia	29653316	4	I-Disease
.	29653316	4	O
We	29653316	4	O
identified	29653316	4	O
85	29653316	4	O
patients	29653316	4	O
and	29653316	4	O
40	29653316	4	O
unaffected	29653316	4	O
mutation	29653316	4	O
carriers	29653316	4	O
,	29653316	4	O
belonging	29653316	4	O
to	29653316	4	O
29	29653316	4	O
branches	29653316	4	O
of	29653316	4	O
the	29653316	4	O
founder	29653316	4	O
pedigree	29653316	4	O
.	29653316	4	O
The	29653316	4	O
observed	29653316	4	O
clinical	29653316	4	O
heterogeneity	29653316	4	O
can	29653316	4	O
guide	29653316	4	O
clinical	29653316	4	O
diagnosis	29653316	4	O
,	29653316	4	O
genetic	29653316	4	O
testing	29653316	4	O
,	29653316	4	O
and	29653316	4	O
counseling	29653316	4	O
of	29653316	4	O
mutation	29653316	4	O
carriers	29653316	4	O
.	29653316	4	O
Analysis	29653316	4	O
of	29653316	4	O
known	29653316	4	O
modifiers	29653316	4	O
,	29653316	4	O
suggested	29653316	4	O
effects	29653316	4	O
of	29653316	4	O
GRN	29653316	4	O
rs5848	29653316	4	O
,	29653316	4	O
microtubule	29653316	4	O
-	29653316	4	O
associated	29653316	4	O
protein	29653316	4	O
tau	29653316	4	O
H1	29653316	4	O
/	29653316	4	O
H2	29653316	4	O
,	29653316	4	O
and	29653316	4	O
chromosome	29653316	4	O
9	29653316	4	O
open	29653316	4	O
reading	29653316	4	O
frame	29653316	4	O
72	29653316	4	O
G4C2	29653316	4	O
repeat	29653316	4	O
length	29653316	4	O
on	29653316	4	O
onset	29653316	4	O
age	29653316	4	O
but	29653316	4	O
explained	29653316	4	O
only	29653316	4	O
a	29653316	4	O
minor	29653316	4	O
fraction	29653316	4	O
of	29653316	4	O
the	29653316	4	O
variability	29653316	4	O
.	29653316	4	O

Among	29656768	1	O
the	29656768	1	O
genes	29656768	1	O
involved	29656768	1	O
in	29656768	1	O
immune	29656768	1	O
function	29656768	1	O
,	29656768	1	O
we	29656768	1	O
identified	29656768	1	O
a	29656768	1	O
rare	29656768	1	O
stop	29656768	1	O
-	29656768	1	O
gain	29656768	1	O
variant	29656768	1	O
(	29656768	1	O
p.Q48X	29656768	1	O
)	29656768	1	O
in	29656768	1	O
mixed	29656768	1	O
lineage	29656768	1	O
kinase	29656768	1	O
domain	29656768	1	O
like	29656768	1	O
pseudokinase	29656768	1	O
(	29656768	1	O
MLKL	29656768	1	O
)	29656768	1	O
gene	29656768	1	O
present	29656768	1	O
exclusively	29656768	1	O
in	29656768	1	O
6	29656768	1	O
LOAD	29656768	1	O
cases	29656768	1	O
.	29656768	1	O
MLKL	29656768	1	B-Gene
is	29656768	1	O
expressed	29656768	1	O
in	29656768	1	O
neurons	29656768	1	O
,	29656768	1	O
and	29656768	1	O
the	29656768	1	O
its	29656768	1	O
expression	29656768	1	O
levels	29656768	1	O
in	29656768	1	O
the	29656768	1	O
p.Q48X	29656768	1	B-Var
carriers	29656768	1	O
were	29656768	1	O
significantly	29656768	1	O
lower	29656768	1	B-NegReg
than	29656768	1	O
that	29656768	1	O
in	29656768	1	O
age	29656768	1	O
-	29656768	1	O
matched	29656768	1	O
wild	29656768	1	O
-	29656768	1	O
type	29656768	1	O
controls	29656768	1	O
.	29656768	1	O
MLKL	29656768	1	B-Gene
loss	29656768	1	B-NegReg
-	29656768	1	I-NegReg
of	29656768	1	I-NegReg
-	29656768	1	I-NegReg
function	29656768	1	I-NegReg
mutation	29656768	1	B-Var
might	29656768	1	O
contribute	29656768	1	O
to	29656768	1	O
late	29656768	1	O
-	29656768	1	O
onset	29656768	1	O
ApoE	29656768	1	O
4	29656768	1	O
-	29656768	1	O
negative	29656768	1	O
AD	29656768	1	B-Disease
in	29656768	1	O
the	29656768	1	O
Hong	29656768	1	O
Kong	29656768	1	O
Chinese	29656768	1	O
population	29656768	1	O
.	29656768	1	O

Germline	29706558	4	O
pathogenic	29706558	4	O
variants	29706558	4	O
in	29706558	4	O
PALB2	29706558	4	O
and	29706558	4	O
other	29706558	4	O
cancer	29706558	4	O
-	29706558	4	O
predisposing	29706558	4	O
genes	29706558	4	O
in	29706558	4	O
families	29706558	4	O
with	29706558	4	O
hereditary	29706558	4	O
diffuse	29706558	4	O
gastric	29706558	4	O
cancer	29706558	4	O
without	29706558	4	O
CDH1	29706558	4	O
mutation	29706558	4	O
:	29706558	4	O
a	29706558	4	O
whole	29706558	4	O
-	29706558	4	O
exome	29706558	4	O
sequencing	29706558	4	O
study	29706558	4	O
.	29706558	4	O

Loss	29726959	1	B-NegReg
of	29726959	1	I-NegReg
function	29726959	1	I-NegReg
(	29726959	1	O
LoF	29726959	1	O
)	29726959	1	O
mutations	29726959	1	B-Var
in	29726959	1	O
the	29726959	1	O
MC4R	29726959	1	O
pathway	29726959	1	O
,	29726959	1	O
including	29726959	1	O
mutations	29726959	1	O
in	29726959	1	O
the	29726959	1	O
pro	29726959	1	O
-	29726959	1	O
opiomelanocortin	29726959	1	O
(	29726959	1	B-Gene
POMC	29726959	1	I-Gene
)	29726959	1	I-Gene
,	29726959	1	O
prohormone	29726959	1	O
convertase	29726959	1	O
1	29726959	1	O
(	29726959	1	B-Gene
PCSK1	29726959	1	I-Gene
)	29726959	1	I-Gene
,	29726959	1	O
leptin	29726959	1	O
receptor	29726959	1	O
(	29726959	1	B-Gene
LEPR	29726959	1	I-Gene
)	29726959	1	I-Gene
,	29726959	1	O
or	29726959	1	O
MC4R	29726959	1	B-Gene
genes	29726959	1	O
,	29726959	1	O
have	29726959	1	O
been	29726959	1	O
shown	29726959	1	O
to	29726959	1	O
cause	29726959	1	O
early	29726959	1	B-Disease
-	29726959	1	I-Disease
onset	29726959	1	I-Disease
severe	29726959	1	I-Disease
obesity	29726959	1	I-Disease
.	29726959	1	O
These	29726959	1	O
estimates	29726959	1	O
increase	29726959	1	O
when	29726959	1	O
we	29726959	1	O
include	29726959	1	O
a	29726959	1	O
small	29726959	1	O
subset	29726959	1	O
of	29726959	1	O
less	29726959	1	O
rare	29726959	1	O
variants	29726959	1	O
:	29726959	1	O
	29726959	1	O
-	29726959	1	O
MSH	29726959	1	O
/	29726959	1	O
POMC	29726959	1	O
,	29726959	1	O
PCSK1	29726959	1	O
N221D	29726959	1	O
,	29726959	1	O
and	29726959	1	O
a	29726959	1	O
PCSK1	29726959	1	O
LoF	29726959	1	O
variant	29726959	1	O
(	29726959	1	O
T640A	29726959	1	O
)	29726959	1	O
.	29726959	1	O
To	29726959	1	O
further	29726959	1	O
define	29726959	1	O
the	29726959	1	O
MC4R	29726959	1	O
pathway	29726959	1	O
and	29726959	1	O
its	29726959	1	O
potential	29726959	1	O
impact	29726959	1	O
on	29726959	1	O
obesity	29726959	1	O
,	29726959	1	O
we	29726959	1	O
tested	29726959	1	O
associations	29726959	1	O
between	29726959	1	O
body	29726959	1	O
mass	29726959	1	O
index	29726959	1	O
(	29726959	1	O
BMI	29726959	1	O
)	29726959	1	O
and	29726959	1	O
LoF	29726959	1	O
mutation	29726959	1	O
burden	29726959	1	O
in	29726959	1	O
the	29726959	1	O
POMC	29726959	1	O
,	29726959	1	O
PCSK1	29726959	1	O
,	29726959	1	O
and	29726959	1	O
LEPR	29726959	1	O
genes	29726959	1	O
in	29726959	1	O
various	29726959	1	O
populations	29726959	1	O
.	29726959	1	O

Mutations	29727693	1	B-Var
in	29727693	1	O
C11orf70	29727693	1	B-Gene
Cause	29727693	1	B-Reg
Primary	29727693	1	B-Disease
Ciliary	29727693	1	I-Disease
Dyskinesia	29727693	1	I-Disease
with	29727693	1	O
Randomization	29727693	1	O
of	29727693	1	O
Left	29727693	1	O
/	29727693	1	O
Right	29727693	1	O
Body	29727693	1	O
Asymmetry	29727693	1	O
Due	29727693	1	O
to	29727693	1	O
Defects	29727693	1	B-NegReg
of	29727693	1	O
Outer	29727693	1	O
and	29727693	1	O
Inner	29727693	1	O
Dynein	29727693	1	O
Arms	29727693	1	O
.	29727693	1	O
We	29727693	1	O
identified	29727693	1	O
loss	29727693	1	O
-	29727693	1	O
of	29727693	1	O
-	29727693	1	O
function	29727693	1	O
mutations	29727693	1	O
in	29727693	1	O
the	29727693	1	O
open	29727693	1	O
-	29727693	1	O
reading	29727693	1	O
frame	29727693	1	O
C11orf70	29727693	1	O
in	29727693	1	O
PCD	29727693	1	O
individuals	29727693	1	O
from	29727693	1	O
five	29727693	1	O
distinct	29727693	1	O
families	29727693	1	O
.	29727693	1	O
Transmission	29727693	1	O
electron	29727693	1	O
microscopy	29727693	1	O
analyses	29727693	1	O
and	29727693	1	O
high	29727693	1	O
-	29727693	1	O
resolution	29727693	1	O
immunofluorescence	29727693	1	O
microscopy	29727693	1	O
demonstrate	29727693	1	O
that	29727693	1	O
loss	29727693	1	B-NegReg
-	29727693	1	I-NegReg
of	29727693	1	I-NegReg
-	29727693	1	I-NegReg
function	29727693	1	I-NegReg
mutations	29727693	1	B-Var
in	29727693	1	O
C11orf70	29727693	1	B-Gene
cause	29727693	1	O
immotility	29727693	1	O
of	29727693	1	O
respiratory	29727693	1	O
cilia	29727693	1	O
and	29727693	1	O
sperm	29727693	1	O
flagella	29727693	1	O
,	29727693	1	O
respectively	29727693	1	O
,	29727693	1	O
as	29727693	1	O
a	29727693	1	O
result	29727693	1	O
of	29727693	1	O
the	29727693	1	O
loss	29727693	1	B-NegReg
of	29727693	1	O
axonemal	29727693	1	O
outer	29727693	1	O
(	29727693	1	O
ODAs	29727693	1	O
)	29727693	1	O
and	29727693	1	O
inner	29727693	1	O
dynein	29727693	1	O
arms	29727693	1	O
(	29727693	1	O
IDAs	29727693	1	O
)	29727693	1	O
,	29727693	1	O
indicating	29727693	1	O
that	29727693	1	O
C11orf70	29727693	1	O
is	29727693	1	O
involved	29727693	1	O
in	29727693	1	O
cytoplasmic	29727693	1	O
assembly	29727693	1	O
of	29727693	1	O
dynein	29727693	1	O
arms	29727693	1	O
.	29727693	1	O

More	29738522	1	O
broadly	29738522	1	O
,	29738522	1	O
our	29738522	1	O
findings	29738522	1	O
suggest	29738522	1	O
that	29738522	1	O
detrimental	29738522	1	O
mutations	29738522	1	O
likely	29738522	1	O
arising	29738522	1	O
in	29738522	1	O
immediately	29738522	1	O
preceding	29738522	1	O
generations	29738522	1	O
with	29738522	1	O
incomplete	29738522	1	O
penetrance	29738522	1	O
may	29738522	1	O
also	29738522	1	O
be	29738522	1	O
responsible	29738522	1	O
for	29738522	1	O
some	29738522	1	O
apparently	29738522	1	O
sporadic	29738522	1	O
diseases	29738522	1	O
.	29738522	1	O

Here	29861108	1	O
,	29861108	1	O
we	29861108	1	O
report	29861108	1	O
the	29861108	1	O
identification	29861108	1	O
of	29861108	1	O
a	29861108	1	O
distinct	29861108	1	O
syndrome	29861108	1	O
due	29861108	1	O
to	29861108	1	O
de	29861108	1	O
novo	29861108	1	O
or	29861108	1	O
inherited	29861108	1	O
heterozygous	29861108	1	O
mutations	29861108	1	O
in	29861108	1	O
Tousled	29861108	1	O
-	29861108	1	O
like	29861108	1	O
kinase	29861108	1	O
2	29861108	1	O
(	29861108	1	O
TLK2	29861108	1	O
)	29861108	1	O
in	29861108	1	O
38	29861108	1	O
unrelated	29861108	1	O
individuals	29861108	1	O
and	29861108	1	O
two	29861108	1	O
affected	29861108	1	O
mothers	29861108	1	O
,	29861108	1	O
using	29861108	1	O
whole	29861108	1	O
-	29861108	1	O
exome	29861108	1	O
and	29861108	1	O
whole	29861108	1	O
-	29861108	1	O
genome	29861108	1	O
sequencing	29861108	1	O
technologies	29861108	1	O
,	29861108	1	O
matchmaker	29861108	1	O
databases	29861108	1	O
,	29861108	1	O
and	29861108	1	O
international	29861108	1	O
collaborations	29861108	1	O
.	29861108	1	O
Analysis	29861108	1	O
of	29861108	1	O
cell	29861108	1	O
lines	29861108	1	O
from	29861108	1	O
three	29861108	1	O
affected	29861108	1	O
individuals	29861108	1	O
showed	29861108	1	O
that	29861108	1	O
mutations	29861108	1	O
act	29861108	1	O
through	29861108	1	O
a	29861108	1	O
loss	29861108	1	O
-	29861108	1	O
of	29861108	1	O
-	29861108	1	O
function	29861108	1	O
mechanism	29861108	1	O
in	29861108	1	O
at	29861108	1	O
least	29861108	1	O
two	29861108	1	O
case	29861108	1	O
subjects	29861108	1	O
.	29861108	1	O
This	29861108	1	O
work	29861108	1	O
illustrates	29861108	1	O
the	29861108	1	O
power	29861108	1	O
of	29861108	1	O
international	29861108	1	O
data	29861108	1	O
sharing	29861108	1	O
,	29861108	1	O
by	29861108	1	O
the	29861108	1	O
identification	29861108	1	O
of	29861108	1	O
40	29861108	1	O
individuals	29861108	1	O
from	29861108	1	O
26	29861108	1	O
different	29861108	1	O
centers	29861108	1	O
in	29861108	1	O
7	29861108	1	O
different	29861108	1	O
countries	29861108	1	O
,	29861108	1	O
allowing	29861108	1	O
the	29861108	1	O
identification	29861108	1	O
,	29861108	1	O
clinical	29861108	1	O
delineation	29861108	1	O
,	29861108	1	O
and	29861108	1	O
genotype	29861108	1	O
-	29861108	1	O
phenotype	29861108	1	O
evaluation	29861108	1	O
of	29861108	1	O
a	29861108	1	O
distinct	29861108	1	O
NDD	29861108	1	O
caused	29861108	1	O
by	29861108	1	O
mutations	29861108	1	O
in	29861108	1	O
TLK2	29861108	1	O
.	29861108	1	O

In	29889573	4	O
2006	29889573	4	O
,	29889573	4	O
mutations	29889573	4	B-Var
in	29889573	4	O
progranulin	29889573	4	O
gene	29889573	4	O
(	29889573	4	B-Gene
GRN	29889573	4	I-Gene
)	29889573	4	I-Gene
that	29889573	4	O
cause	29889573	4	O
haploinsufficiency	29889573	4	O
were	29889573	4	O
found	29889573	4	O
in	29889573	4	O
familial	29889573	4	O
cases	29889573	4	B-Reg
of	29889573	4	O
frontotemporal	29889573	4	B-Disease
dementia	29889573	4	I-Disease
(	29889573	4	O
FTD	29889573	4	O
)	29889573	4	O
.	29889573	4	O
Patients	29889573	4	O
with	29889573	4	O
null	29889573	4	O
mutations	29889573	4	O
in	29889573	4	O
GRN	29889573	4	O
display	29889573	4	O
very	29889573	4	O
low	29889573	4	O
-	29889573	4	O
plasma	29889573	4	O
PGRN	29889573	4	O
levels	29889573	4	O
;	29889573	4	O
this	29889573	4	O
analysis	29889573	4	O
is	29889573	4	O
useful	29889573	4	O
for	29889573	4	O
identifying	29889573	4	O
mutation	29889573	4	O
carriers	29889573	4	O
,	29889573	4	O
independent	29889573	4	O
of	29889573	4	O
the	29889573	4	O
clinical	29889573	4	O
presentation	29889573	4	O
,	29889573	4	O
and	29889573	4	O
in	29889573	4	O
those	29889573	4	O
before	29889573	4	O
the	29889573	4	O
appearance	29889573	4	O
of	29889573	4	O
symptoms	29889573	4	O
.	29889573	4	O
Areas	29889573	4	O
covered	29889573	4	O
:	29889573	4	O
Here	29889573	4	O
,	29889573	4	O
we	29889573	4	O
review	29889573	4	O
the	29889573	4	O
current	29889573	4	O
knowledge	29889573	4	O
of	29889573	4	O
PGRN	29889573	4	O
physiological	29889573	4	O
functions	29889573	4	O
and	29889573	4	O
GRN	29889573	4	O
mutations	29889573	4	O
associated	29889573	4	O
with	29889573	4	O
FTD	29889573	4	O
;	29889573	4	O
we	29889573	4	O
also	29889573	4	O
summarize	29889573	4	O
state	29889573	4	O
of	29889573	4	O
the	29889573	4	O
art	29889573	4	O
clinical	29889573	4	O
trials	29889573	4	O
and	29889573	4	O
those	29889573	4	O
compounds	29889573	4	O
able	29889573	4	O
to	29889573	4	O
replace	29889573	4	O
PGRN	29889573	4	O
loss	29889573	4	O
in	29889573	4	O
preclinical	29889573	4	O
models	29889573	4	O
.	29889573	4	O

Germline	29912901	1	O
mutations	29912901	1	O
and	29912901	1	O
somatic	29912901	1	O
inactivation	29912901	1	O
of	29912901	1	O
TRIM28	29912901	1	O
in	29912901	1	O
Wilms	29912901	1	O
tumour	29912901	1	O
.	29912901	1	O
Wilms	29912901	1	O
tumour	29912901	1	O
is	29912901	1	O
a	29912901	1	O
childhood	29912901	1	O
tumour	29912901	1	O
that	29912901	1	O
arises	29912901	1	O
as	29912901	1	O
a	29912901	1	O
consequence	29912901	1	O
of	29912901	1	O
somatic	29912901	1	O
and	29912901	1	O
rare	29912901	1	O
germline	29912901	1	O
mutations	29912901	1	O
,	29912901	1	O
the	29912901	1	O
characterisation	29912901	1	O
of	29912901	1	O
which	29912901	1	O
has	29912901	1	O
refined	29912901	1	O
our	29912901	1	O
understanding	29912901	1	O
of	29912901	1	O
nephrogenesis	29912901	1	O
and	29912901	1	O
carcinogenesis	29912901	1	O
.	29912901	1	O
Here	29912901	1	O
we	29912901	1	O
report	29912901	1	O
that	29912901	1	O
germline	29912901	1	O
loss	29912901	1	B-NegReg
of	29912901	1	I-NegReg
function	29912901	1	I-NegReg
mutations	29912901	1	B-Var
in	29912901	1	O
TRIM28	29912901	1	B-Gene
predispose	29912901	1	O
children	29912901	1	O
to	29912901	1	O
Wilms	29912901	1	B-Disease
tumour	29912901	1	I-Disease
.	29912901	1	O
Inactivation	29912901	1	B-NegReg
of	29912901	1	O
TRIM28	29912901	1	B-Gene
,	29912901	1	O
either	29912901	1	O
germline	29912901	1	O
or	29912901	1	O
somatic	29912901	1	O
,	29912901	1	O
occurred	29912901	1	O
through	29912901	1	O
inactivating	29912901	1	B-Var
mutations	29912901	1	I-Var
,	29912901	1	O
loss	29912901	1	B-Var
of	29912901	1	I-Var
heterozygosity	29912901	1	I-Var
or	29912901	1	O
epigenetic	29912901	1	B-Var
silencing	29912901	1	I-Var
.	29912901	1	O

Mutational	29935645	1	O
and	29935645	1	O
functional	29935645	1	O
studies	29935645	1	O
on	29935645	1	O
NR5A1	29935645	1	B-Gene
gene	29935645	1	O
in	29935645	1	O
46	29935645	1	B-Disease
,	29935645	1	I-Disease
XY	29935645	1	I-Disease
disorders	29935645	1	I-Disease
of	29935645	1	I-Disease
sex	29935645	1	I-Disease
development	29935645	1	I-Disease
:	29935645	1	I-Disease
identification	29935645	1	O
of	29935645	1	O
six	29935645	1	O
novel	29935645	1	O
loss	29935645	1	B-NegReg
of	29935645	1	I-NegReg
function	29935645	1	I-NegReg
mutations	29935645	1	B-Var
.	29935645	1	O
OBJECTIVE	29935645	1	O
:	29935645	1	O
To	29935645	1	O
study	29935645	1	O
the	29935645	1	O
functional	29935645	1	O
properties	29935645	1	O
of	29935645	1	O
six	29935645	1	O
novel	29935645	1	O
missense	29935645	1	O
mutations	29935645	1	O
of	29935645	1	O
the	29935645	1	O
NR5A1	29935645	1	O
gene	29935645	1	O
encoding	29935645	1	O
the	29935645	1	O
steroidogenic	29935645	1	O
factor	29935645	1	O
1	29935645	1	O
(	29935645	1	O
SF-1	29935645	1	O
)	29935645	1	O
identified	29935645	1	O
in	29935645	1	O
six	29935645	1	O
patients	29935645	1	O
with	29935645	1	O
46	29935645	1	O
,	29935645	1	O
XY	29935645	1	O
disorders	29935645	1	O
of	29935645	1	O
sex	29935645	1	O
development	29935645	1	O
(	29935645	1	O
DSD	29935645	1	O
)	29935645	1	O
and	29935645	1	O
to	29935645	1	O
describe	29935645	1	O
their	29935645	1	O
relative	29935645	1	O
phenotype	29935645	1	O
-	29935645	1	O
genotype	29935645	1	O
relationship	29935645	1	O
.	29935645	1	O
MAIN	29935645	1	O
OUTCOME	29935645	1	O
MEASURE	29935645	1	O
(	29935645	1	O
S	29935645	1	O
)	29935645	1	O
:	29935645	1	O
Sanger	29935645	1	O
sequencing	29935645	1	O
and	29935645	1	O
multiplex	29935645	1	O
ligation	29935645	1	O
-	29935645	1	O
dependent	29935645	1	O
probe	29935645	1	O
amplification	29935645	1	O
analysis	29935645	1	O
to	29935645	1	O
identify	29935645	1	O
the	29935645	1	O
mutations	29935645	1	O
or	29935645	1	O
deletions	29935645	1	O
/	29935645	1	O
duplications	29935645	1	O
of	29935645	1	O
the	29935645	1	O
NR5A1	29935645	1	O
gene	29935645	1	O
.	29935645	1	O
Functional	29935645	1	O
studies	29935645	1	O
by	29935645	1	O
transactivation	29935645	1	O
assays	29935645	1	O
to	29935645	1	O
predict	29935645	1	O
the	29935645	1	O
impact	29935645	1	O
of	29935645	1	O
mutations	29935645	1	O
on	29935645	1	O
molecular	29935645	1	O
function	29935645	1	O
.	29935645	1	O
RESULT	29935645	1	O
(	29935645	1	O
S	29935645	1	O
)	29935645	1	O
:	29935645	1	O
NR5A1	29935645	1	B-Gene
exons	29935645	1	O
sequencing	29935645	1	O
identified	29935645	1	B-Reg
in	29935645	1	I-Reg
six	29935645	1	O
46	29935645	1	B-Disease
,	29935645	1	I-Disease
XY	29935645	1	I-Disease
DSD	29935645	1	I-Disease
patients	29935645	1	O
six	29935645	1	O
novel	29935645	1	O
mutations	29935645	1	O
:	29935645	1	O
p.T40R	29935645	1	B-Var
,	29935645	1	O
p.T47C	29935645	1	B-Var
,	29935645	1	O
p.G328W	29935645	1	B-Var
,	29935645	1	O
p.A351E	29935645	1	B-Var
,	29935645	1	O
p.R427W	29935645	1	B-Var
,	29935645	1	O
and	29935645	1	O
p.Q460R	29935645	1	B-Var
.	29935645	1	O
Five	29935645	1	O
missense	29935645	1	O
variants	29935645	1	O
were	29935645	1	O
heterozygous	29935645	1	O
,	29935645	1	O
and	29935645	1	O
one	29935645	1	O
was	29935645	1	O
homozygous	29935645	1	O
(	29935645	1	O
p.R427W	29935645	1	O
)	29935645	1	O
.	29935645	1	O
Functional	29935645	1	O
analysis	29935645	1	O
revealed	29935645	1	O
a	29935645	1	O
significant	29935645	1	O
loss	29935645	1	B-NegReg
of	29935645	1	O
DNA	29935645	1	O
-	29935645	1	O
binding	29935645	1	O
and	29935645	1	O
transactivation	29935645	1	O
ability	29935645	1	O
for	29935645	1	O
all	29935645	1	O
variants	29935645	1	O
,	29935645	1	O
except	29935645	1	O
for	29935645	1	O
p.Q460R	29935645	1	O
,	29935645	1	O
which	29935645	1	O
showed	29935645	1	O
a	29935645	1	O
modest	29935645	1	O
reduced	29935645	1	O
activity	29935645	1	O
compared	29935645	1	O
with	29935645	1	O
that	29935645	1	O
of	29935645	1	O
the	29935645	1	O
wild	29935645	1	O
-	29935645	1	O
type	29935645	1	O
protein	29935645	1	O
.	29935645	1	O
Phenotypes	29935645	1	O
associated	29935645	1	O
with	29935645	1	O
these	29935645	1	O
mutations	29935645	1	O
varied	29935645	1	O
from	29935645	1	O
males	29935645	1	O
with	29935645	1	O
spontaneous	29935645	1	O
puberty	29935645	1	O
,	29935645	1	O
substantial	29935645	1	O
T	29935645	1	O
production	29935645	1	O
,	29935645	1	O
and	29935645	1	O
possible	29935645	1	O
fertility	29935645	1	O
,	29935645	1	O
to	29935645	1	O
females	29935645	1	O
with	29935645	1	O
and	29935645	1	O
without	29935645	1	O
mllerian	29935645	1	O
structures	29935645	1	O
and	29935645	1	O
primary	29935645	1	O
amenorrhea	29935645	1	O
.	29935645	1	O
CONCLUSION	29935645	1	O
(	29935645	1	O
S	29935645	1	O
)	29935645	1	O
:	29935645	1	O
We	29935645	1	O
describe	29935645	1	O
six	29935645	1	O
novel	29935645	1	O
mutations	29935645	1	B-Var
in	29935645	1	O
NR5A1	29935645	1	B-Gene
gene	29935645	1	O
and	29935645	1	O
showed	29935645	1	O
that	29935645	1	O
they	29935645	1	O
might	29935645	1	O
affect	29935645	1	B-Reg
protein	29935645	1	O
structure	29935645	1	O
,	29935645	1	O
therefore	29935645	1	O
compromising	29935645	1	B-NegReg
seriously	29935645	1	O
the	29935645	1	O
SF-1	29935645	1	O
role	29935645	1	O
in	29935645	1	O
regulating	29935645	1	O
gonadal	29935645	1	O
development	29935645	1	O
.	29935645	1	O

Targeted	29957067	4	O
Next	29957067	4	O
Generation	29957067	4	O
Sequencing	29957067	4	O
Revealed	29957067	4	O
Novel	29957067	4	O
PRPF31	29957067	4	B-Gene
Mutations	29957067	4	B-Var
in	29957067	4	B-Reg
Autosomal	29957067	4	B-Disease
Dominant	29957067	4	I-Disease
Retinitis	29957067	4	I-Disease
Pigmentosa	29957067	4	I-Disease
.	29957067	4	O
AIMS	29957067	4	O
:	29957067	4	O
This	29957067	4	O
study	29957067	4	O
aimed	29957067	4	O
to	29957067	4	O
identify	29957067	4	O
the	29957067	4	O
pathogenic	29957067	4	O
mutations	29957067	4	O
in	29957067	4	O
two	29957067	4	O
Chinese	29957067	4	O
families	29957067	4	O
with	29957067	4	O
autosomal	29957067	4	O
dominant	29957067	4	O
RP	29957067	4	O
(	29957067	4	O
adRP	29957067	4	O
)	29957067	4	O
and	29957067	4	O
in	29957067	4	O
a	29957067	4	O
patient	29957067	4	O
with	29957067	4	O
sporadic	29957067	4	O
RP	29957067	4	O
.	29957067	4	O
Targeted	29957067	4	O
next	29957067	4	O
generation	29957067	4	O
sequencing	29957067	4	O
(	29957067	4	O
NGS	29957067	4	O
)	29957067	4	O
was	29957067	4	O
applied	29957067	4	O
to	29957067	4	O
identify	29957067	4	O
mutations	29957067	4	O
in	29957067	4	O
these	29957067	4	O
patients	29957067	4	O
.	29957067	4	O
For	29957067	4	O
pathogenic	29957067	4	O
mutation	29957067	4	O
analyses	29957067	4	O
,	29957067	4	O
stringent	29957067	4	O
NGS	29957067	4	O
data	29957067	4	O
analyses	29957067	4	O
and	29957067	4	O
segregation	29957067	4	O
analyses	29957067	4	O
were	29957067	4	O
applied	29957067	4	O
.	29957067	4	O
Primers	29957067	4	O
were	29957067	4	O
designed	29957067	4	O
to	29957067	4	O
validate	29957067	4	O
the	29957067	4	O
identified	29957067	4	O
mutations	29957067	4	O
by	29957067	4	O
Sanger	29957067	4	O
sequencing	29957067	4	O
analyses	29957067	4	O
.	29957067	4	O
RESULTS	29957067	4	O
:	29957067	4	O
A	29957067	4	O
novel	29957067	4	O
heterozygous	29957067	4	O
insertion	29957067	4	O
frameshift	29957067	4	O
mutation	29957067	4	O
c.1226	29957067	4	O
_1227insA	29957067	4	O
,	29957067	4	O
p.T410Dfs*65	29957067	4	O
,	29957067	4	O
and	29957067	4	O
a	29957067	4	O
novel	29957067	4	O
heterozygous	29957067	4	O
stopgain	29957067	4	O
mutation	29957067	4	O
c.1015	29957067	4	O
C	29957067	4	O
>	29957067	4	O
T	29957067	4	O
,	29957067	4	O
p.Q339*	29957067	4	O
were	29957067	4	O
identified	29957067	4	O
in	29957067	4	O
PRPF31	29957067	4	O
.	29957067	4	O
A	29957067	4	O
known	29957067	4	O
c.527	29957067	4	O
3	29957067	4	O
A	29957067	4	O
>	29957067	4	O
G	29957067	4	O
splicing	29957067	4	O
mutation	29957067	4	O
was	29957067	4	O
identified	29957067	4	O
in	29957067	4	O
one	29957067	4	O
of	29957067	4	O
the	29957067	4	O
adRP-074	29957067	4	O
families	29957067	4	O
.	29957067	4	O
All	29957067	4	O
mutations	29957067	4	O
were	29957067	4	O
found	29957067	4	O
to	29957067	4	O
co	29957067	4	O
-	29957067	4	O
segregate	29957067	4	O
with	29957067	4	O
the	29957067	4	O
disease	29957067	4	O
,	29957067	4	O
and	29957067	4	O
none	29957067	4	O
of	29957067	4	O
these	29957067	4	O
mutations	29957067	4	O
were	29957067	4	O
detected	29957067	4	O
in	29957067	4	O
500	29957067	4	O
control	29957067	4	O
samples	29957067	4	O
.	29957067	4	O
CONCLUSIONS	29957067	4	O
:	29957067	4	O
Our	29957067	4	O
data	29957067	4	O
identified	29957067	4	O
two	29957067	4	O
new	29957067	4	O
autosomal	29957067	4	O
dominant	29957067	4	O
mutations	29957067	4	O
in	29957067	4	O
PRPF31	29957067	4	O
,	29957067	4	O
expanding	29957067	4	O
the	29957067	4	O
mutational	29957067	4	O
spectrum	29957067	4	O
of	29957067	4	O
this	29957067	4	O
gene	29957067	4	O
.	29957067	4	O

Heterogeneous	30068891	2	O
nature	30068891	2	O
of	30068891	2	O
diabetes	30068891	2	B-Disease
in	30068891	2	O
a	30068891	2	O
family	30068891	2	O
with	30068891	2	O
a	30068891	2	O
gain	30068891	2	B-PosReg
-	30068891	2	I-PosReg
of	30068891	2	I-PosReg
-	30068891	2	I-PosReg
function	30068891	2	I-PosReg
mutation	30068891	2	B-Var
in	30068891	2	O
the	30068891	2	O
ATP	30068891	2	O
-	30068891	2	O
binding	30068891	2	O
cassette	30068891	2	O
subfamily	30068891	2	O
C	30068891	2	O
member	30068891	2	O
8	30068891	2	O
(	30068891	2	B-Gene
ABCC8	30068891	2	I-Gene
)	30068891	2	I-Gene
gene	30068891	2	O
.	30068891	2	O
Gain	30068891	2	B-PosReg
-	30068891	2	I-PosReg
of	30068891	2	I-PosReg
-	30068891	2	I-PosReg
function	30068891	2	I-PosReg
ATP	30068891	2	O
-	30068891	2	O
binding	30068891	2	O
cassette	30068891	2	O
subfamily	30068891	2	O
C	30068891	2	O
member	30068891	2	O
8	30068891	2	O
(	30068891	2	B-Gene
ABCC8	30068891	2	I-Gene
)	30068891	2	I-Gene
mutations	30068891	2	B-Var
are	30068891	2	O
known	30068891	2	O
to	30068891	2	O
cause	30068891	2	B-Reg
neonatal	30068891	2	B-Disease
diabetes	30068891	2	I-Disease
mellitus	30068891	2	I-Disease
and	30068891	2	O
maturity	30068891	2	B-Disease
-	30068891	2	I-Disease
onset	30068891	2	I-Disease
diabetes	30068891	2	I-Disease
in	30068891	2	O
the	30068891	2	O
young	30068891	2	O
.	30068891	2	O
However	30068891	2	O
,	30068891	2	O
the	30068891	2	O
intrafamilial	30068891	2	O
heterogeneous	30068891	2	O
nature	30068891	2	O
of	30068891	2	O
diabetes	30068891	2	O
caused	30068891	2	O
by	30068891	2	O
the	30068891	2	O
ABCC8	30068891	2	O
mutation	30068891	2	O
is	30068891	2	O
not	30068891	2	O
fully	30068891	2	O
understood	30068891	2	O
to	30068891	2	O
date	30068891	2	O
.	30068891	2	O
To	30068891	2	O
clarify	30068891	2	O
the	30068891	2	O
intrafamilial	30068891	2	O
heterogeneous	30068891	2	O
nature	30068891	2	O
of	30068891	2	O
monogenetic	30068891	2	O
diabetes	30068891	2	O
,	30068891	2	O
we	30068891	2	O
conducted	30068891	2	O
a	30068891	2	O
case	30068891	2	O
study	30068891	2	O
on	30068891	2	O
a	30068891	2	O
family	30068891	2	O
with	30068891	2	O
ABCC8	30068891	2	O
mutations	30068891	2	O
.	30068891	2	O
Five	30068891	2	O
gene	30068891	2	O
mutation	30068891	2	O
carriers	30068891	2	O
with	30068891	2	O
ABCC8	30068891	2	O
(	30068891	2	O
c.1819	30068891	2	O
G	30068891	2	O
>	30068891	2	O
A	30068891	2	O
/	30068891	2	O
p.V607M	30068891	2	O
)	30068891	2	O
were	30068891	2	O
identified	30068891	2	O
in	30068891	2	O
this	30068891	2	O
family	30068891	2	O
,	30068891	2	O
and	30068891	2	O
the	30068891	2	O
onset	30068891	2	O
and	30068891	2	O
severity	30068891	2	O
of	30068891	2	O
diabetes	30068891	2	O
progressively	30068891	2	O
worsened	30068891	2	O
across	30068891	2	O
the	30068891	2	O
three	30068891	2	O
generations	30068891	2	O
.	30068891	2	O
Each	30068891	2	O
of	30068891	2	O
the	30068891	2	O
ABCC8	30068891	2	O
gene	30068891	2	O
mutation	30068891	2	O
carrier	30068891	2	O
family	30068891	2	O
members	30068891	2	O
were	30068891	2	O
diagnosed	30068891	2	O
with	30068891	2	O
diabetes	30068891	2	O
as	30068891	2	O
follows	30068891	2	O
:	30068891	2	O
the	30068891	2	O
grandfather	30068891	2	O
with	30068891	2	O
type	30068891	2	O
2	30068891	2	O
diabetes	30068891	2	O
at	30068891	2	O
35	30068891	2	O
years	30068891	2	O
of	30068891	2	O
age	30068891	2	O
,	30068891	2	O
the	30068891	2	O
aunt	30068891	2	O
with	30068891	2	O
slowly	30068891	2	O
-	30068891	2	O
progressive	30068891	2	O
insulin	30068891	2	O
-	30068891	2	O
dependent	30068891	2	O
diabetes	30068891	2	O
at	30068891	2	O
18	30068891	2	O
years	30068891	2	O
of	30068891	2	O
age	30068891	2	O
,	30068891	2	O
the	30068891	2	O
mother	30068891	2	O
with	30068891	2	O
ketosis	30068891	2	O
-	30068891	2	O
onset	30068891	2	O
insulin	30068891	2	O
-	30068891	2	O
dependent	30068891	2	O
diabetes	30068891	2	O
at	30068891	2	O
14	30068891	2	O
years	30068891	2	O
of	30068891	2	O
age	30068891	2	O
,	30068891	2	O
the	30068891	2	O
sister	30068891	2	O
with	30068891	2	O
impaired	30068891	2	O
glucose	30068891	2	O
tolerance	30068891	2	O
at	30068891	2	O
9	30068891	2	O
years	30068891	2	O
of	30068891	2	O
age	30068891	2	O
,	30068891	2	O
and	30068891	2	O
the	30068891	2	O
proband	30068891	2	O
with	30068891	2	O
transient	30068891	2	O
neonatal	30068891	2	O
diabetes	30068891	2	O
at	30068891	2	O
birth	30068891	2	O
.	30068891	2	O
The	30068891	2	O
present	30068891	2	O
study	30068891	2	O
shows	30068891	2	O
the	30068891	2	O
heterogeneous	30068891	2	O
nature	30068891	2	O
of	30068891	2	O
diabetes	30068891	2	O
in	30068891	2	O
a	30068891	2	O
family	30068891	2	O
with	30068891	2	O
a	30068891	2	O
gain	30068891	2	O
-	30068891	2	O
of	30068891	2	O
-	30068891	2	O
function	30068891	2	O
mutation	30068891	2	O
in	30068891	2	O
the	30068891	2	O
ABCC8	30068891	2	O
gene	30068891	2	O
.	30068891	2	O

Activating	30094493	2	O
human	30094493	2	O
epidermal	30094493	2	O
growth	30094493	2	O
factor	30094493	2	O
receptor	30094493	2	O
2	30094493	2	O
(	30094493	2	O
HER2	30094493	2	O
)	30094493	2	O
gene	30094493	2	O
mutation	30094493	2	O
in	30094493	2	O
bone	30094493	2	O
metastases	30094493	2	O
from	30094493	2	O
breast	30094493	2	O
cancer	30094493	2	O
.	30094493	2	O
In	30094493	2	O
addition	30094493	2	O
to	30094493	2	O
amplification	30094493	2	O
,	30094493	2	O
point	30094493	2	B-Var
mutations	30094493	2	I-Var
of	30094493	2	O
the	30094493	2	O
human	30094493	2	O
epidermal	30094493	2	O
growth	30094493	2	O
factor	30094493	2	O
receptor	30094493	2	O
2	30094493	2	O
(	30094493	2	O
HER2	30094493	2	O
)	30094493	2	O
gene	30094493	2	O
(	30094493	2	B-Gene
ERBB2	30094493	2	I-Gene
)	30094493	2	I-Gene
have	30094493	2	O
been	30094493	2	O
shown	30094493	2	O
to	30094493	2	O
activate	30094493	2	B-PosReg
the	30094493	2	O
corresponding	30094493	2	O
signaling	30094493	2	O
pathway	30094493	2	O
in	30094493	2	O
breast	30094493	2	B-Disease
cancer	30094493	2	I-Disease
.	30094493	2	O
The	30094493	2	O
prevalence	30094493	2	O
of	30094493	2	O
ERBB2	30094493	2	O
/	30094493	2	O
HER2	30094493	2	O
mutation	30094493	2	O
in	30094493	2	O
bone	30094493	2	O
metastasis	30094493	2	O
of	30094493	2	O
breast	30094493	2	O
cancer	30094493	2	O
and	30094493	2	O
the	30094493	2	O
associated	30094493	2	O
phenotype	30094493	2	O
are	30094493	2	O
not	30094493	2	O
known	30094493	2	O
.	30094493	2	O
In	30094493	2	O
this	30094493	2	O
study	30094493	2	O
,	30094493	2	O
bone	30094493	2	O
metastases	30094493	2	O
from	30094493	2	O
breast	30094493	2	O
cancer	30094493	2	O
patients	30094493	2	O
(	30094493	2	O
n	30094493	2	O
=	30094493	2	O
231	30094493	2	O
)	30094493	2	O
were	30094493	2	O
analyzed	30094493	2	O
for	30094493	2	O
ERBB2	30094493	2	O
/	30094493	2	O
HER2	30094493	2	O
mutation	30094493	2	O
.	30094493	2	O
In	30094493	2	O
7	30094493	2	O
patients	30094493	2	O
(	30094493	2	O
3%	30094493	2	O
;	30094493	2	O
median	30094493	2	O
age	30094493	2	O
70	30094493	2	O
years	30094493	2	O
,	30094493	2	O
range	30094493	2	O
50	30094493	2	O
-	30094493	2	O
83	30094493	2	O
years	30094493	2	O
)	30094493	2	O
,	30094493	2	O
gain	30094493	2	O
-	30094493	2	O
of	30094493	2	O
-	30094493	2	O
function	30094493	2	O
mutations	30094493	2	O
of	30094493	2	O
ERBB2	30094493	2	O
/	30094493	2	O
HER2	30094493	2	O
were	30094493	2	O
detected	30094493	2	O
.	30094493	2	O
The	30094493	2	O
most	30094493	2	O
frequent	30094493	2	O
mutation	30094493	2	O
was	30094493	2	O
p.L755S	30094493	2	O
(	30094493	2	O
71%	30094493	2	O
)	30094493	2	O
.	30094493	2	O
In	30094493	2	O
29%	30094493	2	O
of	30094493	2	O
mutated	30094493	2	O
cases	30094493	2	O
,	30094493	2	O
p.V777L	30094493	2	O
was	30094493	2	O
found	30094493	2	O
.	30094493	2	O
Mutation	30094493	2	O
frequency	30094493	2	O
was	30094493	2	O
4.4%	30094493	2	O
in	30094493	2	O
the	30094493	2	O
lobular	30094493	2	O
subgroup	30094493	2	O
and	30094493	2	O
17.4%	30094493	2	O
in	30094493	2	O
the	30094493	2	O
pleomorphic	30094493	2	O
subtype	30094493	2	O
of	30094493	2	O
lobular	30094493	2	O
cancer	30094493	2	O
(	30094493	2	O
n	30094493	2	O
=	30094493	2	O
23	30094493	2	O
)	30094493	2	O
,	30094493	2	O
respectively	30094493	2	O
.	30094493	2	O
Among	30094493	2	O
the	30094493	2	O
14%	30094493	2	O
of	30094493	2	O
metastatic	30094493	2	O
luminal	30094493	2	O
cancers	30094493	2	O
with	30094493	2	O
estrogen	30094493	2	O
receptor	30094493	2	O
gene	30094493	2	O
(	30094493	2	O
ESR1	30094493	2	O
)	30094493	2	O
mutation	30094493	2	O
,	30094493	2	O
conveying	30094493	2	O
resistance	30094493	2	O
against	30094493	2	O
aromatase	30094493	2	O
inhibitors	30094493	2	O
,	30094493	2	O
no	30094493	2	O
concomitant	30094493	2	O
ERBB2	30094493	2	O
/	30094493	2	O
HER2	30094493	2	O
mutation	30094493	2	O
occurred	30094493	2	O
.	30094493	2	O
We	30094493	2	O
conclude	30094493	2	O
that	30094493	2	O
activating	30094493	2	B-PosReg
HER2	30094493	2	B-Gene
mutation	30094493	2	B-Var
is	30094493	2	O
present	30094493	2	O
in	30094493	2	O
about	30094493	2	O
3%	30094493	2	O
of	30094493	2	O
bone	30094493	2	O
metastases	30094493	2	O
from	30094493	2	O
breast	30094493	2	B-Disease
cancers	30094493	2	I-Disease
,	30094493	2	O
with	30094493	2	O
significantly	30094493	2	O
higher	30094493	2	B-PosReg
rates	30094493	2	I-PosReg
in	30094493	2	O
the	30094493	2	O
pleomorphic	30094493	2	O
subtype	30094493	2	O
of	30094493	2	O
lobular	30094493	2	O
cancer	30094493	2	O
.	30094493	2	O

A	30144815	4	O
novel	30144815	4	O
MFSD8	30144815	4	B-Gene
mutation	30144815	4	B-Var
in	30144815	4	O
a	30144815	4	O
Russian	30144815	4	O
patient	30144815	4	O
with	30144815	4	B-Reg
neuronal	30144815	4	B-Disease
ceroid	30144815	4	I-Disease
lipofuscinosis	30144815	4	I-Disease
type	30144815	4	O
7	30144815	4	O
:	30144815	4	O
a	30144815	4	O
case	30144815	4	O
report	30144815	4	O
.	30144815	4	O
To	30144815	4	O
date	30144815	4	O
more	30144815	4	O
than	30144815	4	O
440	30144815	4	O
NCL	30144815	4	O
-	30144815	4	O
causing	30144815	4	O
mutations	30144815	4	O
in	30144815	4	O
13	30144815	4	O
genes	30144815	4	O
are	30144815	4	O
known	30144815	4	O
.	30144815	4	O
We	30144815	4	O
identified	30144815	4	O
a	30144815	4	O
novel	30144815	4	O
homozygous	30144815	4	O
mutation	30144815	4	O
in	30144815	4	O
MFSD8	30144815	4	O
gene	30144815	4	O
(	30144815	4	O
c.525	30144815	4	O
T	30144815	4	O
>	30144815	4	O
A	30144815	4	O
,	30144815	4	O
p.Cys175Ter	30144815	4	O
)	30144815	4	O
.	30144815	4	O
To	30144815	4	O
our	30144815	4	O
knowledge	30144815	4	O
,	30144815	4	O
this	30144815	4	O
is	30144815	4	O
the	30144815	4	O
first	30144815	4	O
report	30144815	4	O
of	30144815	4	O
MFSD8	30144815	4	O
gene	30144815	4	O
mutation	30144815	4	O
in	30144815	4	O
a	30144815	4	O
Russian	30144815	4	O
patient	30144815	4	O
with	30144815	4	O
variant	30144815	4	O
late	30144815	4	O
-	30144815	4	O
infantile	30144815	4	O
NCL	30144815	4	O
.	30144815	4	O
Also	30144815	4	O
we	30144815	4	O
confirmed	30144815	4	O
that	30144815	4	O
NCL	30144815	4	O
should	30144815	4	O
be	30144815	4	O
suspected	30144815	4	O
in	30144815	4	O
patients	30144815	4	O
with	30144815	4	O
Rett	30144815	4	O
-	30144815	4	O
like	30144815	4	O
phenotype	30144815	4	O
at	30144815	4	O
onset	30144815	4	O
and	30144815	4	O
negative	30144815	4	O
MECP2	30144815	4	O
mutation	30144815	4	O
.	30144815	4	O

Heterozygotes	30187709	2	O
for	30187709	2	O
gain	30187709	2	B-PosReg
-	30187709	2	I-PosReg
of	30187709	2	I-PosReg
-	30187709	2	I-PosReg
function	30187709	2	I-PosReg
(	30187709	2	O
GOF	30187709	2	O
)	30187709	2	O
alleles	30187709	2	B-Var
of	30187709	2	O
the	30187709	2	O
STAT1	30187709	2	B-Gene
gene	30187709	2	O
usually	30187709	2	O
display	30187709	2	O
autosomal	30187709	2	B-Disease
dominant	30187709	2	I-Disease
chronic	30187709	2	I-Disease
mucocutaneous	30187709	2	I-Disease
candidiasis	30187709	2	I-Disease
(	30187709	2	O
CMC	30187709	2	O
)	30187709	2	O
and	30187709	2	O
a	30187709	2	O
wide	30187709	2	O
range	30187709	2	O
of	30187709	2	O
clinical	30187709	2	O
features	30187709	2	O
,	30187709	2	O
such	30187709	2	O
as	30187709	2	O
bronchiectasis	30187709	2	B-Disease
.	30187709	2	O
Whole	30187709	2	O
-	30187709	2	O
exome	30187709	2	O
sequencing	30187709	2	O
revealed	30187709	2	B-Reg
a	30187709	2	O
c.800	30187709	2	B-Var
C	30187709	2	I-Var
>	30187709	2	I-Var
T	30187709	2	I-Var
(	30187709	2	O
p.Ala267Val	30187709	2	O
)	30187709	2	O
heterozygous	30187709	2	O
mutation	30187709	2	O
in	30187709	2	O
the	30187709	2	O
STAT1	30187709	2	B-Gene
gene	30187709	2	O
.	30187709	2	O
This	30187709	2	O
is	30187709	2	O
the	30187709	2	O
first	30187709	2	O
report	30187709	2	O
of	30187709	2	O
a	30187709	2	O
Korean	30187709	2	O
patient	30187709	2	O
with	30187709	2	O
a	30187709	2	O
GOF	30187709	2	O
pathogenic	30187709	2	O
variant	30187709	2	O
in	30187709	2	O
STAT1	30187709	2	O
.	30187709	2	O

Mutations	30296255	4	B-Var
in	30296255	4	O
Cu	30296255	4	O
/	30296255	4	O
Zn	30296255	4	O
superoxide	30296255	4	O
dismutase	30296255	4	O
1	30296255	4	O
(	30296255	4	B-Gene
SOD1	30296255	4	I-Gene
)	30296255	4	I-Gene
lead	30296255	4	B-Reg
to	30296255	4	I-Reg
Amyotrophic	30296255	4	B-Disease
Lateral	30296255	4	I-Disease
Sclerosis	30296255	4	I-Disease
(	30296255	4	O
ALS	30296255	4	O
)	30296255	4	O
,	30296255	4	O
a	30296255	4	O
neurodegenerative	30296255	4	O
disease	30296255	4	O
that	30296255	4	O
disproportionately	30296255	4	O
affects	30296255	4	O
glutamatergic	30296255	4	O
and	30296255	4	O
cholinergic	30296255	4	O
motor	30296255	4	O
neurons	30296255	4	O
.	30296255	4	O
Introduction	30296255	4	O
of	30296255	4	O
ALS	30296255	4	O
patient	30296255	4	O
amino	30296255	4	O
acid	30296255	4	O
changes	30296255	4	O
A4V	30296255	4	O
,	30296255	4	O
H71Y	30296255	4	O
,	30296255	4	O
L84V	30296255	4	O
,	30296255	4	O
G85R	30296255	4	O
or	30296255	4	O
G93A	30296255	4	O
into	30296255	4	O
the	30296255	4	O
C.	30296255	4	O
elegans	30296255	4	O
sod-1	30296255	4	O
gene	30296255	4	O
yielded	30296255	4	O
single	30296255	4	O
-	30296255	4	O
copy	30296255	4	O
/	30296255	4	O
knock	30296255	4	O
-	30296255	4	O
in	30296255	4	O
ALS	30296255	4	O
SOD1	30296255	4	O
models	30296255	4	O
.	30296255	4	O
A4V	30296255	4	O
,	30296255	4	O
H71Y	30296255	4	O
,	30296255	4	O
G85R	30296255	4	O
,	30296255	4	O
and	30296255	4	O
G93A	30296255	4	O
animals	30296255	4	O
showed	30296255	4	O
increased	30296255	4	O
SOD1	30296255	4	O
protein	30296255	4	O
accumulation	30296255	4	O
and	30296255	4	O
oxidative	30296255	4	O
stress	30296255	4	O
induced	30296255	4	O
degeneration	30296255	4	O
,	30296255	4	O
consistent	30296255	4	O
with	30296255	4	O
a	30296255	4	O
toxic	30296255	4	O
gain	30296255	4	O
of	30296255	4	O
function	30296255	4	O
in	30296255	4	O
cholinergic	30296255	4	O
motor	30296255	4	O
neurons	30296255	4	O
.	30296255	4	O
By	30296255	4	O
contrast	30296255	4	O
,	30296255	4	O
H71Y	30296255	4	O
,	30296255	4	O
L84V	30296255	4	O
,	30296255	4	O
and	30296255	4	O
G85R	30296255	4	O
lead	30296255	4	O
to	30296255	4	O
glutamatergic	30296255	4	O
neuron	30296255	4	O
degeneration	30296255	4	O
due	30296255	4	O
to	30296255	4	O
sod-1	30296255	4	O
loss	30296255	4	O
of	30296255	4	O
function	30296255	4	O
after	30296255	4	O
oxidative	30296255	4	O
stress	30296255	4	O
.	30296255	4	O

A	30361506	1	O
homozygous	30361506	1	O
loss	30361506	1	B-NegReg
-	30361506	1	I-NegReg
of	30361506	1	I-NegReg
-	30361506	1	I-NegReg
function	30361506	1	I-NegReg
mutation	30361506	1	B-Var
leading	30361506	1	O
to	30361506	1	O
CYBC1	30361506	1	B-Gene
deficiency	30361506	1	O
causes	30361506	1	O
chronic	30361506	1	B-Disease
granulomatous	30361506	1	I-Disease
disease	30361506	1	I-Disease
.	30361506	1	O
Mutations	30361506	1	B-Var
in	30361506	1	O
genes	30361506	1	O
encoding	30361506	1	O
subunits	30361506	1	O
of	30361506	1	O
the	30361506	1	O
phagocyte	30361506	1	O
NADPH	30361506	1	O
oxidase	30361506	1	O
complex	30361506	1	O
are	30361506	1	O
recognized	30361506	1	O
to	30361506	1	O
cause	30361506	1	B-Reg
chronic	30361506	1	B-Disease
granulomatous	30361506	1	I-Disease
disease	30361506	1	I-Disease
(	30361506	1	O
CGD	30361506	1	O
)	30361506	1	O
,	30361506	1	O
a	30361506	1	O
severe	30361506	1	O
primary	30361506	1	O
immunodeficiency	30361506	1	O
.	30361506	1	O
Analyzing	30361506	1	O
two	30361506	1	O
brothers	30361506	1	O
diagnosed	30361506	1	O
with	30361506	1	O
CGD	30361506	1	O
we	30361506	1	O
identify	30361506	1	O
a	30361506	1	O
homozygous	30361506	1	O
loss	30361506	1	B-NegReg
-	30361506	1	I-NegReg
of	30361506	1	I-NegReg
-	30361506	1	I-NegReg
function	30361506	1	I-NegReg
mutation	30361506	1	O
,	30361506	1	O
p.Tyr2Ter	30361506	1	B-Var
,	30361506	1	O
in	30361506	1	O
CYBC1	30361506	1	B-Gene
.	30361506	1	O
Imputation	30361506	1	O
of	30361506	1	O
p.Tyr2Ter	30361506	1	O
into	30361506	1	O
155	30361506	1	O
K	30361506	1	O
chip	30361506	1	O
-	30361506	1	O
genotyped	30361506	1	O
Icelanders	30361506	1	O
reveals	30361506	1	O
six	30361506	1	O
additional	30361506	1	O
homozygotes	30361506	1	O
,	30361506	1	O
all	30361506	1	O
with	30361506	1	O
signs	30361506	1	O
of	30361506	1	O
CGD	30361506	1	O
,	30361506	1	O
manifesting	30361506	1	O
as	30361506	1	O
colitis	30361506	1	O
,	30361506	1	O
rare	30361506	1	O
infections	30361506	1	O
,	30361506	1	O
or	30361506	1	O
a	30361506	1	O
severely	30361506	1	O
impaired	30361506	1	O
PMA	30361506	1	O
-	30361506	1	O
induced	30361506	1	O
neutrophil	30361506	1	O
oxidative	30361506	1	O
burst	30361506	1	O
.	30361506	1	O
Homozygosity	30361506	1	O
for	30361506	1	O
p.Tyr2Ter	30361506	1	B-Var
consequently	30361506	1	O
associates	30361506	1	B-Reg
with	30361506	1	I-Reg
inflammatory	30361506	1	B-Disease
bowel	30361506	1	I-Disease
disease	30361506	1	I-Disease
(	30361506	1	O
IBD	30361506	1	O
)	30361506	1	O
in	30361506	1	O
Iceland	30361506	1	O
(	30361506	1	O
P	30361506	1	O
=	30361506	1	O
8.3	30361506	1	O
10	30361506	1	O
-	30361506	1	O
8	30361506	1	O
;	30361506	1	O
OR	30361506	1	O
=	30361506	1	O
67.6	30361506	1	O
)	30361506	1	O
,	30361506	1	O
as	30361506	1	O
well	30361506	1	O
as	30361506	1	O
reduced	30361506	1	O
height	30361506	1	O
(	30361506	1	O
P	30361506	1	O
=	30361506	1	O
3.3	30361506	1	O
10	30361506	1	O
-	30361506	1	O
4	30361506	1	O
;	30361506	1	O
-	30361506	1	O
8.5	30361506	1	O
cm	30361506	1	O
)	30361506	1	O
.	30361506	1	O

Exposures	30535219	1	O
:	30535219	1	O
Loss	30535219	1	O
-	30535219	1	O
of	30535219	1	O
-	30535219	1	O
function	30535219	1	O
(	30535219	1	O
LOF	30535219	1	O
)	30535219	1	O
variants	30535219	1	O
in	30535219	1	O
genes	30535219	1	O
at	30535219	1	O
AF	30535219	1	O
loci	30535219	1	O
and	30535219	1	O
common	30535219	1	O
genetic	30535219	1	O
variation	30535219	1	O
across	30535219	1	O
the	30535219	1	O
whole	30535219	1	O
genome	30535219	1	O
.	30535219	1	O
At	30535219	1	O
least	30535219	1	O
1	30535219	1	O
LOF	30535219	1	O
variant	30535219	1	O
in	30535219	1	O
TTN	30535219	1	O
,	30535219	1	O
the	30535219	1	O
gene	30535219	1	O
encoding	30535219	1	O
the	30535219	1	O
sarcomeric	30535219	1	O
protein	30535219	1	O
titin	30535219	1	O
,	30535219	1	O
was	30535219	1	O
present	30535219	1	O
in	30535219	1	O
2.1%	30535219	1	O
of	30535219	1	O
case	30535219	1	O
participants	30535219	1	O
compared	30535219	1	O
with	30535219	1	O
1.1%	30535219	1	O
in	30535219	1	O
control	30535219	1	O
participants	30535219	1	O
(	30535219	1	O
odds	30535219	1	O
ratio	30535219	1	O
[	30535219	1	O
OR	30535219	1	O
]	30535219	1	O
,	30535219	1	O
1.76	30535219	1	O
[	30535219	1	O
95%	30535219	1	O
CI	30535219	1	O
,	30535219	1	O
1.04	30535219	1	O
-	30535219	1	O
2.97	30535219	1	O
]	30535219	1	O
)	30535219	1	O
.	30535219	1	O
The	30535219	1	O
proportion	30535219	1	O
of	30535219	1	O
individuals	30535219	1	O
with	30535219	1	O
early	30535219	1	B-Disease
-	30535219	1	I-Disease
onset	30535219	1	I-Disease
AF	30535219	1	I-Disease
who	30535219	1	O
carried	30535219	1	O
a	30535219	1	O
LOF	30535219	1	B-PosReg
variant	30535219	1	B-Var
in	30535219	1	O
TTN	30535219	1	B-Gene
increased	30535219	1	B-PosReg
with	30535219	1	O
an	30535219	1	O
earlier	30535219	1	O
age	30535219	1	O
of	30535219	1	O
AF	30535219	1	O
onset	30535219	1	O
(	30535219	1	O
P	30535219	1	O
value	30535219	1	O
for	30535219	1	O
trend	30535219	1	O
,	30535219	1	O
4.92	30535219	1	O
10	30535219	1	O
-	30535219	1	O
4	30535219	1	O
)	30535219	1	O
,	30535219	1	O
and	30535219	1	O
6.5%	30535219	1	O
of	30535219	1	O
individuals	30535219	1	O
with	30535219	1	O
AF	30535219	1	O
onset	30535219	1	O
prior	30535219	1	O
to	30535219	1	O
age	30535219	1	O
30	30535219	1	O
carried	30535219	1	O
a	30535219	1	O
TTN	30535219	1	O
LOF	30535219	1	O
variant	30535219	1	O
(	30535219	1	O
OR	30535219	1	O
,	30535219	1	O
5.94	30535219	1	O
[	30535219	1	O
95%	30535219	1	O
CI	30535219	1	O
,	30535219	1	O
2.64	30535219	1	O
-	30535219	1	O
13.35	30535219	1	O
]	30535219	1	O
;	30535219	1	O
P	30535219	1	O
=	30535219	1	O
1.65	30535219	1	O
10	30535219	1	O
-	30535219	1	O
5	30535219	1	O
)	30535219	1	O
.	30535219	1	O
The	30535219	1	O
association	30535219	1	O
between	30535219	1	O
TTN	30535219	1	O
LOF	30535219	1	O
variants	30535219	1	O
and	30535219	1	O
AF	30535219	1	O
was	30535219	1	O
replicated	30535219	1	O
in	30535219	1	O
an	30535219	1	O
independent	30535219	1	O
study	30535219	1	O
of	30535219	1	O
1582	30535219	1	O
patients	30535219	1	O
with	30535219	1	O
early	30535219	1	O
-	30535219	1	O
onset	30535219	1	O
AF	30535219	1	O
(	30535219	1	O
cases	30535219	1	O
)	30535219	1	O
and	30535219	1	O
41	30535219	1	O
200	30535219	1	O
control	30535219	1	O
participants	30535219	1	O
(	30535219	1	O
OR	30535219	1	O
,	30535219	1	O
2.16	30535219	1	O
[	30535219	1	O
95%	30535219	1	O
CI	30535219	1	O
,	30535219	1	O
1.19	30535219	1	O
-	30535219	1	O
3.92	30535219	1	O
]	30535219	1	O
;	30535219	1	O
P	30535219	1	O
=	30535219	1	O
.01	30535219	1	O
)	30535219	1	O
.	30535219	1	O
Conclusions	30535219	1	O
and	30535219	1	O
Relevance	30535219	1	O
:	30535219	1	O
In	30535219	1	O
a	30535219	1	O
case	30535219	1	O
-	30535219	1	O
control	30535219	1	O
study	30535219	1	O
,	30535219	1	O
there	30535219	1	O
was	30535219	1	O
a	30535219	1	O
statistically	30535219	1	O
significant	30535219	1	B-Reg
association	30535219	1	I-Reg
between	30535219	1	O
an	30535219	1	O
LOF	30535219	1	B-NegReg
variant	30535219	1	B-Var
in	30535219	1	O
the	30535219	1	O
TTN	30535219	1	B-Gene
gene	30535219	1	O
and	30535219	1	O
early	30535219	1	B-Disease
-	30535219	1	I-Disease
onset	30535219	1	I-Disease
AF	30535219	1	I-Disease
,	30535219	1	O
with	30535219	1	O
the	30535219	1	O
variant	30535219	1	O
present	30535219	1	O
in	30535219	1	O
a	30535219	1	O
small	30535219	1	O
percentage	30535219	1	O
of	30535219	1	O
participants	30535219	1	O
with	30535219	1	O
early	30535219	1	O
-	30535219	1	O
onset	30535219	1	O
AF	30535219	1	O
(	30535219	1	O
the	30535219	1	O
case	30535219	1	O
group	30535219	1	O
)	30535219	1	O
.	30535219	1	O

Loss	30683861	1	B-NegReg
-	30683861	1	I-NegReg
of	30683861	1	I-NegReg
-	30683861	1	I-NegReg
function	30683861	1	I-NegReg
mutations	30683861	1	B-Var
in	30683861	1	O
QRICH2	30683861	1	B-Gene
cause	30683861	1	B-Reg
male	30683861	1	B-Disease
infertility	30683861	1	I-Disease
with	30683861	1	O
multiple	30683861	1	O
morphological	30683861	1	O
abnormalities	30683861	1	O
of	30683861	1	O
the	30683861	1	O
sperm	30683861	1	O
flagella	30683861	1	O
.	30683861	1	O
Here	30683861	1	O
,	30683861	1	O
we	30683861	1	O
identify	30683861	1	O
and	30683861	1	O
functionally	30683861	1	O
characterize	30683861	1	O
homozygous	30683861	1	O
loss	30683861	1	O
-	30683861	1	O
of	30683861	1	O
-	30683861	1	O
function	30683861	1	O
mutations	30683861	1	O
of	30683861	1	O
QRICH2	30683861	1	O
in	30683861	1	O
two	30683861	1	O
infertile	30683861	1	O
males	30683861	1	O
with	30683861	1	O
MMAF	30683861	1	O
from	30683861	1	O
two	30683861	1	O
consanguineous	30683861	1	O
families	30683861	1	O
.	30683861	1	O
Our	30683861	1	O
findings	30683861	1	O
strongly	30683861	1	O
suggest	30683861	1	O
that	30683861	1	O
the	30683861	1	O
genetic	30683861	1	O
mutations	30683861	1	B-Var
of	30683861	1	O
human	30683861	1	O
QRICH2	30683861	1	B-Gene
can	30683861	1	O
lead	30683861	1	B-Reg
to	30683861	1	I-Reg
male	30683861	1	B-Disease
infertility	30683861	1	I-Disease
with	30683861	1	O
MMAF	30683861	1	O
and	30683861	1	O
that	30683861	1	O
QRICH2	30683861	1	O
is	30683861	1	O
essential	30683861	1	O
for	30683861	1	O
sperm	30683861	1	O
flagellar	30683861	1	O
formation	30683861	1	O
.	30683861	1	O
